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Chapter I 
 
INTRODUCTION 
 
Respiratory syncytial virus 
Respiratory syncytial virus (RSV) is a leading cause of serious viral lower 
respiratory tract (LRT) illness in infants (41) and the elderly worldwide (25). RSV infects 
4-5 million children each year, and with more than 125,000 admitted to the hospital in the 
US, RSV is the leading cause of hospitalization in children less than one year old (40). 
Although mortality is only 1% among admitted infants, infants with chronic lung disease, 
congenital heart disease, or marked prematurity are at higher risk of increased length of 
hospitalization and increased mortality (53). Globally, RSV causes more than 30 million 
LRT infections annually, resulting in more than 3 million hospitalizations (40). RSV is 
also an important cause of LRT infections in adults with cardiopulmonary disease, severe 
combined immunodeficiency, or following transplantation (21, 24, 40). 
RSV illness presents primarily as bronchiolitis or pneumonia with peak incidence 
between the ages of 2-8 months. Most children have been infected by the age of 3 years, 
and reinfection is common but is often limited to the upper respiratory tract (53). Therapy 
for RSV infection is limited to supportive care, including supplemental oxygen, 
mechanical ventilation, and fluid replacement. Ribavirin, a purine RNA analog, may be 
used in severe cases of RSV infection. In high-risk infants, passively administered 
antibody (Synagis ®, palivizumab) is effective for prophylaxis but not therapy (53).  
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Due to the high morbidity and mortality associated with RSV infection and the 
lack of available therapies, an RSV vaccine is of high priority. However, RSV presents a 
unique challenge for vaccine development, including age of first infection, immune 
evasion, and the legacy of a failed clinical trial using a formalin-inactivated (FI) whole 
virus vaccine. Immunization of children with the FI-RSV actually resulted in exacerbated 
disease, with increased rates of hospitalization and mortality (20, 51). Current vaccine 
efforts for pediatric populations are largely focused on live-attenuated strains, produced 
by either serial passage in the cold or generated using recombinant virus systems (21). 
Live-attenuated vaccines, however, are often too restricted for replication in older 
populations that have previously been exposed to RSV (37). Vaccine strategies in these 
populations include subunit vaccines, virus-like particle (VLP) vaccines, and both 
replication-competent and defective gene-base vectors (21, 40). While many strategies 
are being explored, further insights into the biology of the virus and its interaction with 
the host may contribute to vaccine development or targeted therapeutics.  
 
RSV proteins and the life cycle 
RSV was isolated from chimpanzees with upper respiratory tract infections in 
1956. The virus is a member of the Paramyxoviridae family, subfamily Pneumovirinae, 
with a single-stranded, negative-sense RNA genome encoding 11 proteins. Figure 1-1 
shows a schematic of a filamentous RSV virion consisting of a lipid membrane that is 
derived from the host cell and three glycoproteins: fusion (F) protein, attachment (G) 
protein, and small hydrophobic (SH) protein. The F protein mediates viral fusion with the 
cellular membrane. The G protein plays a role in viral attachment, and SH protein is  
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Figure 1-1. Schematic of RSV filamentous virion. RSV F (blue), G (red), SH (green) 
are depicted on the surface of the virion as transmembrane proteins, while M (yellow) 
and the viral RNP complex (black) are shown on the interior of the viral particle. Figure 
provided by Thomas Utley. 
 
  
F
G
SH
M
Ribonucleprotein complex
(N, P, M2-1, L, -ssRNA)
Figure 1-1. Schematic of RSV filamentous virion. RSV F (blue), G (red), SH (green) 
are depicted on the surface of the virion as transmembrane proteins, while M (yellow) and 
the viral RNP complex (black) are shown on the interior of the viral particle. Figure 
provided by Tom Utley.
	   4 
thought to inhibit apoptosis (31). RSV also contains six internal structural proteins: 
matrix (M) protein, nucleoprotein (N), phosphoprotein (P), large (L) polymerase protein, 
and two isoforms of matrix protein 2 (M2-1 and M2-1). The M protein provides the 
structural framework for the virus particle. RSV N, P, and L form the ribonucleoprotein 
(RNP) complex, which encapsidates the RSV genome, and functions as the RNA-
dependent RNA polymerase. M2-1 and M2-2 are accessory proteins that control 
transcription and translation (103). RSV also encodes two non-structural proteins, NS1 
and NS2, which inhibit interferon induction, interferon signaling, and apoptosis (21). 
Figure 1-2 shows a transmission electron micrograph of an assembling virion at the cell 
surface and provides a summary of the function of each viral protein (21).  
RSV infects the apical surface of polarized lung epithelial cells (Figure 1-3). Infection 
begins with attachment of the virion to the cell membrane, a process that is mediated by 
the F and G proteins. Low-affinity interaction with cellular glycosaminoglycans, 
particularly heparin sulfate (26, 54), are thought to stabilize the virion on the cell surface 
so that F can specifically interact with nucleolin (89). Although nucleolin is sufficient for 
infection of non-permissive cells, the trigger for virus-cell fusion is unknown. The F 
protein is sufficient for fusion in vitro, but other cellular proteins may play a role (5, 60, 
94). After fusion, the viral genome and viral RNA-dependent RNA polymerase, 
consisting of N, P, L, and M2-1, are released into the cytoplasm. The viral polymerase 
begins making viral transcripts for each viral protein in the cytoplasm, which is followed 
by translation using the host ribosomal machinery (103). The viral glycoproteins are 
thought to traffic through the secretory pathway to the apical surface of polarized 
epithelial cells, while the internal proteins are translated in the cytoplasm (10). 
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Figure 1-2. RSV proteins and their role in viral replication. Panel A shows a 
negatively stained transmission electron micrograph of RSV virions assembling and 
budding from the cell membrane. Individual proteins and their functions are indicated. 
Panel B shows a schematic of the viral genome is shown. The amino acid length of each 
protein is indicated above each gene. Figure was originally published by Collins and 
Melero, 2001 (21).   
i re 1-2. RSV proteins and their role in viral replication. Panel A shows a negatively stained 
tranmission electron micrograph of RSV virions assembling and budding from the cell mem-
rane. Individual proteins and their functions are indicated. Pan l B shows a sch mati  of the 
viral genome i  shown. The amino acid length of ach protein is indicated above eac  gene. 
Figure repro u ed from a published r view a ticle. 
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Upon accumulation of viral proteins, the viral polymerase switches from 
transcription to viral replication, a process thought to be controlled by M2-2. Viral 
proteins accumulate in the cytoplasm in discrete aggregates, termed inclusion bodies. 
These viral inclusion bodies contain RSV M, N, P, L, M2-1 and -2 proteins and the 
vRNA (55, 57). It is suspected that the ribonucleoprotein (RNP) complexes form in the 
inclusions and then traffic to the apical membrane, where they meet with the surface 
glycoproteins F, G, and SH arriving from the Golgi apparatus through the secretory 
pathway (9). RSV proteins and viral RNA assemble into virus filaments at the apical cell 
surface (77). These filaments are thought to contribute to cell-cell spread of the virus and 
morphologically resemble the filamentous form of virions seen in EM studies of virus 
produced in polarized cells (97). Live imaging has shown these structures to be dynamic, 
with rotation and directional movement (3, 80). Membrane scission is thought to occur in 
a Vps4-independent manner (97), resulting in pleomorphic particles ranging from 150-
250 nm in diameter for spherical forms and up to 10 µm long in filamentous forms (4).  
 
RSV assembly and budding 
 To produce progeny virions, RSV must coordinate assembly between proteins 
translated in the cytoplasm, glycoproteins that have trafficked to the cell surface through 
the secretory pathway, and the newly synthesized genomic RNA. RNP assembly is 
thought to occur within the viral inclusion bodies since the viral polymerase proteins and 
genomic RNA are found to co-localize at these structures (57). However, it is unknown 
how the RNP complex traffics to the cell surface to meet with the other viral proteins at 
the cell surface. When the M protein is not present, N and P accumulate in viral inclusion  
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Figure 1-3 Diagram of the RSV life cycle. (1) The RSV virion attaches to the epithelial 
cell. (2) The viral ribonucleoprotein complex is delivered to the cytoplasm. (3) The 
genome is transcribed into viral mRNAs, which are then translated on host ribosomes (4) 
either at the endoplasmic reticulum for the glycoproteins or free cytoplasmic ribosomes. 
(5) A switch occurs from transcription to replication of the viral genome. (6) 
Glycoproteins are trafficked from the endoplasmic reticulum to the Golgi apparatus 
where they are modified. (7) All the virion components must be trafficked to the apical 
membrane. (8) Assembled virions bud from the infected cell. Figure provided by Thomas 
Utley 
Figure 1-3 Diagram of the RSV life cycle.  (1) The RSV virion attaches to the cell.  
(2) The viral ribonucleoprotein complex is delivered to the cyt plasm.  (3) The genome is 
transcribed into viral mRNAs, which are then translated on host ribosomes (4) either at the 
endoplasmic reticulum for the glycoproteins or free cytoplasmic ribosomes.  (5) A 
switch occurs from transcription to replication of the viral genome.  (6) glycoproteins are 
trafficked from the ER to the Golgi apparatus where they are modified.  (7) All the virion 
components must be trafficked to the apical membrane.  (8) Assembled virions bud from 
the infected cell. Figure provided by Tom Utley
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bodies and viral filaments do not form, suggesting that M might be responsible for 
trafficking the RNP complex to the cell surface (64). This hypothesis is consistent with 
the observation of M colocalization with N in inclusion bodies and co-precipitation with 
RNP complexes (33, 95). RSV M has been shown to associate with the plasma membrane 
(61) and specifically sorts into detergent-resistant membranes when F is present (44). M 
has two distinct domains that have a large positively charged surface, allowing it to 
interact with phospholipids (43, 66). In contrast, specific residues in the cytoplasmic 
domain of G affect M colocalization with G. However, G is not essential for the 
generation of progeny virus, and M can localize with F in the absence of G. Thus, M may 
associate with both F and G independently (34). Furthermore, F and G form a complex at 
the cell surface that is detectable by immunoprecipitation (59). These data suggest a 
model for RSV assembly in which viral polymerase proteins produce nascent genomic 
RNA in inclusion bodies in the cytoplasm and form the RNP complex. The RNP complex 
can then associate with M, which is capable of associating with the plasma membrane, F, 
and G at the cell surface, carrying along the RNP complex to that site. 
 Localization of viral proteins to the cell surface, however, is not sufficient for 
viral assembly into filaments. In order for filaments to form, viral proteins must deform 
the host cell membrane outward to initiate bud formation and then elongate the bud 
through the incorporation of additional membrane to create long filaments. To form a free 
particle, a membrane scission event must occur to release the viral particle from the cell 
membrane. All of these processes are energy intensive and require complex coordination 
of surface proteins and nucleocapsids containing RNA and viral proteins (18). Several 
models have been proposed for membrane bending by viral proteins. Figure 1-4 shows 
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how the membrane can be either pulled outward by packing of surface proteins to 
promote positive or negative membrane curvature. The membrane could also be pushed 
outward by internal virion proteins or interactions between viral surface and internal 
proteins, allowing coordination of multiple forces to drive membrane deformation (99). 
Previous work in the field has shown F, M, N, and P to be the minimum requirements for 
passage of a minigenome construct, indicating that these four proteins are the minimum 
requirements for packing vRNA into cell free particles (91). Many other paramyxoviruses 
also require both internal and membrane proteins for budding. For example, 
parainfluenza virus (PIV) 5 and mumps both require M, NP, and a glycoprotein. 
However, other paramyxoviruses require only the M protein for efficient VLP formation, 
e.g. PIV1, Sendai virus, and measles virus (43). Since both internal and surface proteins 
are required, RSV assembly into filaments likely involves a combination of surface and 
internal protein driven forces.  
 The final step in viral assembly and budding involves a membrane scission event 
to sever the assembled viral particle from the host cell membrane. Many viruses 
accomplish this task by usurping host machinery for multivesicular body formation (46). 
Endosomal sorting complex required for transport (ESCRT) proteins utilize a final 
common ATPase Vps4 to perform membrane scission (46). Using dominant-negative 
inhibitors of Vps4, the pathway can be disrupted, resulting in membranous vesicles still 
tethered to the original membrane (82). The use of ESCRT proteins in viral budding has 
been well characterized for many viruses, including HIV and other paramyxoviruses (18). 
However, RSV budding is unaffected by inhibition of Vps4, suggesting that it uses a 
novel mechanism to accomplish membrane scission (97). Furthermore, there is evidence  
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Figure 1-4. Models of virus budding driven by viral proteins. Panel A shows a model 
of viral budding driven by glycoproteins pulling on the host membrane. Panel B shows a 
model of virus budding driven by internal virion proteins pushing outward on the host 
membrane as internal protein oligomerize (I) or by pre-assembled proteins (II). Panel C 
shows both pulling and pushing forces acting in concert to drive viral bud formation. 
Figure was originally published by Welsch et al, 2007. (99). 
  
Figure 1-4. Models of virus budding driven by viral proteins. Panel A shows a model of 
viral budding driven by glycoproteins pulling on the h st membrane. Panel B shows a model of 
virus budding driven by internal virion proteins pushing outward on the host membrane. Panel 
C shows both pulling and pushing forces acing in concert to drive viral bud formation. Figure 
reproduced from a published review article. 
	   11 
that budding for a number of viruses is ESCRT independent (102). Although the 
mechanism for ESCRT independence is unknown for many viruses, influenza appears to 
use a viral protein mediated mechanism to accomplish membrane scission through use of 
an amphipathic helix in the cytoplasmic tail of the M2 protein (78). While it is likely that 
host proteins play some role in viral budding, viral proteins may be sufficient to perform 
membrane scission to produce free virions.  
  
RSV F protein 
 The RSV F protein is a trimeric type I integral membrane protein that traffics 
though the cellular secretory pathway. It is responsible for viral fusion with the host cell 
membrane as well as the characteristic syncytia produced in RSV-infected cultures. The 
F protein has an endoplasmic reticulum (ER) signal sequence, a large ectodomain that 
mediates fusion, a 23-amino-acid transmembrane domain (TM), and 24-amino-acid 
cytoplasmic tail (CT). The non-fusogenic single-chain F0 precursor is cleaved by furin-
like proteases at two sites to produce F1 and F2 which remain connected by disulfide 
bridges (84). Unlike other paramyxovirus F proteins, RSV F does not require other viral 
proteins to fuse membranes (21). Fusion is accomplished through the use of two heptad 
repeats (HR1 and HR2) and a hydrophobic fusion peptide. In the pre-fusion form of the 
protein, the fusion peptide is thought to be sequestered, and HR1 and HR2 are not 
associated. Following an unknown trigger, the fusion peptide is thought to insert in the 
target membrane. The F protein goes through a conformation change in which HR1 
interacts with HR2 to form a six helix bundle in the F trimer. The formation of the six-
helix bundle brings the viral and target membranes together so fusion can occur (23, 84). 
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 Although the fusion function of the F protein has been well characterized, the F 
protein also plays a role in viral assembly. The F protein traffics to the apical surface in 
the absence of other viral proteins or viral RNA. The CT is completely dispensable for 
apical trafficking (10). Deletion of the CT leads to a 100- to 1,000-fold decrease in viral 
titer in a multi-cycle growth assay and results in a virus that is incapable of assembling 
into filaments. Deletion of the CT, however, dos not affect the capacity of the F protein to 
mediate cell-cell fusion, suggesting that the CT plays a role in assembly rather than entry 
(8, 69).  
Coordination of RSV assembly by protein F’s CT is consistent with many other 
studies citing paramyxovirus glycoprotein cytoplasmic tails as crucial to both assembly 
and budding (reviewed in 43). For RSV and HMPV, both members of the Pneumovirus 
subfamily, the G protein is dispensable for viral replication in vitro (6, 92). Although the 
F CT may be sufficient for generation of progeny virions, optimal incorporation of viral 
proteins and RNA might require both F and G since residues in the RSV G protein CT 
are thought to be important for interactions with M (35).  However, for the 
Paramyxoviridae subfamily, the requirement of glycoprotein CTs varies with each virus. 
For measles virus and Sendai virus assembly, the F protein CT is required. Newcastle 
disease virus F and HN glycoproteins interact with different internal viral proteins, M and 
N respectively. In contrast, the F and HN CTs of parainfluenza virus 5 serve somewhat 
redundant functions (43). The lack of a common theme for role of CT domains in 
paramyxoviruses may simply indicate that many questions about the specific mechanisms 
of viral assembly remain unanswered, and further investigation into the RSV F CT may 
contribute to general knowledge regarding glycoprotein CT-mediated viral assembly. 
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RSV interactions with the host membrane  
The formation of RSV particles at the cell surface also requires viral interactions 
with the host cell lipid membrane. The plasma membrane contains regions where lipid 
and protein composition differ from the rest of the plasma membrane. These 
microdomains can serve as platforms for cell signaling, protein trafficking, and other 
cellular functions. Lipid rafts, a type of lipid microdomain, are cholesterol- and 
sphingolipid-enriched regions that often function to concentrate proteins within defined 
regions for a functional purpose (11). Lipid rafts can function as assembly and budding 
platforms for viruses, including HIV-1, Ebola virus, and influenza virus (79).  
Many membrane microdomain studies focus on cholesterol dependence and 
detergent insolubility, such as with Triton X-100, that results in detergent-resistant 
membranes (DRMs). Cholesterol-depletion studies indicate that cholesterol is required 
for viral filament formation but is dispensable for inclusion bodies (101). Inhibiting the 
synthesis of raft-associated phosphatidylinositol 3,4,5-triphosphate [PIP(3)] impairs the 
formation of progeny virus (101). Furthermore, RSV assembles into filaments at lipid 
microdomains that are rich in the lipid-raft ganglioside GM1 (13), and ultrastructural 
analysis indicates that GM1 incorporates into viral filaments (48). RSV proteins localize 
with lipid microdomain-specific dyes and raft-associated proteins, such as caveolin-1, 
CD44, and RhoA (62). Specifically, the RSV F protein associates with DRMs in the 
absence of other viral proteins though an unidentified domain in the extracellular portion 
of the protein (28) and localize with raft-associated clusters of differentiation (CD) 55 
and 59 (13). Disruption of RhoA signaling using a Clostridium botulinum exotoxin C3 
results in relocalization of F from DRMs to non-lipid raft structures (62).  
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Internal virion proteins also localize to lipid microdomains. RSV M associates 
with membranes by itself; however, this interaction is thought to be stabilized by viral 
glycoproteins and interaction with the host cytoskeleton (44). In the presence of the F 
protein, M is able to sort into DRMs using triton X-100 insolubility assays (44) and 
flotation gradients (61). Finally, the viral polymerase complex associates with lipid raft 
proteins, with M2-1 showing a greater degree of partitioning into these lipid structures 
(63). These studies indicate that viral proteins localize to specific lipid microdomains that 
facilitate viral assembly. However, the specific mechanisms by which lipid interactions 
aid viral assembly have not been well defined.  
 
RSV and the host cytoskeleton  
Manipulation of the plasma membrane also likely involves a variety of host 
proteins that function at the cell surface. Many cellular structures extending outward from 
the cell surface depend on actin polymerization (e.g., microvilli, filapodia, lamellipodia, 
and membrane ruffles). Lipid microdomains have also been linked to the cortical actin 
network (56). In fact, is involved in multiple aspects of the RSV life cycle, but the 
specific role of actin in RSV assembly is not well understood. Gross disruption of the 
cytoskeleton using inhibitors of polymerization and depolymerization reduces viral 
replication (50). Both actin and profilin, an actin modulatory protein, are required for 
optimal RSV replication without the need for actin polymerization (14, 15, 42, 45). 
Consistent with these results, β-actin and other actin-related proteins colocalize with RSV 
F at the cell surface and have been found in a variety of sucrose gradient-purified RSV 
preparations by immunoblot analysis and mass spectrometry (14, 27, 75, 95). A caveat of 
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these studies, however, is that while many quality-control measures were used to ensure 
purification, the pleomorphic nature of RSV virions makes them difficult to purify from 
other membrane-bound vesicles of similar size that may contain actin (86). Therefore, 
while the role of actin has been well characterized for RSV transcription, the function of 
actin in RSV assembly and budding remains unclear.  
In contrast to β-actin incorporation into viral particles, filamentous actin (F-actin) 
is found at the base of viral filaments, consistent with its role as the cortical actin 
network, but is absent from the filaments themselves (47). Additionally, inclusion bodies 
are often localized near the plasma membrane, near viral filaments. Actin is associated 
with both inclusion bodies and the base of filaments (47). These data support the 
hypothesis that F-actin may serve a structural role in viral filament formation, but it does 
not form the structure of the filament itself. Other cytoskeletal proteins are also excluded 
from viral filaments, such at ezrin and tubulin (97). The exclusion of F-actin and ezrin 
from viral filaments can be used to distinguish viral filaments from cellular structures 
protruding from the membrane. Other actin-associated proteins, however, colocalize with 
viral filaments. Filamin A and caveolin-1 associate with viral filaments by 
immunofluorescence and in budded particles by mass spectrometry (12, 75). Actin 
interacts with caveolin-1, a lipid raft protein, and filament A interacts with caveolin-1, 
suggesting another link between actin-associated proteins, lipid rafts, and RSV assembly. 
Exclusion and inclusion of certain cellular proteins from viral filaments also suggests 
some type of specific sorting of viral and host proteins into filaments (97), a process that 
likely is highly regulated and probably involves interactions among viral proteins, host 
proteins, and lipid microdomains. 
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Finally, disruption of actin-related proteins or actin-associated signaling pathways 
affects protein trafficking or filament formation, respectively. RSV infection results in 
activation of RhoA, a kinase involved in actin cytoskeletal rearrangement (38). Inhibition 
of RhoA results in a reduced number of blunted filaments and a shift to more spherical 
particle morphology, although the total number of progeny was unaffected (39). 
Treatment of RSV-infected cells with a phosphatidyl-3-kinase (PI3K) inhibitor or Rac 
GTPase, a downstream effector of PI3K, prevents formation of viral filaments but does 
not affect virus protein expression or trafficking of viral glycoproteins to the cell surface 
(47). These data suggest a role for actin signaling in viral assembly. 
 
Host proteins associated with viral filaments 
The apical recycling endosome (ARE) is implicated in RSV assembly and 
budding. The ARE is part of a network of endosomes present in polarized epithelium that 
is responsible for maintaining the composition of membranes at apical and basolateral 
membranes (68). The endosomal network is regulated by a series of Ras-related small 
GTPase proteins called Rabs (73). Rab11 and Rab25 are associated specifically with the 
ARE, which is responsible for the slow recycling of cargo to the apical membrane and is 
also involved in transcytosis (36, 67, 96). Rab proteins depend on motor proteins for 
trafficking and adapters to confer cargo specificity. Myosin Vb is an actin motor protein 
that binds Rab11, and Rab11-family interaction proteins (FIPs) confer cargo specificity 
for Rab11 endosomes. Dominant-negative inhibitors of myosin Vb or Rab11-FIP1 
disrupts viral filament formation and results in diminished infectious viral progeny (9). In 
contrast, disruption of Rab11-FIP2 causes an increase in cell-associated virus and longer 
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viral filaments on the surface of infected cells, suggesting a defect in membrane scission 
to produce free virions (97). Although these studies show that ARE proteins are involved 
in RSV assembly and budding, a direct interaction between ARE and viral proteins has 
not been shown. Thus, the mechanism by which the ARE functions in RSV assembly and 
budding remains undetermined.  
A number of heat shock proteins are also associated with viral structures. HSP90 
is associated with viral filaments and inclusion bodies, as shown by immunofluorescence. 
Inhibition of HSP90 leads to loss of viral filament formation and reduced viral spread in 
vitro.  Furthermore, HSP70 and HSC70 colocalize with RSV inclusion bodies and mass 
spectrometry studies suggest they are physically associated with budded particles. 
However, the mechanisms by which these proteins affect viral assembly are currently 
unknown.  
 
Thesis overview 
 The experiments described in this thesis were designed to identify the host and 
viral determinants of RSV assembly and budding. In chapter II, I show that viral 
filaments are the likely sites of viral assembly at the cell surface. Interestingly, these data 
also show that viral filaments are formed by selective sorting of viral proteins into 
filaments and the exclusion of host cytosolic and membrane proteins. In chapter III, I 
identify viral determinants of filamentous assembly by showing that a specific Phe amino 
acid in the F CT is necessary for incorporation of internal virion proteins into virus-like 
filaments and virus-like particles (VLPs). Finally, in chapter IV, I discuss the viral 
interactions with the host cell as explored by yeast two-hybrid (Y2H) screens. The data 
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show that a number of host proteins localize to viral structures, but none are essential for 
viral replication. Collectively, these studies suggest that viral proteins are the driving 
factors behind viral assembly and budding. Chapter V summarizes the data and offers 
directions for future studies.  
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Chapter II 
 
CHARACTERIZATION OF RSV FILAMENTS AT THE CELL SURFACE 
 
Introduction 
Although many aspects of the RSV life cycle have been studied, the mechanisms 
by which RSV assembles and buds are not well defined. For viral assembly, the viral 
structural proteins and the viral RNA must traffic to the cell surface and coordinate with 
viral glycoproteins to assemble into filaments and form free virions. RSV matures at the 
apical surface of infected polarized cells (77). RSV F protein can traffic to the apical 
surface independent of other viral proteins as directed by the transmembrane domain 
(10). Mutations in the cytoplasmic domain of F affect viral assembly into filaments (83). 
RSV N localizes underneath the apical surface independent of viral glycoproteins (2). 
The M protein may be responsible for targeting the viral RNP complex to the cell surface 
from inclusion bodies, which likely are the sites of RNA replication (64).  
In addition to viral determinants, many host proteins have been implicated in the 
process of virus assembly and budding. The apical recycling system, lipid microdomains, 
actin-associated proteins, and actin-related signaling have been implicated in RSV 
assembly and budding. In this chapter, I sought to characterize the structural features of 
viral filaments, investigating both viral and host cell components. Viral assembly into 
filaments and budding of VLPs required F, M, N, and P. Additionally, viral filaments 
excluded host cytoskeleton proteins, actin-associated proteins, and lipid raft and non-raft 
proteins, and in fact, were shown to form independently of cytoskeletal rearrangement. 
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The results suggest that although some cytoskeletal elements are peripherally associated 
with the assembly mechanism, RSV assembles into filaments using a mechanism that is 
independent of the host cytoskeleton and most actin-associated proteins. These data 
suggest that viral proteins are the principal mechanical factors driving the formation of 
viral particles at the cell surface. This finding is remarkable considering the length and 
structural complexity of the viral filaments. 
 
Materials and methods 
Cell culture and wt RSV virus preparations. HEp-2 cells (ATCC CCL-23) were 
maintained in OPTI-MEM I medium (Invitrogen) containing 2% (v/v) fetal bovine serum 
(FBS), 1% (v/v) L-glutamine, 2.5 µg/mL amphotericin B, and 1% (v/v) penicillin-
streptomycin. HEK 293T cells were maintained in DMEM/F12 containing 10% (v/v) 
FBS, 1% (v/v) L-glutamine, 2.5 µg/mL amphotericin B, and 1% (v/v) penicillin-
streptomycin. MDCK cells were maintained in DMEM containing 10% (v/v) FBS, 1% 
(v/v) L-glutamine, and 1% (v/v) penicillin-streptomycin. All transfections were 
performed using Effectene Transfection Reagent (Qiagen) for HEp-2 cells according to 
package instructions, except as noted for filament formation and VLP assay. YFP-GL-
GPI and YFP-GT46 were a kind gift from Anne Kenworthy. The RSV wt strain A2 was 
expanded in HEp-2 cells. For filament visualization, HEp-2 cell monolayers on 12 mm 
micro cover glasses (VWR, No. 2) were inoculated at an MOI=1.0 and incubated for 24 
hours.  
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Filament formation by transfection. Plasmids encoding the RSV F protein along with 
pcDNA3.1 plasmids containing inserts encoding the RSV A2 strain matrix (M), 
nucleoprotein (N), and phosphoprotein (P) gene (synthesized by GeneArt, Regensburg, 
Germany) were transfected into HEp-2 cell culture monolayers using 0.2 µg of each 
plasmid DNA, and cells were incubated for 72 hours. Cells were fixed, immunostained, 
and imaged as described below.  
 
Fixation and immunostaining. Cells were fixed with 3.7% (w/v) paraformaldehyde in 
phosphate buffered saline (PBS) for 10 min. Cells were permeabilized with 0.3% (w/v) 
Triton X-100 and 3.7% paraformaldehyde in PBS for 10 min at RT. After fixation, cells 
were blocked in 3% (w/v) BSA in PBS for 60 min followed by addition of primary 
antibody (ab) in the blocking solution for 60 min. Cells then were washed three times in 
PBS, and species-specific IgG Alexa Fluor (Invitrogen) was added at a dilution of 
1:1,000 in block solution for 60 min to detect primary abs. Cells were washed three times 
in PBS and fixed on glass slides using Prolong Antifade kit (Invitrogen). All steps were 
performed at room temperature (RT). Images were obtained on a Zeiss inverted LSM510 
confocal microscope using a 40x / 1.30 Plan-Neofluar or 63x/1.40 Plan-Apochromat oil 
lens. Anti-RSV M (clone B135), anti-RSV P protein (clone 3_5), and anti-RSV N protein 
(clone B130) monoclonal abs were a kind gift of Earling Norrby and Ewa Bjorling. An 
anti-RSV F protein humanized mouse monoclonal ab (palivizumab; MedImmune) was 
obtained from the Vanderbilt Pharmacy. F-actin was visualized using rhodamine 
phalloidin, and TO-PRO-3 iodide was used to visualize the nucleus (Invitrogen). Tubulin 
was visualized using an antibody to the alpha-tubulin (Abcam). 
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Imaging with RSV-specific RNA probe and live cell delivery.  Single-copy sensitive 
RNA probes designed to target the RSV genomic gene-start regions were delivered into 
RSV wt- or mock-infected HEp-2 cells using streptolysin O reversible permeabilization 
24 hours after inoculation, as previously described (81).  After probe delivery, cells were 
immunostained for RSV proteins as described above. Images were processed in Volocity 
imaging software (version 5.1; Improvision). Shadow and highlight input sliders were 
adjusted to the beginning and end of the histogram curve to optimize tonal levels for the 
entire image; middle tones were not adjusted. 
 
VLP assay with 35S methionine and 35S cysteine metabolic labeling. For each sample, 3 
million HEK 293T cells were transfected using program Q-001 on an Amaxa 
electroporator with Nucleofector solution V and 5 µg of total DNA. After electroporation, 
cells were plated in 6 well plates that were pre-coated with poly-L-lysine in normal 
growth media. For the RSV infection, HEK 293T cells were inoculated with wt RSV 
stain A2 at an MOI=0.1. After a 5 hour recovery period, cell were transferred to 10% 
(v/v) dialyzed FBS containing DMEM that lacked the amino acids cysteine and 
methionine. 35S-cysteine and 35S-mehionine were added to the labeling media at 50 
µCi/mL. After 72 hours, cell lysates were harvested using a single detergent lysis buffer 
(50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, pH 8.0) containing 1:200 dilution of 
mammalian protease inhibitor cocktail (Sigma). Cell supernatant was clarified using low 
speed centrifugation and pelleted through a 20% sucrose cushion using a Sorvall AH-650 
rotor at 28,000 rpm for 3 hours. Pellets were resuspended in 60% iodixanol and layered 
on top with 40% and 10% iodixanol. Gradients were centrifuged at 50,000 rpm for 18 
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hours at 4° C and collected in 1 mL fractions. Each fraction was immunoprecipitated for 
RSV F using a mixture of three mouse monoclonal antibodies to F (1 µg/mL) and protein 
G agarose beads. Cell lysates and immunoprecipitations were separated on 4-12% 
NuPAGE Bis-Tris gels and transferred to Invitrolon PVDF membrane (Invitrogen). 
Membranes were dried, and exposed	  to	  Kodak	  BioMax	  MS-­‐1	  autoradiography	  film	  using	  a	  Kodak	  Biomax	  TransScreen	  LE	  and	  incubated	  at	  -­‐80°	  C	  for	  2-­‐7	  days	  before	  film	  was	  developed. 
 
Cytoskeletal inhibitors. HEp-2 cells were treated with actin or tubulin inhibitors, as 
previously described (50). Briefly, cytochalasin D (Sigma) was prepared at 2 mg/ml in 
ethanol; latrunculin A (Enzo Life Sciences) at 1 mg/ml in ethanol; nocodazole (Sigma) at 
10 mg/ml in DMSO; and paclitaxel (Sigma) at 25 mg/ml in ethanol. Inhibitor 
concentrations were optimized previously for maximum effect by cell morphology with 
the least amount of toxicity. For immunostaining, HEp-2 cell monolayers on 12 mm 
micro cover glasses (VWR, No. 2) were inoculated at an MOI=1.0 and incubated with 
medium containing either vehicle or the indicated inhibitor for 24 hr.  
 
RSV infections and viral titration. For quantification of viral yield in the presence of 
inhibitors, HEp-2 cell monolayers were inoculated at an MOI=0.05. Cells were then 
washed and medium was added containing either vehicle or indicated inhibitor. At 3 days 
post infection, cell supernatant was harvested and normalized for volume. The samples 
were then clarified of cellular debris by centrifugation in a microcentrifuge at 13,000 rpm 
for 10 min. The resulting supernatant was designated as supernatant virus. The cell 
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monolayer was resuspended in an equal volume of medium, scraped, and freeze/thawed 
3x using a dry ice/ethanol bath and a 37 °C water bath. The samples then were clarified 
of cellular debris by centrifugation in a microcentrifuge at 13,000 rpm for 10 min. The 
resulting solution was designated cell-associated virus.  
 
Flow cytometric assay for quantitative surface expression of RSV F. HEp-2 cells were 
inoculated with RSV for 1 hour at 37 °C at an MOI=3.0. The inoculum then was removed 
and each inhibitor was added, as described above. After 24 hours, cells were treated with 
20 mM EDTA in PBS to form a single cell suspension. Cells were washed two times in 
wash buffer (2% FBS in PBS) and then incubated with palivizumab at 1 µg/mL for 30 
min at RT. An Alexa Fluor goat anti-mouse 488 secondary antibody suspension was used 
at a final concentration of 2 µg/mL. Cells were analyzed on a five-laser custom LSR II 
flow cytometer (Becton Dickinson) in the Vanderbilt Medical Center Flow Cytometry 
Shared Resource. Data analysis was performed using FlowJo (version 7.6.1). Weighted 
mean fluorescent intensity (MFI) was calculated by multiplying the raw mean fluorescent 
intensity by the frequency of positive cells. Statistical analysis was performed using a 
Student T-test of three independent experiments. P values less than 0.05 were considered 
significant.  
 
Live imaging of viral filaments. MDCK cells were grown on Mattek glass bottom dishes 
and infected with RSV at an MOI=1.0 for 18-24 hours. RSV genomic probes were 
delivered as described above, and live cells were imaged using a Zeiss Axiovert 200M 
microscope with an 63x, NA 1⁄4 1.4 Plan-Apochromat objective, using Chroma 49004 
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ET-Cy3 and 49006 ET-Cy5 filter sets, with 350-ms exposures. An EXFO excite 120 light 
source with a ND (neutral density) 1⁄4 0.4 (40% transmission) was used for fluorescence 
excitation, and a Hamamatsu ORCA-ER AG for taking digital images. Videos were 
deconvolved using Volocity iterative deconvolution algorithm (81).  
 
Results 
RSV infection induced virus filaments that contain viral structural proteins and 
viral genomic RNA. I first tested whether the cell-surface filaments induced by RSV 
infection of epithelial cells contained all of the expected RSV structural proteins. HEp-2 
cell monolayer cultures were inoculated with wt RSV strain A2 and incubated in 
complete growth medium for 24 hours. The cell monolayers were fixed and 
immunostained for RSV F, M, N, or P protein. In addition, we also stained cells for the 
presence of RSV genomic RNA using a fluorescently-conjugated probe designed to 
hybridize to RSV gene start sequences (81). Figure 2-1 shows RSV filaments protruding 
from the cell membrane (A-P). Morphologically, these filaments often were clustered and 
kinked, and they stained brightly with antibodies to RSV F protein. The filamentous 
structures contained RSV F, M, N, P, and viral RNA, indicating that both structural and 
genomic components are present. Thus, these filaments likely are virions assembling at 
the plasma membrane prior to budding.1 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 This figure has been previously published as part of an original manuscript. Shaikh et al. 2012. A critical 
phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly 
of internal viral proteins into viral filaments and particles. mBio. 2012 Feb 7;3(1). pii: e00270-11. doi: 
10.1128/mBio.00270-11. Print 2012 
	   26 
 
Figure 2-1. RSV F, M, N, P, and viral RNA localize to viral filaments during 
infection. HEp-2 cells were inoculated with RSV strain A2 at a MOI=1.0 and incubated 
for 24 hours. RSV F, M, N, and P were detected by indirect immunofluorescence; vRNA 
was detected using an RNA probe specific to the RSV genomic gene start sequences; 
actin was detected using phalloidin. Column 1 (panels A, E, I, and M) shows the entire 
cell. Panels B-D, F-H, J-L, and N-P show an enlargement of the inset shown in column 1. 
Column 2 (panels B, F, J, and N) shows RSV M, N, P, vRNA, or phalloidin staining 
only; column 3 (panels C, G, K, and O) shows RSV F only; and column 4 (panels D, H, L 
and P) shows the overlay with RSV F in red and RSV M, N, P, vRNA, or actin in green. 
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Figure 1. RSV F, M, N, P, and viral RNA localize to viral filaments during infection. HEp-2 
cells were inoculated with RSV strain A2 at a MOI=1.0 and incubated for 24 hours. RSV F, M, 
N, and P were detected by indirect immunofluorescence; vRNA was detected using an RNA 
probe specific to the RSV genomic gene start sequences; actin was detected using phalloidin. 
Column 1 (panels A, E, I, and M) sho s the ntire cell. Panels B-D, F-H, J-L, and N-P show 
an enlargement of the inset shown in column 1. Column 2 (panels B, F, J, and N) shows RSV 
M, N, P, vRNA, or phalloidin staining only; column 3 (panels C, G, K, and O) shows RSV F 
only; and column 4 (panels D, H, L and P) shows the overlay with RSV F in red and RSV M, 
N, P, vRNA, or actin in green. 
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RSV virus-like filaments can be generated independent of viral infection. I next 
sought to determine the minimal requirements for RSV filament formation by 
transfecting combinations of plasmids encoding RSV proteins. Transfection of cDNAs 
encoding RSV F, M, N, and P genes into HEp-2 cells induced formation of virus-like 
filaments that resembled viral filamentous structures formed during infection. Figure 2-2 
A-D shows a representative image of filaments formed when these four RSV structural 
proteins were expressed in HEp-2 cells. Consistent with RSV filaments formed during 
infection, virus-like filaments contained RSV proteins and were often kinked, clustered, 
and stained brightly for the F protein (Fig. 2-2A). RSV M was also present in these 
transfection based filaments (Fig. 2-2B), as were RSV N and P. RSV F was necessary for 
virus-like filament formation (Fig. 2-2 E-H), and in fact, exclusion of any single gene of 
the four during transfection eliminated filament formation (Fig. 2-2 I-T). Thus, the 
filaments formed using the transfection-based assay were similar to filaments formed 
during viral infection in both morphology and composition. 2 
 
Expression of RSV viral filament proteins also results in budded particles that 
contain F, M, N, and P.  To determine whether expression of these four proteins could 
lead to production of budded particles, we developed a VLP assay using HEK 293T cells 
and radiolabeling, which was necessary due to the inefficiency of RSV VLP formation 
and subsequent inability to detect viral proteins by immunoblot. Figure 2-3A shows an 
overall schematic of the assay. Cells were transfected with empty vector, F only, or with 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Investigations into the minimum requirements for virus-like filament formation were based on the similar 
studies performed other members of the Crowe laboratory: Thomas Utley, Sunny Mok, and Mike 
Lindquist.	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Figure 2-2: RSV F, M, N, and P are necessary and sufficient for generation of 
filaments independent of viral infection. HEp-2 cells were transfected with plasmids 
encoding cDNAs for all four proteins (F, M, N, and P) or with three proteins, with the 
missing protein indicated for the row. Column 2 (panels A, E, I, M, and Q) shows RSV F 
staining. Column 2 (panels B, F, J, N, and R) shows RSV M staining. Column 3 (panels 
C, G, K, O, and S) shows the overlay of columns 1 and 2 with RSV F in red and RSV M 
in green. Column 4 (panels D, H, L, P, and T) shows an enlargement of the inset 
indicated in column 3. 
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all four proteins. Cells were metabolically labeled with 35S-methionine and 35S-cysteine 
for 72 hours. Cell lysates were harvested, and expression of each protein was confirmed 
by immunoprecipitation with an antibody directed against each individual protein. Figure 
2-3B shows the result of cell lysate immunoprecipitations. When transfected with 
plasmids encoding cDNAs for all four proteins, each was able to be detected using 
immunoprecipitation by their respective antibodies. RSV P, however, could not be 
detected due to the lack of available purified antibody. Supernatant from hybridoma 
clone 3_5 was used for immunoprecipitation, but insufficient antibody was present to 
detect the viral protein.  
To detect budded particles, cell supernatants were clarified to remove cell debris, 
pelleted through a 20% sucrose cushion to remove free protein, and subjected to an 
iodixanol flotation gradient. Fractions from the flotation gradient were 
immunoprecipitated using a mixture of monoclonal antibodies to the F protein, separated 
using SDS-PAGE, and visualized by exposure to film using a 35S intensifying screen. 
Figure 2-3C shows that in contrast to empty vector and F only controls, protein bands that 
correspond to the appropriate size of all four proteins were detected in the same flotation 
gradient fraction by immunoprecipitation using F-specific antibodies. These data suggest 
that all four proteins are present in particles that contain the F protein. In contrast to the 
cell lysates, a band corresponding to the P protein is detectable, since P is likely in the 
same particle as F. Additionally, cells were infected with RSV, and viral particles were 
harvested and processed in a similar manner as transfected samples. Figure 2-3D shows  
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Figure 2-3: Expression of RSV F, M, N, and P results in budded particles containing 
all four proteins that are detectable using a 35S-VLP assay. Panel A shows a 
schematic of the VLP assay. Panel B: total cell lysate was collected from transfected cells 
and bands were detected by immunoprecipitations with the corresponding antibody or 
hybridoma supernatant. Panel C: cell supernatant from transfected or infected cells was 
clarified, pelleted through a sucrose cushion, and floated on an iodixanol gradient. Bands 
were detected after immunoprecipitation with an antibody to F.  
 
  
	   31 
that virions are present the same density as VLPs, indicating that VLPs recapitulate viral 
budding. 3 
 
Viral filaments are distinct from cytoskeleton-based host protrusions at the cell 
surface. To adhere to the extracellular matrix, a host cell must use both cellular junctions 
and cytoskeleton-based protrusions (e.g., microvilli, filapodia, lamellipodia, and 
membrane ruffles). Since RSV filaments resemble host cell protrusions that contain 
cytoskeletal proteins, we next sought to determine whether viral filaments are distinct 
from cell projections. Therefore, I visualized F-actin using phalloidin and tubulin using 
an antibody to alpha-tubulin. Figure 2-4 panels A-E show that viral filaments, marked by 
the presence of RSV F protein, did not contain F-actin, and panels F-J show that tubulin 
is also not present in filaments. Although the viral and host filamentous structures often 
occurred in the same regions of the plasma membrane, viral filaments were distinct from 
the cell projections that contained cytoskeletal proteins. These data are consistent with 
previously published data showing that F-actin is not found in viral filaments (47).  
 
Viral filaments are formed by selective sorting of viral proteins into filaments and 
exclusion of both cytosolic and membrane proteins. Although F-actin is excluded from 
viral filaments, other studies have shown that β-actin can localize to viral filaments and 
budded virions (75, 95) and that actin-associated signaling pathways are important for 
RSV filamentous assembly (39). Previously, others in the Crowe laboratory found that  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Radiolabeling VLP studies were performed in collaboration with Sunny Mok, a former post-doctoral 
fellow in the laboratory of James Crowe.  
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Figure 2-4: Viral filaments are distinct from host structures that contain actin or 
tubulin. Mock or RSV-infected HEp-2 cells were stained for F and actin or tubulin. 
Panels A and F show mock infected cells. Panels B and G show RSV infected cells. 
Panels C-E and H-J show an enlargement of the inset shown in panels B and G. Panels C 
and H show actin and tubulin staining only, respectively; panels D and I show F staining 
only; and panels E and J show the overlay with F in red and actin or tubulin in green.  
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disruption of the function of the apical recycling endosome (ARE) reduced RSV 
assembly and budding but did not interrupt trafficking of viral proteins to the cell surface 
(9). Additionally, many actin-associated proteins are found in myosin Vb-marked 
endosomes when the function of the protein was disrupted during RSV infection (Thomas 
Utley, unpublished data)4. I sought to replicate some of these data in HEp-2 cells by 
determining whether these actin-associated proteins localized to viral filaments. HEp-2 
cell culture monolayers were either mock-infected or infected with wt RSV and incubated 
for 24 hours in complete growth medium. Figure 2-5 shows the localization of these 
proteins in mock- and RSV-infected cells. I first examined members of the ezrin, radixin, 
and moesin (ERM) family of proteins. Ezrin localized diffusely throughout the cytoplasm 
and to membrane protrusions at the cell surface (Fig. 2-5A). These protrusions, however, 
were distinct from viral filaments that form at the cell surface in RSV-infected cells (Fig. 
2-5B). Moesin and radixin localized largely underneath the plasma membrane and also to 
membrane protrusions (Fig. 2-5C and 2-5E, respectively). Like ezrin, neither of these 
proteins co-localized with RSV F in viral filaments but remained in distinct host 
structures (Fig. 2-5D and 2-5F, respectively).  
 Next, we examined a number of other actin-associated proteins that either 
crosslink actin or connect the cortical actin network to the plasma membrane. Eplin, an 
actin crosslinker, did not localize to viral filaments (Figure 2-5G and 2-5H). EBP50, a 
scaffold protein that connects membrane proteins to ERM proteins, localized diffusely 
throughout the cytoplasm (Fig. 2-5I and 2-5J), but was excluded from viral filaments 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 This work has been described previously as part of Thomas J. Utley’s thesis entitled, “Investigations into 
the assembly and budding of respiratory syncytial virus.” 	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(Fig. 2F). Annexin A2 is another protein that has been reported to link membrane 
glycoproteins to the actin cytoskeleton. Although this protein localized diffusely 
throughout the cell (Fig. 2-5K), it did not localize to viral filaments (Fig. 2-5L). Finally, 
we examined two α-actinin proteins that are members of the large and diverse spectrin 
family of proteins. The α-actinin 1 and 4 proteins, which are expressed in non-muscle 
cells, are actin-binding proteins that are involved in actin crosslinking and also may 
mediate attachment of the plasma membrane to the actin cytoskeleton (47). While α-
actinin 1 was excluded from viral filaments completely (Fig. 2-5M and 2-5N), α-actinin 4 
showed some minor co-localization with viral filaments, with variation from cell to cell 
(Fig. 2-5O and 2-5P). These data suggest that most actin-associated proteins are excluded 
from viral assembly structures, again providing evidence for specific sorting of proteins 
into viral filaments and exclusion of host proteins including cytoskeletal elements.  
Next, I sought to determine whether membrane proteins were sorted selectively or 
excluded from viral filaments. I used two membrane-protein constructs, YFP-GL-GPI 
and YFP-GT46 to mark raft or non-raft membrane microdomains, respectively. These 
constructs were a gift from Anne Kenworthy at Vanderbilt University and have been 
described previously (52). YFP-GL-GPI is a GPI anchored membrane protein that 
associates with lipid rafts, while the YFP-GT46 membrane protein does not localize to 
lipid rafts (52). Figure 2-6 shows that while both membrane proteins localized to the 
plasma membrane (panels A and F), neither YFP-GL-GPI (panels B-E) nor YFP-GT46 
(panels G-J) were present in viral filaments marked by RSV F. These data indicate that 
viral glycoproteins are selectively sorted into viral filaments. 
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Figure 2-5: Actin associated cytoskeletal proteins are excluded from viral filaments. 
HEp-2 cells were inoculated with RSV stain A2 at an MOI=1.0 and incubated for 24 
hours. RSV F and the indicated cellular proteins were detected by indirect 
immunofluorescence. Columns 1 and 3 (panels A, C, E, G, I, K, M and O) show mock 
infected cells, while columns 2 and 4 (panels B, D, F, H, J, L, N, and P) show RSV 
infected cells. RSV F is shown in green and the indicated cellular protein is shown in red. 
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Figure 2-6: Raft and non-raft membrane protein constructs are excluded from viral 
filaments. HEp-2 cells were transfected with plasmids encoding YFP-GL-GP1 or YFP-
GT46 and inoculated with RSV. Panels A and F show mock-infected HEp-2 cells with 
the indicated YFP construct. Panels B-E and G-J show RSV-infected cells with the 
indicated YFP construct. Panels B and G show the whole cell with F in red and the YFP 
protein in green. Panels C-E and H-J show an enlargement of the inset in panels B and G, 
respectively. Panels C and H show F staining only; panels D and I show the YFP protein 
staining only; and panels E and J show the overlay with F in red and the YPF protein in 
green.  
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Cytoskeletal rearrangement is not necessary for viral assembly into filaments. Since 
actin-associated proteins are mostly excluded from viral filaments and may not affect 
viral replication, I and a rotation student in the Crowe laboratory, Ryan Craven, next 
sought to determine whether cytoskeletal polymerization is necessary for viral assembly 
into filaments. Nicole Kallewaard, a former graduate student in the Crowe laboratory, 
had determined previously the inhibitor concentrations that resulted in maximum affect 
on the cytoskeleton with the least cellular toxicity (50). The effect of inhibitor 
concentrations on virus replication was determined to be similar to the previously 
reported results, showing 0.95 to 2.4 log10 pfu/mL reduction in supernatant-associated 
virus and 0.6 to 1.6 log10 pfu/mL reduction in cell-associated virus (Figure 2-7Q).  
 Using the same conditions, I tested whether gross cytoskeletal disruptions 
affected viral assembly into filaments. HEp-2 cell culture monolayers were inoculated 
with wt RSV strain A2 and incubated in growth medium containing the indicated 
inhibitor or vehicle for 24 hours. Cells were immunostained for RSV F protein to mark 
viral filaments and for actin or tubulin, depending on which cytoskeletal function was 
disrupted. Remarkably, viral assembly into filaments at the cell surface was not inhibited 
when actin or tubulin polymerization was disrupted (Fig. 2-7A-P). Cells treated with 
cytochalasin D (Fig. 2-7B and 2-7D) or latrunculin A (Fig. 2-7F and 2-7H) showed a lack 
of cortical actin structure underneath the plasma membrane. However, this disruption did 
not affect the formation of viral filaments (Fig. 2-7D and 2-7H). Viral filaments, 
however, often appeared to originate from depolymerized actin aggregates (highlighted 
by the insets in Fig. 2-7D and 2-7H). These images suggest that although actin 
polymerization is not necessary for viral filament formation, actin or actin-related 
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proteins in these aggregates may play in anchoring filaments. Inhibition of tubulin 
polymerization using nocodazole (Fig. 2-7I-L) or depolymerization of tubulin using 
paclitaxel (Fig. 2-7M-P) also did not affect viral assembly into filaments. Finally, we 
determined whether F protein surface expression was altered by disruption of the 
cytoskeleton, using flow cytometry (Fig. 2-7R). F protein surface expression was not 
altered in the presence of inhibitors, suggesting that cytoskeletal rearrangements are not 
necessary for F protein expression or trafficking to the cell surface. Collectively, these 
data indicate that viral filaments can initiate membrane deformation and elongate by a 
virus-mediated mechanism distinct from that used by actin- or tubulin-based cellular 
protrusions. 
 Since viral assembly into filaments was unaffected at 24 hours post inoculation 
(h.p.i.)., I next asked whether filaments form at earlier timepoints during infection. Figure 
2-8 shows HEp-2 cells that were treated with vehicle, latrunculin A, or paclitaxel. Viral 
filaments were visualized at 12, 18, or 24 h.p.i. Actin was visualized for vehicle- and 
latrunculin A-treated cells, and tubulin was visualized for paclitaxel-treated cells. At 12 
h.p.i., vehicle-treated cells show many viral filaments. However, the number and length 
of viral filaments were noticeably reduced in latrunculin A- or paclitaxel-treated cells. 
Similar results were obtained at 18 h.p.i., though the number of filaments in inhibitor-
treated cells did increase compared to cells at 12 h.p.i.. As seen in Figure 2-7, many viral 
filaments were present at 24 h.p.i.. These data indicate that while viral filamentous 
assembly occurs when actin or tubulin polymerization is disrupted, cytoskeletal  
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Figure 2-7: Viral assembly into filaments is not dependent on the cytoskeletal 
polymerization. HEp-2 cells were inoculated with RSV wt strain A2 at an MOI=1.0 and 
incubated for 24 hours with medium containing either vehicle of the indicated inhibitor. 
At 24 hours cells were fixed, and RSV F, actin, and tubulin were detected by indirect 
immunofluorescence. Column 1 (panels A, E, I, and M) shows mock-infected cells in the 
presence of vehicle. Column 2 (panels B, F, J, and N) shows mock-infected cells in the 
presence of the indicated inhibitor. Column 3 (panels C, G, K, and O) shows RSV-
infected cells in the presence of vehicle. Column 4 (panels D, H, L, and P) shows RSV-
infected cells in the presence of the indicated inhibitor. Panel Q: HEp-2 cells were 
infected with RSV at an MOI=0.1 for 72 hours. Supernatant and cell-associated fractions 
were collected in duplicate and quantified using a viral plaque assay. Viral yields are 
presented in log10 pfu/mL. Panel R: total surface expression of RSV F was determined by 
flow cytometric analysis in mock-infected or RSV-infected cells (MOI=3.0) treated with 
vehicle or the indicated inhibitor for 24 hours. Data are plotted as mean, and error bars 
represent standard deviation. Weighted mean fluorescence intensity (MFI) is MFI 
multiplied by the frequency of positive cells. 
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Figure 2-8: Disruption of the cytoskeleton affects the number and length of viral 
filaments early in infection. HEp-2 cells were inoculated with RSV wt strain A2 at an 
MOI=1.0 and incubated for 12, 18, or 24 hours with medium containing either vehicle of 
the indicated inhibitor. Cells were fixed, and RSV F, actin, and tubulin were detected by 
indirect immunofluorescence. Vehicle and latrunculin A treated cells were stained for F 
and actin. Paclitaxel treated cells were stained for F and tubulin. Column 1 (panels A, D 
and G) shows cells at 12 h.p.i.; column 2 (panels B, E, and H) shows cells at 18 h.p.i.; 
and column 3 show cells 24 h.p.i. RSV F is shown in green and actin or tubulin is shown 
in red.  
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polymerization may be required for other steps during viral replication or trafficking of 
host proteins required for viral assembly.5 
 
Viral filaments are dynamic structures that may directly bud to form free virions. 
Although viral filaments contain all of the viral structural and genomic components, no 
direct evidence exists that viral filaments eventually pinch off from the host membrane to 
become free virions. To directly visualize viral filaments, I performed live-cell 
microscopy of RSV-infected cells and labeled the vRNA using the oligonucleotide probe 
described in Figure 2-1. The cells were imaged, and the resulting videos were 
deconvoluted using Volocity software to remove out-of-focus light. Figure 2-9 shows a 
timecourse of images obtained from a single video.  The results indicate that viral 
filaments are not stationary structures on the cell surface. The directional and rotational 
movement has been described previously, indicating that it is not simply Brownian 
motion (80). However the source of this motion is unknown. In frame 2-9B, a viral 
filament (indicated by the white arrow) that was not in focus previously (frame 2-9A) 
appears in the focal plain. In frames 2-9C through 2-9E, a single viral filament appears to 
separate from the cell surface and can be seen moving away from the cell surface in 
frames 2-9F through 2-9I. Due the focal plane of the live-cell imaging and the tendency 
of RSV to remain cell-associated, the membrane scission event was not visualized.  
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Cytoskeletal inhibitor studies was performed with assistance from Ryan Craven during a laboratory 
rotation in the Interdisciplinary Graduate Program in the Biomedical and Biological sciences 
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Figure 2-9: Viral filaments may directly become free virions. MDCK cells were 
infected with RSV and treated with a fluorescent vRNA probe (red). Collected video was 
deconvoluted using Volocity software. Frames A-I were captured as part of a timecourse 
using QuickTime player to best illustrate the path of viral filament that may have 
separated from the cell surface (indicated by the white arrow).  
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Therefore, further investigation of viral budding using live-cell imaging will be required 
to determine whether viral filaments eventually become free virions. 6 
 
Discussion 
The mechanism of RSV assembly and budding is of interest since it appears to 
use an unconventional pathway that is independent of host proteins of the multi-vesicular 
body apparatus (97). A number of viruses coopt the host cytoskeleton and related proteins 
to accomplish viral assembly and budding, such as vaccinia virus, PIV3, and many 
herpesviruses (88). I sought to determine if RSV achieves its unique program using apical 
cytoskeleton or related proteins for assembly and budding. Although I and others have 
reported that actin-associated proteins localize in or near viral assembly structures (75), it 
is remarkable that viral assembly into long, complex filamentous structures that require 
the manipulation of the plasma membrane can occur without the need for actin 
polymerization. The data suggest that viral constituents achieve complex tasks at the 
membrane, including specific sorting of viral proteins into the filaments while excluding 
most host proteins, extrusion of long membranous structures from the cell without a 
cytoskeletal infrastructure, incorporation of nucleocapsids, and scission of the membrane 
to release infectious particles. Viral elements, or recruited host proteins, provide the 
dynamic mechanical force to initiate and extend viral filaments, not polymerization of the 
cytoskeleton.  
The findings that inhibition of actin polymerization is not required for assembly 
and budding does not completely exclude the possibility that the cortical actin network or 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 Live imaging of viral filaments was performed with assistance from Aaron Lifland and Phillip Santangelo 
at the Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 
Atlanta, Georgia, USA 
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associated proteins still function in an accessory structural role for viral replication. Actin 
polymerization is necessary for optimal viral replication (15, 47, 50), and our observation 
of multiple viral filaments radiating from actin aggregates under depolymerizing 
conditions also supports the hypothesis that actin plays an accessory structural role in 
replication. In fact, other groups have described actin at the base of viral filaments (47), 
and β-actin interacts with RSV N (95). Some investigators have reported β-actin in viral 
particles (75, 95). Furthermore, actin-associated pathways are important for viral 
filamentous assembly (7, 39). Finally, actin enhances viral transcription, although its role 
as a transcription enhancing factor does not rely on the ability to polymerize (42).  
Since actin does not provide the physical infrastructure for a viral filament, the 
structure for a complex, kinked viral filament may be determined by the viral proteins 
themselves. I show here that the four major RSV structural proteins are required for 
filament formation independent of viral infection and budding of VLPs and that these 
viral filaments are distinct from actin-based cellular structures. Similarly, a study 
examining viral filaments by scanning electron microscopy showed that in the absence of 
the M protein, short filament-like structures with F and G were observed on the cell 
surface (64). These data suggest that while the viral glycoproteins are sufficient for the 
initial outward bud formation, the structure of the filament is driven by the M protein. 
The matrix proteins of other viruses, such as Ebola virus, have been shown to 
oligomerize into higher order structures (32); it is possible that oligomerization of the 
RSV M protein is responsible for elongation of the structure of viral filaments. 
Nevertheless, the remarkable finding of this study is that complex, structured RSV 
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filaments form apparently normally even when actin or microtubule function is 
completely inhibited.  
 
Chapter summary 
In this chapter, I present data that characterizes RSV assembly into filaments at 
the cell surface. I show that the minimum requirements for viral filament assembly and 
budding of VLPs are four structural proteins: F, M, N, and P. Second, I show sorting of 
viral protein constituents for viral assembly into filaments is a process that is highly 
regulated, involving viral proteins while excluding the host cytoskeleton, actin-associated 
proteins, and host lipid-raft and non-raft membrane proteins. Third, I show that the 
physical structure of viral filaments does not depend on rearrangement of the actin or 
tubulin cytoskeleton, although inhibition of cytoskeletal rearrangement does affect 
optimal viral replication. Finally, I show that viral filaments may directly become free 
virions. These data indicate that viral assembly into filaments is largely driven by viral 
proteins.  
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Chapter III 
 
A CRITICAL PHENYLALANINE RESIDUE IS REQUIRED FOR VIRAL 
FILAMENTOUS ASSEMBLY AT THE CELL SURFACE7 
 
Introduction 
Previously, others in the Crowe laboratory showed that the F protein traffics to the 
apical surface in the absence of any other viral protein or viral RNA and that the F-
protein cytoplasmic tail (F CT) was dispensable for apical trafficking (10). It is unlikely, 
however, that a paramyxovirus would retain such a domain if it did not play some role in 
replication or pathogenesis, and indeed other investigators showed that a virus lacking the 
F CT had a 100- to 1,000-fold decrease in viral titers in a multicycle growth curve. This 
mutant virus did not form filaments at the cell surface but was capable of mediating cell-
cell fusion (8, 69). Furthermore, the cytoplasmic tail (CT) of many paramyxovirus 
glycoproteins is important for assembly and budding (43). 
Since the F CT is required for efficient replication but not for fusion or 
trafficking, I hypothesized that the F CT coordinates the assembly of viral proteins into 
filaments at the cell surface. In this chapter, I demonstrate that a key phenylalanine (Phe) 
residue at position 22 in the F CT is critical for RSV assembly into filaments at the cell 
surface. Moreover, when this Phe was mutated, RSV F could not recruit RSV M, N, and 
P efficiently into VLPs. These findings indicate that the F CT, and specifically Phe22 of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 Data in this chapter were published in Shaikh et al. 2012. A critical phenylalanine residue in the 
respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into 
viral filaments and particles. mBio. 2012 Feb 7;3(1). pii: e00270-11. doi: 10.1128/mBio.00270-11. Print 
2012 
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the F CT, is responsible for recruitment of internal viral proteins into filamentous 
structures at the cell surface for efficient assembly and subsequent budding. 
 
Materials and methods 
Cell culture and wt RSV virus preparations. HEp-2 cells (ATCC CCL-23) were 
maintained in Opti-MEM I medium (Invitrogen) containing 2% (vol/vol) fetal bovine 
serum (FBS), 1% (vol/vol) l-glutamine, 2.5 µg/ml amphotericin B, and 1% (vol/vol) 
penicillin-streptomycin. Suspension 293-F cells were maintained as recommended by the 
manufacturer (Freestyle 293 Expression System; Invitrogen). Transfections were 
performed using the Effectene transfection reagent (Qiagen) for HEp-2 cells and the 
Polyfect transfection reagent (Qiagen) for 293-F cells. The RSV wt strain A2 was 
expanded in HEp-2 cells. 
 
RSV infections. For filament visualization, HEp-2 cell monolayers on 12-mm micro-
cover glasses (no. 2; VWR) were inoculated at a multiplicity of infection (MOI) of 1.0 
and incubated for 24 h. For flow cytometric analysis, HEp-2 cells in tissue culture flasks 
were inoculated at an MOI of 3.0 and incubated for 24 h. For the virus-like particle 
(VLP) assay, 293-F cells were infected at an MOI of 0.05 for 72 h. 
 
Generation of RSV F protein mutant constructs. All DNAs encoding the RSV fusion (F) 
protein constructs in this study were made from a sequence-optimized cDNA encoding 
the RSV wt strain A2 F protein in the pcDNA3.1 plasmid vector (Invitrogen) (5). DNAs 
encoding RSV F proteins with truncations or other alterations of the cytoplasmic tail at 
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the C terminus of the protein were cloned using PCR primers to amplify the desired 
length of the tail and subcloned into pcDNA3.1. Targeted mutations, insertions, or 
deletions were introduced using the Lightning site-directed mutagenesis kit (Stratagene) 
and confirmed by sequencing. 
 
Filament formation. Plasmids encoding the wt or a mutant RSV F protein along with 
pcDNA3.1 plasmids containing inserts encoding the RSV A2 strain matrix (M), 
nucleoprotein (N), and phosphoprotein (P) gene (synthesized by GeneArt, Regensburg, 
Germany) were transfected into HEp-2 cell culture monolayers using 0.2 µg of each 
plasmid DNA, and cells were incubated for 72 h. Cells were fixed, immunostained, and 
imaged as described below. All images for virus-like filament formation were collected 
in a single experiment using identical microscopy parameters. 
 
Fixation and immunostaining. Cells were fixed with 3.7% (wt/vol) paraformaldehyde in 
phosphate-buffered saline (PBS) for 10 min. Cells were permeabilized with 0.3% (wt/vol) 
Triton X-100 and 3.7% paraformaldehyde in PBS for 10 min at room temperature (RT). 
After fixation, cells were blocked in 3% (wt/vol) bovine serum albumin (BSA) in PBS for 
60 min, followed by addition of primary antibody (Ab) in the blocking solution for 60 
min. Cells were then washed three times in PBS, and species-specific IgG Alexa Fluor 
(Invitrogen) was added at a dilution of 1:1,000 in block solution for 60 min to detect 
primary Abs. Cells were washed three times in PBS and fixed on glass slides using the 
Prolong Antifade kit (Invitrogen). All steps were performed at RT. Images were obtained 
on a Zeiss inverted LSM510 confocal microscope using a 63×/1.40 Plan-Apochromat oil 
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lens. Anti-RSV M (clone B135), anti-RSV P protein (clone 3_5), and anti-RSV N protein 
(clone B130) monoclonal Abs were a kind gift of Earling Norrby and Ewa Bjorling. An 
anti-RSV F protein humanized mouse monoclonal Ab (palivizumab; MedImmune) was 
obtained from the Vanderbilt Pharmacy. F-actin was visualized using rhodamine 
phalloidin, and TO-PRO-3 iodide was used to visualize the nucleus (Invitrogen). 
 
Quantitative analysis of images. To determine filament length, images from 12 high-
powered fields were obtained on a Zeiss inverted LSM510 confocal microscope using a 
40×/1.30 Plan-Neofluar oil lens. Images were analyzed using laser scanning microscopy 
(LSM) image acquisition software (Rel 4.2; Zeiss). The length of virus-like filaments was 
determined using the ruler tool in the LSM software to trace individual filaments in the 
images. The four longest filaments measured per cell were used in calculation of overall 
filament length for each construct. For quantitation of the percentage of RSV F-
transfected cells showing filaments, images from 20 high-powered fields were collected 
on a Zeiss inverted LSM510 confocal microscope using a 20×/0.75 Plan-Apochromat 
lens. The percentage of RSV F-transfected cells with filaments was calculated by 
counting the total number of RSV F-transfected cells with filaments and dividing that 
number by the total number of RSV F-transfected cells. 
 
Quantitative analysis of total cell lysate. HEp-2 cells in 6-well plates were transfected 
with 0.4 µg of plasmid DNA encoding the indicated F-protein cytoplasmic tail (CT) 
construct using the Qiagen Effectene transfection reagent. Cells were harvested at 48 h 
after transfection using a single detergent lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 
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1% Triton X-100, pH 8.0) containing a 1:200 dilution of mammalian protease inhibitor 
cocktail (Sigma). Lysates were separated on 4 to 12% NuPAGE Bis-Tris gels and 
transferred to polyvinylidene difluoride (PVDF) membranes using an iBlot dry blotting 
system (Invitrogen). Membranes were blocked for 1 h using Odyssey blocking buffer (Li-
Cor) diluted 1:1 in PBS. Primary abs for β-actin (1:5,000; Abcam) or the RSV F protein 
(motavizumab expressed from recombinant cDNA; 0.85 µg/ml) were diluted in blocking 
buffer diluted 1:1 with PBS + 0.1% Tween 20 (PBS-T), applied to membranes, and 
incubated overnight at 4°C. Membranes then were washed four times in PBS + 0.1% 
Tween for 5 min each. Secondary abs were diluted 1:2,500 (goat anti-human IRDye 
680CW; Kirkegaard & Perry Labs Inc.) or 1:5,000 (goat anti-mouse IRDye 800CW; Li-
Cor) in blocking buffer and added to each membrane for 60 min. Membranes were 
washed four times in PBS-T. Bands were imaged and quantitated using the Odyssey 
infrared imaging system. The quantitative signals from RSV F protein bands were 
normalized against those of β-actin in the same lane and used to generate an expression 
(exp) ratio that represented a comparison of expression of the mutant F protein to that of 
the wt F protein. 
 
Flow cytometric assay for quantitative surface expression of RSV F. HEp-2 cells on 6-
well plates were transfected with 0.4 µg of each plasmid encoding the wt RSV M, N, and 
P proteins and either RSV F wt or a mutant F construct using the Effectene transfection 
reagent (Qiagen). After 48 h, cells were treated with 20 mM EDTA in PBS to form a 
single-cell suspension. Cells were washed two times in wash buffer (2% FBS in PBS) 
and then incubated with palivizumab at 1 µg/mL for 30 min at RT. Cell were washed 
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again two times with wash buffer and immunostained with an Alexa Fluor goat anti-
mouse 488 secondary ab at a final concentration of 2 µg/mL. Cells were washed two 
times in wash buffer and analyzed on a 5-laser custom LSR II flow cytometer (Becton 
Dickinson) in the Vanderbilt Medical Center Flow Cytometry Shared Resource. Data 
analysis was performed using the FlowJo software program (version 7.6.1). Weighted 
mean fluorescent intensity (MFI) was calculated by multiplying the raw mean fluorescent 
intensity by the frequency of positive cells. All flow cytometry data from Fig. 3, 4, and 5 
were collected using the same negative and positive control samples in three independent 
experiments. Statistical analysis was performed using a Student T-test. P values less than 
0.05 were considered significant. 
 
RSV rescue system. The RSV wt strain A2 antigenomic cDNA was constructed by 
sequential ligation of RSV cDNA fragments and placed under control of T7 polymerase 
promoter in a BAC recombineering vector pKBS3. The RSV genome plasmid was 
constructed to contain a T7 termination sequence at the end, preceded by a hepatitis delta 
virus ribozyme motif that mediates self-cleavage to produce an authentic copy of the 
negative-sense RNA genome of RSV (85). Optimized RSV genes N, P, L, and M2-1 
genes, the RSV A2 antigenome were transfected into BHK-T7 cells at	  0.4	  µg of	  N,	  P,	  and	  M2-­‐1	  and	  0.2	  µg of	  L,	  as	  previously	  described	  (49). The T7 polymerase is expected to 
transcribe the RSV antigenome, which undergoes auto-cleavage to remove the T7 
termination sequence, and thus create the negative-sense single stranded RNA genome of 
RSV. N, P, L, and M2-1 are expressed under the CMV early-immediate promoter and 
form a replication complex to start transcription of the RSV negative-sense genome. 
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These transcripts are translated by host ribosomes and lead to the expression of viral 
proteins that contribute to the production of infectious virus. At day 3-6 post transfection, 
cell supernatant and cell lysates subjected to a freeze/thaw, are passed onto a fresh 
monolayer of HEp-2 cells.  
 
VLP assay. A recent protocol developed for the generation of human metapneumovirus 
VLPs (R. G. Cox and J. V. Williams, unpublished results) was modified for the 
production of RSV VLPs. 293-F cells were transfected with plasmids encoding either 
vector alone or RSV M, N, P, and the indicated RSV F construct in equal amounts. 
Seventy-two hours after transfection, cell supernatants and pellets were separated and 
collected by using low-speed centrifugation. Cell pellets were resuspended in cell lysis 
buffer as described above. Cell supernatant was pelleted through a 20% sucrose cushion 
using a Sorvall Surespin 630 rotor at 26,000 rpm for 90 min. The resulting pellet was 
resuspended in equal volumes of cell lysis buffer with protease inhibitors (Sigma). 
Western blotting was performed as described above. The quantitative signals from RSV 
F, M, N, or P protein bands were corrected for background using vector alone and then 
normalized to the signal from wt F CT. Bars represent the means and standard deviations 
for three independent experiments. Statistical analysis was performed using Student T-
test. All values less than 0.05 were considered significant. 
 
Transmission electron microscopy (TEM). VLP transfections were prepared as described 
for the VLP assay with F CT wt. For RSV-infected samples, 293-F cells were inoculated 
at an MOI of 0.05 for 72 h. Cell supernatants were clarified and pelleted though 20% 
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sucrose in sterile MHN buffer (0.1 M MgSO4, 50 mM HEPES, 150 mM NaCl). Pellets 
were resuspended in 20% sucrose in MHN, applied to formvar-carbon grids with 300 
mesh Cu (Ted Pella Inc.), and stained with 1% aqueous sodium phosphotungstate acid 
(Electron Microscopy Sciences). Grids were imaged on a FEI Morgagni electron 
microscope operated at an acceleration voltage of 100 kV. Images were collected using a 
1,000 × 1,000 active pixel charge-coupled-device (CCD) camera (AMT) at a 
magnification of 44,000x. Image contrast was enhanced in the Adobe Photoshop (CS5) 
software program using the levels adjustment. Shadow and highlight input sliders were 
adjusted to the beginning and end of the histogram curve to optimize tonal levels for the 
entire image; middle tones were not adjusted. 
 
Results 
Generation of F CT constructs. In the previous chapter, I established that virus-like 
filaments can be generated independent of viral infection by transfecting HEp-2 cells 
with cDNAs encoding F, M, N, and P (Figure 2-2). Consistent with RSV filaments 
formed during infection, virus-like filaments contained RSV proteins and were often 
kinked, clustered, and stained brightly for the F protein. Virus-like filaments were also 
distinct from host cell protrusions that contained F-actin (Figure 3-2 E-H). Thus, the 
filaments formed using the transfection-based procedure were similar to filaments formed 
during viral infection in both morphology and composition. We used the transfection-
based filament formation assay as a tractable system with which to study the role of the F 
protein CT domain in viral assembly at the plasma membrane. I designed a panel of 
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Figure 3-1. Schematic of F CT constructs. Panel A: F CT mutant constructs were 
generated using site-directed mutagenesis from F CT wt in the pcDNA3.1 vector. 
Functional regions are indicated by color: SS, signal sequence (orange); ectodomain 
(blue); TM, transmembrane domain (green); CT, cytoplasmic domain (purple). Panel B: 
Sequences of the TM and CT domain are indicated for each construct. Point mutations 
are indicated in red. We designated residue K as F CT residue 1. The schematic is not to 
scale.  
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Figure 2
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vector. Functional regions are indicated by color: SS 
= signal sequence (orange), ectodomain (blue), TM = 
transmembrane domain (green), CT = cytoplasmic 
domain (purple); Panel B: Sequences of the TM and 
CT domain are indicated for each construct. Point 
mutations are indicated in red. We designated 
residue K as FCT residue 1. Schematic is not to 
scale. 
FCT F22Y IMITTIIIVIIVILLSLIAVGLLLYCKARSTPVTLSKDQLSGINNIAYSN
FCT S23T IMITTIIIVIIVILLSLIAVGLLLYCKARSTPVTLSKDQLSGINNIAFTN
FCT N24Q IMITTIIIVIIVILLSLIAVGLLLYCKARSTPVTLSKDQLSGINNIAFSQ
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altered cDNAs of the F protein gene in which the CT domain was truncated or otherwise 
mutated (Figure 3-1) using site directed mutagenesis. I then tested the effect of the tail 
mutations on virus-like filament formation at the cell surface using the transfection based 
assay. 8 
 
RSV F CT terminal residues Phe-Ser-Asn are required for filament formation. I 
asked here whether the CT domain was dispensable for viral assembly into filaments at 
the cell surface. When expressed alone, the F protein with an intact cytoplasmic tail (F 
CT wt) did not form virus-like filaments and localized to cellular projections that 
contained F-actin (Fig. 3-2 A-D). However, when coexpressed with M, N, and P, F CT wt 
was able to form virus-like filaments that were distinct from cellular projections 
containing F-actin (Fig. 3-2 E-H). Therefore, I used the presence of F-actin as a marker to 
distinguish virus-like filaments from cellular projections, since only the latter contained 
F-actin. In contrast to F CT wt, deletion of the terminal 3 amino acids from the F CT 
(residues Phe-Ser-Asn, or FSN) resulted in loss of virus-like filament formation and 
altered localization of the F protein only to F-actin-containing cellular protrusions (Fig. 
3-2 I-L). This pattern of altered F staining at the cell surface was similar to the pattern of 
F CT wt when expressed alone in HEp-2 cells (i.e., in the absence of the RSV N, P, and 
M proteins). Deletion of the three terminal amino acids of the CT domain resulted in the 
same phenotype of F distribution as deletion of the entire tail domain (Fig. 3-2 M-P). 
This F CT deletion construct was similar to the transmembrane-domain-plus- 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  Figures 3-1 through 3-9 were previously published as part of an original manuscript. Shaikh et al. 2012. 
A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates 
assembly of internal viral proteins into viral filaments and particles. mBio. 2012 Feb 7;3(1). pii: e00270-11. 
doi: 10.1128/mBio.00270-11. Print 2012	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Figure 3-2: F CT terminal residues Phe-Ser-Asn are required for filamentous 
assembly at the cell surface. HEp-2 cells were transfected with F CT wt only (A to D) or 
with the indicated F CT construct and plasmids encoding RSV M, N, and P (E-P). 
Column 1 shows images of the whole cell (A, E, I, and M). Columns 2 to 4 (B to D, F to 
H, J to L, and N to P) show an enlargement of the corresponding inset in column 1. 
Column 2 shows actin staining only (B, F, J, and N); column 3 shows RSV F staining 
only (C, G, K, and O); and column 4 shows the overlay, with actin in red and RSV F in 
green (D, H, L, and P). (Q) Total cell lysate was collected from HEp-2 cells transfected 
with the indicated F CT construct, and RSV F or actin was detected by immunoblotting. 
The RSV F band was normalized against actin, and the expression (exp) ratio represents a 
normalization to results for F CT wt. (R) Total surface expression of RSV F was 
determined by flow cytometry using HEp-2 cells transfected with the indicated F CT 
construct and RSV M, N, and P. Data are plotted as means, and error bars represent 
standard deviations. Weighted MFI is mean fluorescence intensity (MFI) × the frequency 
of positive cells. MPV F wt is used as a specificity control.  
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Figure 3-2. FCT terminal residues Phe-Ser-Asn are required for filamentous assembly at the cell 
surface. HEp-2 cells were transfected with FCT wt only (A-D) or with indicated FCT construct and plasmids 
encoding RSV M, N, and P (E-P). Column 1 shows images of the whole cell (panels A, E, I, and M). Columns 
2-4 (panels B-D, F-H, J-L, and N-P) show an enlargement of the corresponding inset in column 1. Column 2 
shows actin staining only (panels B, F, J, and N) ; Column 3 shows RSV F staining only (panels C, G, K, and 
O); and column 4 shows the overlay with actin in red and RSV F in green (panels D, H, L, and P). Panel Q: 
total cell lysate was collected from HEp-2 cells transfected with indicated FCT construct, and RSV F or actin 
were detected by immunoblot. RSV F band was normalized against actin, and the expression (exp) ratio 
represents a normalization to FCT wt. Panel R: total surface expression of RSV F was determined by flow 
cytometry using HEp-2 cells transfected with indicated FCT construct and RSV M, N, and P. Data are plotted as 
mean, and error bars represent standard deviation. Weighted MFI = mean fluorescence intensity (MFI) x the 
frequency of positive cells. MPV Fwt is used as a specificity control. 
p < 0.005
p > 0.05
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one-anchor-residue (“TM+1”) construct that we previously described (10) and is 
designated F CTΔ23. For each truncation construct, total cellular expression and total 
surface expression of the F protein were determined to be at levels equivalent to those of 
F CT wt (Fig. 3-2 Q and R, respectively). Therefore, reduced expression or trafficking of 
the mutant protein to the cell surface was not responsible for the failure of these CT 
truncation constructs to form virus-like filaments. These data indicate that the terminal 
CT residues Phe-Ser-Asn are required for assembly of RSV proteins into virus-like 
filaments. 
 
Phe-Ser-Asn residues are sufficient for viral protein assembly into filaments at the 
cell surface. Based on the data presented in Figure 3-2, I next sought to determine 
whether the specific C-terminal residues Phe-Ser-Asn of F CT were necessary for 
filament formation when coexpressed with M, N, and P or, alternatively, if only the 24-
amino-acid length of the CT domain determined filament formation. I mutated all three 
terminal residues to alanines (F CTΔ3 AAA) to test the hypothesis that a CT of a certain 
length was necessary for viral assembly. F CTΔ3 AAA was impaired for virus-like 
filament formation when coexpressed with RSV M, N, and P (Fig. 3-3 E-H) compared to 
F CT wt (Fig. 3-3 A-D). To determine if residues Phe-Ser-Asn were sufficient for virus-
like filament formation, I deleted the entire F CT except for the terminal residues Phe-
Ser-Asn (designated FΔCT FSN). FΔCT FSN formed virus-like filaments at the cell 
surface (Fig. 3-3 I-L) that were similar in length to F CT wt filaments (Fig. 3-3M), but the 
percentage of transfected cells with filaments was reduced 10-fold (Fig. 3-3N). These  
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Figure 3-3. FCT residues Phe-Ser-Asn are sufficient for filamentous assembly at the cell surface. 
HEp-2 cells were transfected with indicated FCT construct and RSV M, N, and P (A-L). Column 1 shows 
images of the whole cell (panels A, E, and I). Columns 2-4 (panels B-D, F-H, and J-L) show an enlarge-
ment of the corresponding inset in column 1. Column 2 shows actin staining only (panels B, F, and J); 
column 3 shows RSV F staining only (panels C, G, and K); and column 4 shows the overlay with RSV F in 
green and actin in red (panels D, H, and L). Panel M and N: HEp-2 cells were transfected as described for 
A-L. Filament length was determined by measuring the length of individual filaments using Zeiss LSM 
software as described in Materials and Methods (panel M). Percent transfected cells was determined by 
counting RSV F transfected cells with filaments and then dividing that number by the total number of RSV 
F transfected cells (panel N). Panel O: total cell lysate was collected from HEp-2 cells transfected with 
indicated FCT construct, and RSV F and actin were detected by immunoblot. RSV F band was normalized 
against actin, and the expression (exp) ratio represents a normalization to FCT wt. Panel P: total surface 
expression of RSV F was determined by flow cytometry using HEp-2 cells transfected with indicated FCT 
construct and RSV M, N, and P. Data are plotted as mean, and error bars represent standard deviation. 
Weighted MFI = mean fluorescence intensity (MFI) x the frequency of positive cells. MPV Fwt is used as a 
specificity control.
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Figure 3-3. F CT residues Phe-Ser-Asn are sufficient for filamentous assembly at the 
cell surface. HEp-2 cells were transfected with the indicated F CT construct and RSV M, 
N, and P (A to L). Column 1 shows images of the whole cell (A, E, and I). Columns 2 to 
4 (B to D, F to H, and J to L) show an enlargement of the corresponding inset in column 
1. Column 2 shows actin staining only (B, F, and J); column 3 shows RSV F staining 
only (C, G, and K); and column 4 shows the overlay, with RSV F in green and actin in 
red (D, H, and L). (M and N) HEp-2 cells were transfected as described for panels A to L. 
Filament length was determined by measuring the lengths of individual filaments using 
Zeiss LSM software as described in Materials and Methods (M). Percent transfected cells 
was determined by counting RSV F-transfected cells with filaments and then dividing 
that number by the total number of RSV F-transfected cells (N). (O) Total cell lysate was 
collected from HEp-2 cells transfected with the indicated F CT construct, and RSV F and 
actin were detected by immunoblotting. The RSV F band was normalized against actin, 
and the expression (exp) ratio represents a normalization to F CT wt. (P) Total surface 
expression of RSV F was determined by flow cytometry using HEp-2 cells transfected 
with the indicated F CT construct and RSV M, N, and P. Data are plotted as means, and 
error bars represent standard deviations. Weighted MFI is mean fluorescence intensity 
(MFI) × the frequency of positive cells. MPV F wt is used as a specificity control.  
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data suggest that other residues in the CT or a minimum length of the CT is important for 
initiation of filament formation. The total cellular expression and total surface expression 
of F CTΔ3 AAA or FΔCT FSN were similar to those of F CT wt, again indicating that 
neither expression nor trafficking to the cell surface was impaired (Fig. 3-3O and 3-3P, 
respectively). These data suggest that the tri-peptide consisting of residues Phe-Ser-Asn 
is necessary and sufficient for assembly of viral structural proteins into virus-like 
filaments at the cell surface. 
 
The Phe residue in the RSV F CT is necessary for filament formation. To determine 
if a specific residue of the F CT Phe-Ser-Asn motif was the determining factor for viral 
assembly into filaments, I designed F CT constructs that contained mutations of each of 
the three terminal residues individually. We compared the capacity of the mutant F CT 
constructs to form virus-like filaments when coexpressed with M, N, and P to that of F 
CT wt (Fig. 3-4 A-D). When the Phe residue was mutated to an alanine (F22A), virus-like 
filaments failed to form, and the F construct colocalized with cellular structures 
containing F-actin (Fig. 3-4 E-H). However, if either the Ser or Asn residue was mutated 
to an Ala, the mutant F CT constructs assembled into virus-like filaments, distinct from 
cellular structures containing F-actin (Fig. 3-4 I-L and 3-4 M-P, respectively). Total 
cellular expression and total surface expression of each of the F CT constructs with single 
amino acid mutations were equivalent to F CT wt levels, indicating that neither 
expression nor trafficking was impaired (Fig. 3-4Q and 3-4R, respectively). We also 
designed and tested F CT constructs with conserved mutations (F22Y, S23T, and N24Q). 
Figure 3-5 shows the effect of these mutations on filament formation. Mutation of Phe to  
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Figure 3-4. The Phe residue at position 22 in the RSV F CT is necessary for 
filamentous assembly at the cell surface. HEp-2 cells were transfected with the 
indicated F CT construct and RSV M, N, and P (A to P). Column 1 shows images of the 
whole cell (A, E, I, and M). Columns 2 to 4 (B to D, F to H, J to L, and N to P) show an 
enlargement of the corresponding inset in column 1. Column 2 shows actin staining only 
(B, F, J, and N); column 3 shows RSV F staining only (C, G, K, and O); and column 4 
shows the overlay, with RSV F in green and actin in red (D, H, L, and P). (Q) Total cell 
lysate was collected from HEp-2 cells transfected with the indicated F CT construct, and 
RSV F or actin were detected by immunoblotting. The RSV F band was normalized 
against actin, and the expression (exp) ratio represents a normalization to F CT wt. (R) 
Total surface expression of RSV F was determined by flow cytometry using HEp-2 cells 
transfected with the indicated F CT construct and RSV M, N, and P. Data are plotted as 
means, and error bars represent standard deviations. Weighted MFI is mean fluorescence 
intensity (MFI) × the frequency of positive cells. MPV F wt is used as a specificity 
control.  
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Figure 3-4. The Phe residue at position 22 in the RSV FCT is necessary for filamentous assembly at the 
cell surface. HEp-2 cells were transfected with indicated FCT construct and RSV M, N, and P (A-P). Column 1 
shows images of the whole cell (panels A, E, I, and M). Columns 2-4 (panels B-D, F-H, J-L, and N-P) show an 
enlargement of the corresponding inset in column 1. Column 2 show actin staining only (panels B, F, J, and N); 
column 3 shows RSV F staining only (panels C, G, K, and O); and column 4 shows the overlay with RSV F in 
green and actin in red (panels D, H, L, and P). Panel Q: total cell lysate was collected from HEp-2 cells trans-
fected with indicated FCT construct, and RSV F or actin were detected by immunoblot. RSV F band was 
normalized against actin, and the expression (exp) ratio represents a normalization to FCT wt. Panel R: total 
surf ce xpressi n of RSV F was determined by flow cyto etry using HEp-2 cells transfected with indicated 
FCT construct and RSV M, N, and P. Data are plotted as mean, and error bars represent standard deviation. 
Weighted MFI =mean fluorescence intensity (MFI) x the frequency of positive cells. MPV Fwt is used as a 
pecificity control. 
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Figure 3-5. Conservative mutations in the F CT have similar results to alanine 
mutations. HEp-2 cells were transfected with the indicated F CT construct and RSV M, 
N, and P. RSV F and N were detected by indirect immunofluorescence (A-F). Filament 
length was determined by measuring the lengths of individual filaments using Zeiss LSM 
software as described in Materials and Methods (G) 
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Tyr (F22Y) did not retain the capacity to form virus-like filaments (Fig. 3-5B). Mutation 
of the Ser to Thr (S23T) or Asn to Gln (N24Q) resulted in F CT constructs are capable of 
forming filaments (Fig. 3-5D and 3-5F). The results from these conservative mutations 
were similar to the data described for the Ala point mutations in Figure 3-4. Finally, I 
also examined the length of virus-like filaments formed when these point mutations were 
introduced into the F CT (Figure 3-5G). Mutation of the Ser or Asn resulted in virus-like 
filament length that was at or greater than that of the wt F CT. Collectively, these data 
show that the Phe residue near the C-terminal end of F CT plays a key role in filamentous 
viral assembly at the plasma membrane. 
 
A recombinant virus lacking residues Phe-Ser-Asn does not result in viable virus. 
Since the terminal residues, particularly the Phe residue, are essential for virus-filament 
formation, I introduced the F CTΔ3 mutation into a recombinant virus using a plasmid-
based virus rescue system. Using a BAC recombineering approach developed by our 
collaborators Anne Hotard and Marty Moore at Emory University, I generated the mutant 
genomic cDNA and transfected the F CTΔ3 cDNA, along with helper plasmids encoding 
RSV N, P, L, and M2-1, into BHK cells that constitutively express T7 polymerase. 
Figure 3-6 shows that at 3 days after transfection, multiple syncytia could be seen, 
indicating that transcripts of F CTΔ3 were being made and expressed in these cells 
(indicated by the red arrows). However, when the supernatant or cell-associated fractions 
were harvested and passed onto a fresh monolayer of HEp-2 cells for expansion, virus 
was not recovered. Although the formation of syncytia normally indicates that virus is 
being generated, syncytia can also occur when the F protein is expressed. During the  
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Figure 3-6. Transfection of genomic cDNA containing the F CTΔ3 mutation results 
in cell-to-cell fusion. BHK-T7 cells were transfected with plasmids encoding the F CTΔ3 
A2 genomic cDNA and helper plasmids: N, P, L, and M2-1. AT 3 days post transfection, 
cells were imaged using phase contrast microscopy. Red arrows indicate syncytia.   
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initial transfection of the genomic construct into BHK cells, F transcript is likely 
generated, and the mutant F protein (F CTΔ3) is expressed at the cell surface, where it 
can mediate cell-to-cell fusion. However, the F CTΔ3 protein may be unable to mediate 
viral assembly and budding. Therefore, the fact that viable virus could not be generated 
from the rescue transfections suggests that alteration of the F CT in this way likely 
drastically affects viral assembly. 9 
 
Development of an RSV VLP assay in 293-F cells. Since a recombinant F CTΔ3 virus 
could not be recovered, I then sought to develop a VLP assay to determine the 
mechanism by which the F CT Phe residue affected viral assembly. Previously, I had 
developed a 293T-cell-based assay using metabolic labeling to detect VLPs (Figure 2-3). 
This assay, however, did not lend itself easily to screening many F CT constructs. In 
collaboration with Reagan Cox and John Williams at Vanderbilt University, I developed 
an RSV VLP assay using 293-F suspension cells. Figure 3-7A shows a general schematic 
of the assay. 293-F cells were used for their high growth rate, dense cell growth, and 
transfection efficiency, all of which have been limiting factors in previous efforts to 
develop VLP assays with conventional transformed epithelial cells lines, such as HEp-2 
cells. Plasmids encoding F, M, N, and P were transfected into cells. At 72 hours post 
transfection, cells were pelleted using low-speed centrifugation. Cell lysates were 
collected, and the clarified supernatants were pelleted through a 20% sucrose cushion to 
remove free protein. The resulting pellet was resuspended in cell lysis buffer, and both 
cell lysates and supernatant pellets were separated by SDS-PAGE. Using this system, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 Images were collected with assistance from Reagan Cox in the laboratory of John Williams on a phase 
contrast microscope in the laboratory of Terence Dermody 
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sufficient quantities of VLPs were produced for protein quantification by immunoblotting 
using the Lycor Odyssey infrared imaging system rather than radiolabeling.  
 Next, I sought to determine the optimal combination of proteins to produce RSV 
VLPs. The F, M, N, and P proteins are the minimal requirements for passage of a 
minigenome construct consisting of the RSV leader and trailer sequences flanking a 
reporter gene (91). I had previously found that the F protein alone is insufficient for 
detectable VLPs using a radiolabeling assay (Figure 2-3). However, as described above, 
the previous assays were not optimal. Figure 3-7B shows the results obtained using 
supernatants harvested from transfection of 293-F cells with plasmids encoding vector 
only, F alone, F and M, F and N, or all four proteins: F, M, N, and P. The results show 
that while F alone is detectable in the supernatant, more F was present in the supernatant 
when M was coexpressed, and the most F was detectable when all four proteins are 
expressed. Furthermore, less M and N was incorporated into VLPs when only two 
proteins were present. In contrast, when all four proteins are expressed, internal proteins 
M, N, and P were efficiently incorporated into VLPs. The data from three independent 
experiments were quantified for each protein by raw I.K.K. counts using the Odyssey 
imaging software (Fig. 3-7 C-F).  
At first glance, these date seem contradictory to the data presented in Figure 2-3. 
However, there are several caveats that need to be considered. First, the original data in 
the literature reflected the capacity of proteins to passage a minigenome not form VLPs. 
Second, VLP production in adherent 293-T cells was highly inefficient, requiring 
radiolabeling to detect VLPs. Third, 293-F cells are suspension cells that have been 
optimized for protein expression and therefore are very likely efficient at protein 
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secretion. Hence, the detection of F in the supernatant when it was expressed by itself 
may reflect the inherent capacity of the F protein to bud, the tendency of 293-F cells to 
secrete protein, or cell sheering. Thus, this system is unlikely to answer the question of 
what proteins are the minimum requirements for RSV budding, but it can still be used to 
determine the effect of F CT mutations on VLPs and incorporation of the internal virion 
proteins.  
Since we found that F, M, N, and P are minimally required for filament formation 
independent of viral infection, we chose to express VLPs using all four proteins to 
recapitulate the minimum requirements for assembly into filaments. RSV VLPs were 
produced by transfecting 293F cells with plasmids encoding the indicated F construct and 
wt M, N, and P. TEM analysis of VLPs showed characteristic F-protein spikes (black 
arrows) on the surface of particles similar to those seen on RSV virion particles produced 
and imaged in the same manner (Fig. 3-8A and B). Second, the diameter of the VLPs was 
similar to that of RSV and within the usual range of diameter of virions grown in other 
cell types (4). In addition to structure, we also compared the protein composition of VLPs 
with that of native virus. Figure 3-8C shows a representative immunoblot comparing the 
level of each viral protein in the VLPs to that in virions. These data were quantified from 
three independent experiments and are presented as percentages of RSV virion protein 
levels (Fig. 3-8D). Compared with virus, the VLPs contained equivalent amounts of the F 
protein but less M, N, and P. Although the ratios of the F protein to internal proteins 
differed between VLPs and RSV, VLPs did still incorporate RSV internal proteins, thus 
allowing us to study the relative capacities of various F CT constructs to incorporate  
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Figure 3-7. Establishment of the 293-F VLP assay. Panel A shows a schematic of the 
VLP assay. 293-F cells were transfected with the indicated plasmids. At 72 hours post 
transfection, cells were pelleted using low speed centrifugation. Cell lysates were 
collected and the clarified supernatants were pelleted through a 20% sucrose cushion to 
remove free protein. The resulting pellet was resuspended in cell lysis buffer, and both 
cell lysates and supernatant pellets were separated by SDS-PAGE. The indicated proteins 
were detected by immunoblot. Panel B shows a representative experiment of the cell 
supernatant fraction from the indicated transfections. Panel C shows a quantification of 
data from three independent experiments as shown in panel E (cell lysates in grey; VLPs 
in black). Data are plotted as means, and error bars represent standard deviations. 
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Figure 3-8. RSV VLPs generated from transfection of F, M, N, and P are similar to 
virions generated and collected in the same manner. 293-F cells were transfected with 
plasmids encoding RSV F CT wt, M, N, and P or infected with RSV at an MOI of 0.05. 
Panels A and B show transmission electron micrographs of a representative VLP and 
virion, respectively. Scale bars represent 100 nm. (C to D) Supernatants from RSV-
infected or F CT wt-transfected cells were clarified and pelleted through a 20% sucrose 
cushion. Panel C shows a representative blot comparing protein levels in VLPs to RSV. 
Panel D shows a quantification of three independent experiments as shown in panel C. 
The indicated protein levels in VLPs were normalized to that of the corresponding 
protein in RSV. 
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internal virion proteins into budded vesicles. Several possibilities could explain the 
discrepancy of ratios. The VLPs may incorporate a higher proportion of F into each 
particle than M, N, and P, compared to those for virions, or there may be vesicles 
containing the F protein alone escaping into the supernatant. I favor the latter, since 
transfection of cDNA encoding the F protein alone led to a baseline transport of F into 
the supernatant (Fig 3-7B).  
 
The Phe residue is required for incorporation of RSV M, N, and P into RSV VLPs. 
Next, I sought to determine why the F CT Phe residue is required for virus assembly into 
filaments. I hypothesized that the F CT is necessary for recruitment of an internal virion 
protein to filaments and therefore also would function in the generation of VLPs. After 
initial validation of the VLP system, I sought to determine how the F CT Phe residue 
affected VLP budding and the incorporation of internal virion proteins. I performed the 
VLP assay as described above and collected the cell pellets for total protein expression. 
Figure 3-9A shows immunoblots from a representative experiment. Data were 
normalized to the levels in the F CT wt sample, and the means and standard deviations 
from three independent experiments are shown in Fig. 3-9B. Compared with F CT wt, 
when residues Phe-Ser-Asn were deleted (F CTΔ3), or Phe was mutated to an Ala 
(F22A), there was a significant loss of RSV M, N, and P protein incorporation into VLPs. 
In contrast, point mutations of residue Ser23 or Asn24 (S23A or N24A, respectively) did 
not affect incorporation of RSV M, N, or P into VLPs. The F CTΔ3 and F22A constructs 
also induced less transfer of the F protein into the supernatant than the F CT wt, S23A, or 
N24A constructs, consistent with less budding of VLPs. These data show that the Phe  
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Figure 3-9. The Phe residue at position 22 in the RSV F CT is necessary for 
incorporation of internal virion proteins into VLPs. 293-F cells were transfected with 
plasmids encoding the indicated F CT construct and RSV M, N, and P. Panel A shows a 
representative experiment with indicated protein levels in cell lysates (left) or VLPs 
(right). Panel B shows a quantification of data from three independent experiments as 
shown in panel A (cell lysates in grey; VLPs in black). Data are plotted as means, and 
error bars represent standard deviations. 
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residue in the F CT is necessary for RSV M, N, and P incorporation into VLPs. 
Collectively, the data in this chapter show that the F CT mediates viral assembly through 
a C-terminal Phe residue in order to incorporate RSV M, N, and P into virus filaments at 
the cell surface prior to budding. 
 
Mutations in the F CT Phe residue affect incorporation of M. Since mutations in the 
Phe residue resulted in loss of incorporation of all internal proteins, I next sought to 
determine which protein was involved. Since M, N, and P are thought to associate in the 
cytoplasm, it is reasonable that lost incorporation of all three proteins may be due to the 
fact that one protein is responsible for recruiting the others into VLPs. Since I previously 
showed that VLPs could be formed by expression of F and only one of the internal 
proteins (Figure 3-7), I performed the 293-F VLP assay using only two proteins, F and 
either M, N, or P. In addition, I used the F CT constructs to determine which one of the 
internal proteins was affected most by mutation in the F CT. Figure 3-10 shows the 
results from these experiments. When F+N or F+P VLPs were produced, there was no 
change in the amount of N or P incorporated with the different F CT constructs (Fig. 3-
9B and 3-9C, respectively). However in the F+M VLPs, the amount of M varied with 
mutations in the F CT (Fig. 3-9A). Mutation of the Phe residue result in less M 
incorporated than with wt F CT. However, more M was incorporated with F CTΔ3 and 
with mutation in the Ser or Asn residues. The reason for this variation is unclear, but may 
include non-specific incorporation when other internal proteins are absent, and the fact 
that variations in the CTs of viral glycoproteins can often affect the amount of 
glycoprotein and internal proteins in VLPs (43). Further study of the interactions between  
	   74 
 
 
Figure 3-10. Incorporation of M into F+M VLPs is affected by mutations in the F 
CT. 293-F cells were transfected with plasmids encoding the indicated F CT construct 
and RSV M, N, or P. Cell lysate and cell supernatants were harvested as described for 
Figure 3-7. Immunoblots from representative experiments for indicated proteins are 
shown. Panel A represents VLPs generated with the indicated F CT construct and M. 
Panel B represents VLPs generated with the indicated F CT construct and N. Panel C 
represents VLPs generated with the indicated F CT construct and P.  
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the F CT and internal virion proteins is necessary to fully understand the mechanism that 
drives incorporation of internal virion proteins into filaments and VLPs. 
 
Discussion 
The RSV F CT domain plays a critical role in viral replication, but the mechanism 
by which the F CT functions in assembly and budding has not been well characterized. In 
this study, I found that a single Phe residue in the F CT at amino acid position 22 
mediates assembly of virus-like filaments, incorporation of RSV internal proteins into 
VLPs, and subsequent budding of VLPs from cells. The finding that a single amino acid 
residue in the F CT can control both assembly and budding is remarkable. I studied the 
role of RSV proteins in assembly of filaments independent of viral infection by 
expressing proteins from plasmids, and I found that filament formation requires the F, M, 
N, and P proteins. This assembly process likely is driven by interactions of these viral 
proteins with each other or collectively with host proteins. Using cDNA-based expression 
of F proteins with alterations in the F CT, I determined the key residue in the F CT is 
required for assembly of virus-like filaments containing the four minimally required 
structural proteins, F, M, N, and P. Furthermore, I used a VLP budding assay under the 
same protein expression conditions to reveal that the F CT coordinates assembly through 
its capacity to incorporate M, N, and P into particles. These data provide a direct link 
between F CT coordination of viral assembly into filaments and budding of viral 
particles. Alternatively, the formation of filaments and virus particles may be two 
different outcomes of essentially the same assembly process, with the Phe residue serving 
in a critical role for both processes. 
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The specific mechanisms that govern F CT-mediated assembly, however, are still 
not well defined. Our data show that expression, trafficking, and surface expression of F 
are not affected by mutations in the F CT. This finding is consistent with findings of 
previous studies indicating that the TM domain of F is responsible for targeting the 
protein to the apical surface (5). Localization to specific lipid microdomains in the 
plasma membrane also appears to depend on an unidentified domain in the ectodomain 
(17). Therefore, it is likely that the F CT Phe residue I identified is critical for a protein-
protein interaction. A simple explanation may be that this residue directly interacts with 
one of the internal virion proteins, such as M, or a complex of these proteins. On the 
other hand, the F protein is a trimer, and the F CT is located in close proximity to the 
plasma membrane. It may be that the hydrophobic Phe residue confers a specific 
conformation to the cytoplasmic portion of the trimer. Finally, the possibility of an 
interaction with a host protein or complex of proteins cannot be excluded. Future studies 
will focus on elucidating the specific protein-protein interactions mediated by the F CT 
and how these interactions lead to the incorporation of other viral proteins into filaments. 
Coordination of RSV assembly by the F CT is consistent with many other studies 
indicating that paramyxovirus glycoprotein cytoplasmic tails are crucial to both assembly 
and budding (13). For RSV and human metapneumovirus (HMPV), members of the 
Pneumovirus subfamily, the G protein is dispensable for viral replication in vitro (18, 19). 
Although the F CT may be sufficient, optimal incorporation of viral proteins and RNA 
might require both F and G, since residues in the RSV G protein CT are thought to be 
important for interactions with M (20). However, for the Paramyxoviridae subfamily, the 
requirement of glycoprotein CTs varies with each virus. For measles virus and Sendai 
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virus assembly, the F protein CT is required. Newcastle disease virus F and HN 
glycoproteins interact with different internal viral proteins, M and N, respectively. In 
contrast, the F and HN CTs of parainfluenza virus 5 serve somewhat redundant functions 
(13). The lack of a common theme for the role of CT domains in paramyxoviruses may 
simply indicate that many questions about the specific mechanisms of viral assembly 
remain unanswered, and further investigation into the RSV F CT may contribute to 
general knowledge regarding glycoprotein CT-mediated assembly for other 
paramyxoviruses. 
In addition to viral protein incorporation, the formation of RSV particles at the 
cell surface requires viral interactions with the host cell membrane. The viral membrane 
first must be deformed outward as an extension of the cell membrane. Then, the particle 
must elongate by incorporation of additional membrane to create long filaments. Finally, 
a scission event must occur to release the viral particle from the cell membrane. All of 
these processes are energy intensive and require complex coordination of surface proteins 
and nucleocapsids containing RNA and viral proteins (21). Many viruses usurp 
endosomal sorting complexes required for transport (ESCRT) machinery to accomplish 
the task of outward bud formation and membrane scission using late domains found in 
viral proteins (13). Viral budding using late domains requires the AAA ATPase Vps4. 
However, inhibition of Vps4 does not affect RSV budding (6), and like other ESCRT-
independent viruses, RSV may use viral protein-mediated pushing and pulling forces to 
initiate membrane bending at lipid microdomains in order to exit the cell (21). RSV 
assembles into filaments at lipid microdomains (22, 23). The RSV F protein associates 
with detergent-resistant membranes (DRMs), as do the RSV M, N, P, M2-1, and L 
	   78 
proteins during viral infection (17, 23–25). Furthermore, the M protein associates with 
lipid microdomains in the presence of the F protein (26). Our data suggest that the Phe 
residue in the F CT is critical for F-protein interactions with internal virion proteins to 
provide both the pulling and pushing forces required to bend the membrane to form 
filaments, presumably at lipid microdomains. Our data also provide some insight about 
how the F CT mediates initial membrane bending and filament elongation. The capacity 
of a shortened CT with only residues Phe-Ser-Asn to form virus-like filaments was 
reduced by 10-fold. However, once the filament formation process was initiated, the 
shortened CT was able to induced filaments that elongated to lengths comparable to those 
generated by F CT wt. These data suggest that other residues, or a minimum length, of 
the CT is important for initiation of outward bud formation. 
Manipulation of the plasma membrane also likely involves a variety of host 
proteins that function at the cell surface. Many cellular structures extending outward from 
the cell surface depend on actin polymerization (e.g., microvilli, filapodia, lamellipodia, 
and membrane ruffles), and lipid microdomains have been linked to the cortical actin 
network (27). In fact, disruption of actin-associated signaling pathways affects filament 
formation, and β-actin and actin-related proteins are found in the same sucrose gradient-
purified fractions as RSV (15, 28–32). However, actin polymerization is dispensable for 
filament formation, and F-actin is excluded from viral filaments (15). While actin and 
actin-related proteins likely are involved in aspects of RSV assembly, our data support 
the hypothesis that the process by which viral proteins extend the cell membrane outward 
to form filaments is distinct from the process used by actin-based cellular structures. 
Exclusion of cellular proteins from viral filaments also suggests a mechanism allowing 
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specific sorting of viral and host proteins into filaments, a process that likely is highly 
regulated and involves interactions among viral proteins, host proteins, and lipid 
microdomains. 
Despite these studies, the mechanism by which RSV assembles and buds is still 
poorly understood. Viral protein-protein and protein-lipid interactions likely play a 
significant role, and further investigation could yield insight into what motifs mediate 
these interactions for both viral and cellular proteins. Further study of RSV assembly and 
budding will contribute to general understanding of how ESCRT pathway-independent 
viruses can exit the cell and how viral surface and internal proteins contribute to egress. 
Finally, understanding the mechanisms that drive RSV assembly and budding could lead 
to targeted development of novel antiviral drugs for prophylactic or therapeutic use 
against RSV infection. 
 
Chapter Summary 
 Since the data from chapter II indicate that viral filamentous assembly is largely 
driven by viral proteins themselves, I sought to define those viral determinants in this 
chapter. These data identify specific residues in the F CT that are important for viral 
assembly into filaments. Furthermore, the data indicate that the mechanism by which the 
Phe residue in the F CT mediates filament formation is through incorporation of internal 
virion proteins though the mechanism remains unknown. Finally, I show that the M 
protein is a likely target of the F CT, although a direct protein interaction is not shown 
and may be mediated by host proteins. Collectively, these data indicate that the F CT is a 
driving force behind viral assembly into filaments.  
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Chapter IV 
 
VIRUS INTERACTIONS WITH THE HOST CELL 
 
Introduction 
In addition to viral determinants, many host proteins are implicated in virus 
assembly and budding. Disruption of apical recycling endosome (ARE) proteins myosin 
Vb and Rab11-family interaction protein 1 (FIP1) results in decreased production of viral 
progeny (9). Additionally, inhibition of Rab11-FIP2 causes increased cell-associated 
infectious virus and longer viral filaments on infected polarized MDCK cells, suggesting 
a defect in membrane scission to produce free virions (97).  Lipids and lipid-associated 
proteins are implicated in RSV assembly (62). RSV proteins associate with detergent-
resistant membranes and co-localize with lipid microdomain markers (13, 28, 62).  
In the previous chapter, I showed that the F CT, and specifically a Phe located 
three residues from the C terminus of F CT, is critical for viral assembly into filaments. 
However, the mechanism by which the F CT coordinates viral assembly and budding is 
not clear, and the role of host factors in viral replication is unclear. In this chapter, I 
describe the use of several approaches to investigate RSV interactions with the host cell. 
First, I test whether the F CT facilitates viral assembly through interaction with host 
factors by validating the results from a Y2H screen. Second, I examine how host factors 
may affect the function of the M protein and its role in viral assembly and budding using 
a Y2H screen host gene expression, knockdown cell lines, and pharmacologic inhibitors. 
Third, I test the role of an exosome pathway in viral budding using chemical inhibitors to 
	   81 
neutral sphingomyelinase. Finally, I further investigate the role of ARE proteins in viral 
replication using a mouse model. These studies further elucidate the function of host 
proteins in RSV replication.  
 
Materials and methods 
Cell culture and wt RSV virus preparations. HEp-2 cells (ATCC CCL-23) were 
maintained in Opti-MEM I medium (Invitrogen) containing 2% (vol/vol) fetal bovine 
serum (FBS), 1% (vol/vol) l-glutamine, 2.5 µg/ml amphotericin B, and 1% (vol/vol) 
penicillin-streptomycin. Human bronchial epithelial cells (HBE σ16) were maintained in 
10% vol/vol) FBS, 1% (vol/vol) l-glutamine, 2.5 µg/mL amphotericin B, and 1% 
(vol/vol) penicillin-streptomycin. Transfections were performed using the Effectene 
transfection reagent (Qiagen) for HEp-2 cells. The RSV wt strain A2 was expanded in 
HEp-2 cells, and RSV/GFP (kindly provided by MedImmune) was expanded in Vero 
cells.  
 
RSV infections and viral titration. For filament visualization, HEp-2 cell monolayers on 
12-mm micro-cover glasses (no. 2; VWR) were inoculated at a multiplicity of infection 
(MOI) of 1.0 and incubated for 24 h. For quantification of viral yield in the presence of 
inhibitors and in knockdown cell lines, HEp-2 cell monolayers were inoculated at various 
MOIs (see assay for details). Cells were then washed and medium was added containing 
either vehicle, indicated inhibitor, or normal media for knockdown cell lines. At time of 
harvest, cell supernatant was harvested and normalized for volume. The samples were 
then clarified of cellular debris by centrifugation in a microcentrifuge at 13,000 rpm for 
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10 min. The resulting supernatant was designated as supernatant virus. The cell 
monolayer was resuspended in an equal volume of medium, scraped, and freeze/thawed 
3x using a dry ice/ethanol bath and a 37 °C water bath. The samples then were clarified 
of cellular debris by centrifugation in a microcentrifuge at 13,000 rpm for 10 min. The 
resulting solution was designated cell-associated virus.  
 
Identification of proteins that interact with RSV F protein cytoplasmic tail by yeast two-
hybrid (Y2H) screening. Bait cloning and Y2H screening were performed by 
Hybrigenics, S.A., Paris, France. A cDNA encoding the RSV strain A2 F cytoplasmic tail 
was synthesized and then PCR-amplified and cloned in a Y2H vector optimized by 
Hybrigenics. The bait construct was checked by sequencing the entire insert, and was 
subsequently transformed in the L40ΔGAL4 yeast strain (30). Fresh human lung tissue 
was obtained from the healthy margins of a lung resection, and then disrupted and total 
RNA extracted. A human normal lung random-primed cDNA library containing ten 
million independent fragments was generated then transformed into the Y187 yeast strain 
and used for mating. High mating efficiency was obtained by using a specific mating 
method (70-72). The screen was first performed on a small scale to adapt the selective 
pressure to the intrinsic property of the bait. Neither toxicity nor auto-activation of the 
bait was observed. Then, the full-scale screen was performed in conditions ensuring a 
minimum of 50 million interactions tested, in order to cover five times the primary 
complexity of the yeast-transformed cDNA library (76). 270 million interactions were 
tested for interaction with RSV F cytoplasmic tail. After selection on medium lacking 
leucine, tryptophan, and histidine, 45 positive clones were picked, and the corresponding 
	   83 
prey fragments were amplified by PCR and sequenced at their 5´ and 3´ junctions. 
Sequences then were filtered and constructed as contigs, as described previously (29), 
and compared to the latest release of the GenBank database using BLASTN (1). A 
Predicted Biological Score (PBS) was attributed to assess the reliability of each 
interaction, as described previously (29). Briefly, the PBS relies on two different levels of 
analysis. First, the local score took into account the redundancy and independency of 
prey fragments, as well as the distributions of reading frames and stop codons in 
overlapping fragments. Second, the global score took into account the interactions found 
in all the screens performed at Hybrigenics using the same library. In addition, potential 
false-positives were flagged by a specific “E” PBS score. This designation was assigned 
by discriminating prey proteins containing “highly connected” domains, previously found 
several times in screens performed on libraries derived from the same organism. The PBS 
scores correlate positively with the biological significance of interactions (76, 100). 
 
Generation of shRNA lentiviruses and cell populations with knockdown of gene 
expression. Five human GIPZ lentiviral shRNAmir constructs were obtained from the 
Vanderbilt Genomic Sciences Resource Core (filamin A (FLNA), alpha clone 
V2LHS_131780, positive GAPDH control, and negative non-silencing and empty vector 
controls). Lentiviruses were produced using the Open Biosystems Trans-Lentiviral GIPZ 
Packaging System (Thermo Scientific) in HEK 293T cells according to kit instructions. 
Briefly, cells were transfected with pGIPZ lentiviral vector and packaging mix. 
Supernatant was collected at 48 and n 72 hours post transfection, clarified at 3,000 rpm 
for 20 min at 4° C, and filtered using a 0.45 µm PES filter unit. Filtered supernatant was 
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concentrated using ultracentrifugation at 23,000 rpm for 2 hours. Pellet was resuspended 
in serum-free DMEM. Transduction efficiency was determined using flow cytometry and 
GFP expression levels in HEp-2 cells in the presence of 10 µg/mL polybrene (Millipore). 
Transduced HEp-2 cells were selected for expression using 5 µg /mL puromycin. 
Expression levels and viral titers were determined from the resulting heterogeneous 
population.  
 
Quantitative analysis of total cell lysate in knockdown populations. HEp-2 cells 
transduced with indicated lentivirus were grown under puromycin selection. Cell lysates 
were harvested using a single detergent lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% 
Triton X-100, pH 8.0) containing 1:200 dilution of mammalian protease inhibitor cocktail 
(Sigma). Lysates were separated on 4-12% NuPAGE Bis-Tris gels and transferred to 
nitrocellulose membranes (Invitrogen).  Membranes were blocked for one hour using 
Odyssey blocking buffer (Li-Cor) diluted 1:1 in PBS.  Primary antibodies for β-actin 
(Abcam, 1:5,000), FLNA (Abcam, 1:500), or GAPDH (Millipore, 1:500) were diluted in 
blocking buffer diluted 1:1 with PBS + 0.1% Tween-20. Secondary antibodies were 
diluted at 1:5,000 (goat anti-mouse IRDye 800CW and donkey anti-goat IRDye700, Li-
Cor) in blocking buffer. Bands were imaged using the Odyssey Infrared Imaging System.  
 
Fixation and immunostaining. Cells were fixed with 3.7% (wt/vol) paraformaldehyde in 
phosphate-buffered saline (PBS) for 10 min. Cells were permeabilized with 0.3% (wt/vol) 
Triton X-100 and 3.7% paraformaldehyde in PBS for 10 min at room temperature (RT). 
After fixation, cells were blocked in 3% (wt/vol) bovine serum albumin (BSA) in PBS for 
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60 min, followed by addition of primary antibody (Ab) in the blocking solution for 60 
min. Cells were then washed three times in PBS, and species-specific IgG Alexa Fluor 
(Invitrogen) was added at a dilution of 1:1,000 in block solution for 60 min to detect 
primary Abs. Cells were washed three times in PBS and fixed on glass slides using the 
Prolong Antifade kit (Invitrogen). All steps were performed at RT. Images were obtained 
on a Zeiss inverted LSM510 confocal microscope using a 63×/1.40 Plan-Apochromat oil 
lens. Anti-RSV M (clone B135), anti-RSV P protein (clone 3_5), and anti-RSV N protein 
(clone B130) monoclonal Abs were a kind gift of Earling Norrby and Ewa Bjorling. An 
anti-RSV F protein humanized mouse monoclonal ab (palivizumab; MedImmune) was 
obtained from the Vanderbilt Pharmacy. F-actin was visualized using rhodamine 
phalloidin, and To-Pro-3 iodide was used to visualize the nucleus (Invitrogen). 
 
Myristoylation inhibitor assays. HEp-2 cells were plated in 48 well plates and inosculated 
with wt RSV at an MOI=1.0 for 1 hour. Cells were then incubated in normal growth 
media or media containing either GW4869 (Calbiochem) or spiroepoxide (Axxora LLC) 
at 100 µM. At 72 h.p.i., supernatant and cell-associated virus was harvested.  
 
nSMase inhibitor assays. HBE-σ16 or Caco-BBE cells were plated in 48 well dishes 
(Costar). Once cell monolayers were confluent cells medium was exchanged for serum- 
free medium containing either DMSO, 10 µM GW4869 in DMSO (Calbiochem), or 10 
µM spiroepoxide in DMSO (Axxora). 16 hours post-treatment cells were infected with 
RSV at an MOI of 1.0 for 1 hour in normal growth medium. Infectious medium was 
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aspirated and replaced by medium containing either the same inhibitor or DMSO. 72 
h.p.i., supernatant- and cell-associated virus was collected and tittered.10 
 
Rab25 mouse studies. Mice were inoculated intranasally with 106 pfu RSV wt strain A2. 
On day 4 after inoculation, mice were sacrificed by CO2 inhalation. The lungs were 
harvested for virus quantification by plaque assay. Lung tissues were ground using a 
glass homogenizer in 3 mL of HBSS (Hanks Balanced Salt Solution) medium. 
Homogenates were clarified by centrifugation in a tabletop centrifuge at 2,000 rpm at 4 
°C for 10 min, and supernatants were used to determine viral titers (65).  
 
Results 
Filamin A localizes to viral filaments. Since I had previously shown that the F CT is 
essential for viral assembly, we sought to determine whether host factors function in viral 
filamentous assembly though interactions with the F CT. Hybrigenics performed a Y2H 
screen using a custom human lung tissue cDNA library and probed with a peptide 
corresponding to the wt F CT as bait. The results from this screen are summarized in 
Table 4-1. I sought to screen candidate F CT-interacting proteins by microscopy to 
determine if any localized to viral structures in infected cells. HEp-2 cell culture 
monolayers were either mock-infected or infected with wt RSV and incubated for 24 
hours in complete growth medium. Cells were fixed and immunostained for RSV F to 
mark viral filaments and the indicated host protein. Figure 4-1 shows the localization of 
these proteins in mock- or RSV-infected cells. Several proteins did not distribute to 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 These methods were developed by Thomas Utley and are described in his thesis entitled, “Investigations 
in the assembly and budding of respiratory syncytial virus.” 
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filaments. Glutamate-ammonia ligase (GLUL) was seen throughout the cell in punctate 
granules, but did not localize to viral filaments in RSV-infected cells (Fig. 4-1 A-D). 
Four and a half LIM domains 2 (FHL2) protein exhibited a diffuse pattern throughout the 
cytoplasm, but it also failed to co-localize with RSV F in viral filaments (Fig. 4-1 E-H). 
In contrast, although filamin A (FLNA) also localized diffusely throughout the 
cytoplasm, it specifically co-localized with RSV F in viral filaments (Fig. 4-1 I-L).  
 To confirm this co-localization, HEp-2 cell culture monolayers were mock-
infected or infected with wt RSV that also encodes a GFP protein (RSV/GFP) to mark 
infected cells (Fig. 4-1 M-P). Compared to neighboring uninfected cells, filamin A in 
infected cells appeared to localize brightly to virus-induced structures at the cell surface 
that were kinked and clustered in a manner consistent with viral filaments. GFP, which 
typically diffuses throughout the cytoplasm when expressed in cells, was excluded from 
these structures, indicating that protein sorting into viral filaments is specific, and 
cytoplasmic diffusion alone is not sufficient for filamin A incorporation into viral 
assembly structures.  
 
Knockdown of filamin A gene expression does not affect viral replication. Since 
filamin A exhibited the greatest degree of localization with viral filaments of any 
cytoskeleton-related proteins examined, I studied its role in assembly and budding. I 
inhibited expression of filamin A to determine if reduction of expression inhibited the 
efficiency of viral replication in infected cells. To reduce filamin A gene expression, I 
generated lentiviruses that express an shRNA hairpin directed against filamin A. HEp-2 
cell culture monolayers were transduced with the filamin A shRNA lentivirus (FLNA) 
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Gene Name Frame Y2H 
Fragments 
Description 
C1orf43 ?? antisense HepC NSSA Transactivated  
COL6A2 IF  Collagen α2 (type IV) chain 
DD5 IF  E3 ubiquitin protein ligase, HECT family 
DGAT1 ?? antisense Diacylglycerol O-acyltransferase  
homolog 1 
FAM114A2 ?? antisense,  
3ʹ′ UTR 
Family with sequence similarity 114, 
member A2 
FHL2 IF  Four and a half LIM domains 2:  
translational regulation 
FLNA var1 IF  Filamin A;  
associated with actin cytoskeleton 
GLUL IF  Glutamate-ammonia ligase 
GOLGA8A ?? antisense,  
3ʹ′  UTR 
Golgi autoantigen,  
golgi matrix protein 
HLA-DRB5 IF  Major histocompatibility complex, class 
II, DRβ5 
HPGD ?? antisense,  
3ʹ′  UTR 
Hydroxyprostaglandin dehydrogenase 15-
(NAD) 
HSPA5 IF  Heat shock 70 kDa protein 5 (glucose-
regulated protein, 78kDa) 
LPL ?? antisense,  
3ʹ′  UTR 
Lipoprotein lipase 
RBM12 IF 3ʹ′  UTR,  
IF stop codon 
RNA binding motif protein 12 
RPL23A ?? antisense Ribosomal protein L23a 
SERPINF1 IF IF stop codon Serpin peptidase inhibitor, clade F 
SGK269 ?? antisense,  
3ʹ′  UTR 
Sugen kinase 269 
SNRP70 IF  Small nuclear ribonucleoprotein 70 kDa 
polypeptide (RNP antigen) 
SP140 IF  SP140 nuclear body protein 
SRP9 IF antisense,  
3ʹ′  UTR 
Signal recognition particle 9 kDa 
TBC1D15 IF  TBC1 domain family, member 15;  
GTPase activating protein 
TGFβ3 IF  Transforming growth factor β3 
Table 4-1. Summary of candidate proteins from F CT Y2H screen of a custom lung 
cDNA library The Y2H screen was performed by Hybrigenics (Paris, France) using the 
wt F CT peptide fused to LexA at the N-terminus as bait to screen a custom human lung 
cDNA library. The candidate proteins are listed by their gene name along with a 
description of the gene and associations. The cDNA fragment also was analyzed for 
being in frame (IF), unknown frame (??), and whether the interaction was with an 
antisense strand (antisense) or in the 3´ UTR (3´ UTR).  
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Figure 4-1. Cellular localization of candidate proteins from an F CT Y2H screen. 
HEp-2 cells were inoculated with RSV strain A2 at than MOI=1.0 and incubated for 24 
hours. RSV F and the indicated cellular proteins were detected by indirect 
immunofluorescence. Column 1 (panels A, E, I, and M) shows mock infected cells, and 
columns 2-4 show RSV infected cells. Column 2 (panels B, F, J, and N) shows the 
indicated RSV protein; column 3 (panels C, G, K, and O) shows the indicated cellular 
proteins; and column 4 (panels D, H, L, and P) shows the overlay with the RSV protein in 
green and the cellular protein in red.   
RSV F
FL
N
A
Mock RSV gene Overlay
FL
N
A
RSV/GFP
Host Protein
RSV F
RSV F
FH
L
G
LU
L
A B C D
E F G H
I J K L
M N O P
Mock Infection RSV Infection
	   90 
or with control lentiviruses encoding no shRNA (empty), an shRNA that is non-silencing 
(N.S.), or an shRNA directed against the housekeeping gene GAPDH. Cells were 
selected for shRNA expression using puromycin, and the resulting puromycin-resistant 
cell lines were screened for protein knockdown and viral replication. Figure 4-2A shows 
that transduction of cells with the filamin A shRNA lentivirus caused a >99% knockdown 
of expression of the protein. As a parallel control, GAPDH expression was inhibited in 
cells transduced with GAPDH shRNA. Transduction with empty vector or non-silencing 
lentiviruses did not affect the expression of either GAPDH or filamin A.  
Since the knockdown of filamin A was efficient, I next infected these lentivirus-
transduced cells with wt RSV strain A2 at an MOI=0.05 to determine the effect of filamin 
A knockdown on viral replication at 72 hours post-infection (h.p.i). Figures 4-2B and 4-
2C show that neither supernatant nor cell-associated viral titer, respectively, were 
affected by the knockdown of filamin A. In addition to filamin A, I also tested whether 
other proteins from the yeast two hybrid F CT interaction screen were required for 
efficient viral replication by expressing shRNA against each protein delivered by 
lentiviruses, as described for filamin A. Expression of shRNA was confirmed by GFP 
expression from a second reading frame, but total viral yield at 72 h.p.i. was not affected 
(Table 4-2). Collectively, these data suggest that although filamin A protein localizes to 
viral filaments, it is not required for viral replication.  
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Figure 4-2. Viral titers in FLNA knockdown cells. HEp-2 cells were transduced with a 
lentivirus encoding an shRNA directed against the indicated protein. After selection, cell 
lysates were harvested and filamin A, GAPDH, and actin were detected by immunoblot 
(A). The same cells then were infected with RSV stain A2 at an MOI=0.05 for 72 hours. 
Both cell-associated (B) and supernatant virus (C) yields were quantified by a plaque 
assay.   
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Gene Name Antibody shRNA Results 
FHL2 + + No co-localization with RSV F;  
shRNA does affect on viral titers 
FLNA, var 1 + + Co-localization with RSV F in viral filaments; 
shRNA does affect on viral titers 
GLUL + + No co-localization with RSV F;  
shRNA does affect on viral titers 
SRP9 + + Antibody did not detect protein by IF;  
shRNA does not affect viral titers 
TBC1D15 + + Antibody did not detect protein by IF;  
shRNA does not affect viral titers 
 
Table 4-2. Summary of results: available antibodies and shRNAs for candidate 
proteins from F CT Y2H screen. The available reagents for the F CT Y2H candidate 
genes are summarized. For genes with available antibodies, HEp-2 cells were inoculated 
with RSV wt strain A2 at an MOI=1.0 for 24 hours. At 24 hours, cells were fixed, and 
RSV F and the indicated cellular protein were detected by indirect immunofluorescence. 
For genes with available shRNA lentivirus constructs, HEp-2 cells were transduced with 
each lentivirus construct. A heterogeneous population was selected using puromycin, and 
expression of the shRNA was confirmed by concomitant expression of GFP. Cells were 
then infected with RSV strain A2 at an MOI=0.05 for 72 hours and both supernatant and 
cell associated virus yields were determined by plaque assay. The results for localization 
to viral filaments marked by RSV F and affect of shRNA expression on viral yields is 
summarized. 
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PICALM localizes to viral inclusion bodies. In addition to an F CT Y2H screen, 
Hybrigenics also performed a Y2H screen with the M protein using the same custom lung 
cDNA library. The results of this screen are summarized in Table 4-3. I chose to test five 
proteins from this list based on protein function and the availability of antibodies. 
Syntaxin 18, (STX18) is a SNARE protein that localizes to the ER membrane and is a 
component of the SNARE complex, which often function in fusing membranes (90). 
Phosphatidylinositol binding clathrin assembly protein (PICALM) recruits clathrin and 
adaptor protein complex 2 (AP2) to cell membranes at sites of coated-pit formation and 
clathrin-vesicle assembly (16). Optineurin (OPTN) is a protein implicated in glaucoma 
that interacts with Rab8 and myosin VI at the Golgi apparatus (19). Guanine nucleotide-
binding proteins (GNAL) are G proteins and may be involved in signaling pathways (98). 
Finally, AP3µ1 is the cargo recognition subunit of the adapter protein 3 complex that is 
involved in endosomal and lysosomal sorting (74). Figure 4-3 shows HEp-2 cells that 
have been mock-inoculated or inoculated with wt RSV at an MOI=1.0 and incubated for 
24 hours. RSV M and the indicated cellular protein were detected by indirect 
immunofluorescence. The results show that AP3µ1 (Figure 4-3A and 4-3B) localized 
diffusely throughout the cell and did not localize exclusively with M. OPTN did co-
localize with the M protein, but also was present diffusely throughout the cell (Figure 4-
3C and 4-3D). PICALM colocalized with M, largely in discrete granules that resembled 
RSV inclusion bodies (Figure 4-3E and 4-3F). The only available antibodies for STX18 
and GNAL did not detect the respective proteins by immunofluorescence.  
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Gene Name Frame Y2H 
Fragments 
Description 
AP3µ1 IF 3ʹ′ UTR 
IF SC 
Cargo recognition subunit of AP3; 
Involved in endosomal sorting 
GMEB1 IF IF SC  
GNAL IF  G protein; signal transduction 
within olfactory neuroepithelium 
GTF2H1 IF   
HLA-DRB1 IF   
OPTN IF  Binds myosin VI at the golgi; 
Co-localizes with Rab8 
PICALM IF IF SC Clathrin assembly protein 
RBM41 IF IF SC  
SNRP70 IF   
STX18 IF  Component of a SNARE complex; 
Localizes to ER membrane 
ZNF91-like IF   
HSP22 IF IF SC  
Protein kinase H11 IF IF SC  
Surfactant pulmonary 
associated protein C 
OOF   
 
Table 4-3. Summary of candidate proteins from M Y2H screen of a custom lung 
cDNA library. The Y2H screen was performed by Hybrigenics (Paris, France) using an 
Mopt peptide fused to LexA at the N-terminus as bait to screen a custom human lung 
cDNA library. The candidate proteins are listed by their gene name along with a 
description of the gene and associations. The cDNA fragment also was analyzed for 
being in frame (IF), out of frame (OOF), and whether the interaction was in the 3´ UTR 
(3´ UTR) or contained an in frame stop codon (IF SC). 
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Figure 4-3. Cellular localization of candidate proteins from an M Y2H screen. HEp-
2 cells were inoculated with RSV strain A2 at than MOI=1.0 and incubated for 24 hours. 
RSV M and the indicated cellular proteins were detected by indirect 
immunofluorescence. RSV M is shown in green and the cellular gene in red. Column 1 
(panels A, C, and E) shows mock infected cells, and columns 2 (panels B, D, and F) 
shows RSV-infected cells.  
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 Since PICALM appeared to localize to viral inclusion bodies, I repeated the above 
experiment and stained for RSV N and P, which mark RSV inclusion bodies. Figure 4-4 
shows the PICALM does indeed colocalize with RSV N and P in inclusion bodies (Fig. 
4-4G and 4-4J, respectively). Next, I attempted to knockdown PICALM by transfecting 
cells with a pool of siRNAs directed against PICALM (Dharmacon) to determine if 
PICALM plays a role in viral replication. As controls, I also used siRNAs to GAPDH or 
a non-specific siRNA as described previously. Transfection with siRNAs resulted in a 
25-50% knockdown of PICALM, and the non-specific siRNAs did not affect PICALM 
expression (Fig. 4-4K and 4-4L). Since inclusion bodies are thought to function as viral 
transcription and replication sites, I tested whether PICALM knockdown, although 
incomplete, had an effect on viral transcripts at 18 h.p.i. using RT-PCR with probes 
directed against the F protein. There was, however, no affect on viral transcripts 
PICALM siRNA treated cells versus untreated or non-specific siRNA treated cells. These 
data show that although PICALM localized to viral inclusion bodies, the protein may not 
play a significant role in viral transcription. Further studies would be necessary to 
determine if PICALM is important for another part of the viral life cycle.  
 
OPTN knockdown does not affect viral replication. In addition to testing PICALM for 
affect on viral replication, I also tested the effect of OPTN knockdown on the ability of 
RSV to replicate in human bronchial epithelial (HBEσ16) cells. For another project, 
Thomas Utley and Josh Heck in the Crowe laboratory had created an OPTN knockdown 
cell line, along with control untreated and non-targeting (N.T.) cell lines, using a 
lentivirus to deliver an shRNA construct under G418 selection. Using these cell lines, 
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Figure 4-4. PICALM localized with N and P in viral inclusion bodies. Panels A-J. 
HEp-2 cells were inoculated with RSV at an MOI=1.0 for 24 hours. RSV M, N, P, and 
PICALM were detected using indirect immunostaining. Mock infected cells 
immunostained for PICALM are shown in column 1 (panel A). Columns 2-4 show RSV 
infected cells. Column 2 (panels B, E, and H) shows the indicated RSV protein staining. 
Column 3 (panels C, F, and I) shows PICALM staining. Column 3 (panels D, G, and J) 
show the overlay with the RSV protein in green and PICALM in red. Panel K and L: 
HEp-2 cells were left untreated or transfected with a pool of siRNA constructs directed 
against PICALM, GAPDH, or non-specific (NS) siRNA. Proteins were detected by 
immunoblot (K) and quantified (L) as a percentage of untreated protein level.  
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I inoculated HBEσ16 cells at an MOI=1.0 for 2, 3, and 6 days and quantified supernatant 
and cell-associated virus at each time point. Figure 4-5 shows that RSV replication was 
lower in OPTN shRNA-expressing cells, compared to untreated or N.T shRNA-
expressing cells in both the supernatant (Fig. 4-5A) and cell-associated fractions (Fig. 
4.6B). However, these data were not statistically significant. Therefore, although OPTN 
is a candidate for interaction with the M protein by Y2H, the results indicate that it does 
not play a significant role in viral replication. 
 
Inhibition of myristoylation does not affect viral replication. In addition to a Y2H 
screen with the M protein, I also performed a motif analysis of the M protein using 
PredictProtein software (data not shown). The results suggest that the M protein is  
myristoylated, which would explain its capacity to associate with membranes (44). To 
test this hypothesis, I treated HEp-2 cells with two small molecule myristoylation 
inhibitors, DL-2-hydroxymyristic acid (2OHM) and 13-oxamyristic acid (13OM), that 
affect replication of other viruses (22). HEp-2 cells were inoculated with RSV at an 
MOI=1.0, and incubated in normal growth media or media containing the indicated 
inhibitor. At 72 h.p.i., both supernatant and cell-associated virus were harvested 
seperately. Figure 4-6 shows that inhibition of cellular myristoylation did not affect viral 
replication. These data do not exclude the possibility that the M protein is myristoylated, 
especially since no positive control is used for these inhibitors. However, these data 
suggest that myristoylation may not be critical for viral replication.  
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Figure 4-5. Viral titers in OPTN knockdown cells. HBEσ16 cells that stably expressed 
the indicated shRNA were infected with RSV at an MOI=1.0 for 2, 3, or 6 days. Viral 
supernatants (A) and cell-associated (B) titers were determined using a plaque assay.   
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Figure 4-6. Myristoylation inhibitors do not affect RSV replication. HEp-2 cells were 
inoculated with wt RSV at an MOI=1.0. Cells were left in normal growth media 
(untreated) or incubated with inhibitor. Viral supernatants (A) and cell-associated (B) 
titers were determined using a plaque assay.   
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Inhibition of exosomes does not affect viral replication. Finally, in addition to Y2H 
screens and motif analysis, I also sought to replicate findings that RSV may use 
exosomes in order to bud from host cells. Previous work in the Crowe laboratory by 
Thomas Utley in the Crowe laboratory found that inhibition of neutral sphingomyelinase 
(nSMase) using two chemical inhibitors results in diminished supernatant but not cell-
associated viral titers. Since the RSV budding mechanism is ESCRT-independent (97), 
the mechanism by which RSV performs that final membrane scission step is unknown. 
The exosome mechanisms of membrane scission involve conversion and placement of 
lipids to create the membrane curvature required to form exocytic vesicles. Formation of 
ceramide, a cone-shaped lipid, by nSMase is sufficient to produce exocytic vesicles (46, 
93). Therefore, it is plausible that RSV recruits nSMase to enrich viral filaments in 
ceramide and thereby produce membrane scission. HBEσ16 cells were treated with 
medium containing DMSO only, GW4869, or spiroepoxide. After treatment, cells were 
inoculated with RSV at an MOI=1.0 for one hour and again incubated in medium 
containing either vehicle or inhibitor. Supernatant and cell-associated virus was 
quantified at 72 h.p.i.. Figure 4-7 shows a representative experiment in which there was 
little effect on RSV replication in the presence of inhibitor. Supernatant virus yield, 
which represents the budded fraction, was reduced by 0.5 log10 pfu/mL in the presence of 
GW4869 but unaffected by spiroexpoxide (Fig. 4-7A). Cell-associated virus yield was 
unaffected in the presence of either inhibitor (Fig. 4-7B). These data are contradictory to 
the results obtained previously. These experiments were repeated six times, with varying 
levels of RSV replication. However, the original results could not be replicated nor was 
an assay readily available to test whether the inhibitors were working properly.  
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 In addition to inhibitor studies, I also examined the localization of endogenous 
and GFP-tagged nSMase2 in HBEσ16 cells. Cells were inoculated with RSV at an 
MOI=1.0, incubated for 24 or 72 hours, and immunostained for F or nSMase2 (Fig. 4-8 
A-H). Cells expressing GFP-nSMase2 were transfected with a plasmid encoding GFP 
fused to nSMase2, a gift from Motohiro Tani that was previously validated (87), 24 hours 
prior to inoculation (Fig. 4-8 I-L). The results show that endogenous nSMase localizes to 
viral filament marked by F at both 24 and 72 h.p.i. (Fig. 4-8 A-H). However, a GFP-
nSMase2 fusion protein did not localize to viral filaments. It is possible that the GFP tag 
interferes with the localization of nSMase2 in viral filaments the antibody may be cross-
reactive with other cellular proteins. The data from these localization studies are similar 
to those obtained previously, but are not consistent with the inhibitor data. The source of 
this discrepancy is unknown, and further studies of the exosome pathway are required to 
conclusively determine whether it is involved in RSV budding. 
 
RSV replication is not affected by knockout of Rab25 in a mouse model. Finally, I 
attempted to determine if knockout of ARE proteins, such as Rab25, affects the ability of 
RSV to replicate in mice (17). Previous studies in the Crowe laboratory by Sean Brock 
and Thomas Utley indicated that the ARE is important for viral assembly and budding (9, 
97). Our collaborator at Vanderbilt, Jim Goldenring, kindly supplied us with Rab25 
knockout (KO) mice on a C57/BL6 background. With the help of Sunny Mok, Rab25 KO 
mice, along with age-matched controls, were infected with 106 PFU RSV intranasally 
under anesthesia. At 6 days post infection, mice were euthanized and the lungs were 
harvested and processed for viral titers. Figure 4-8 shows the viral titers in homogenized 
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Figure 4-7. Viral titers with nSMase inhibitors. HBEσ16 cells were pretreated with 
either vehicle or inhibitor for 16 hours and then inoculated with RSV at an MOI=1.0. 
After inoculation, cells were again treated with either vehicle or inhibitor for 72 hours. 
Viral supernatants (A) and cell-associated (B) titers were determined using a plaque 
assay.   
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Figure 4-8. nSMase localization in RSV-infected cells. HBEσ16 cells were inoculated 
with RSV and incubated for 24 or 72 hours. Cells expressing GFP-nSMase2 were 
transfected 24 hours prior to virus inoculation. RSV F was detected by indirect 
immunofluorescence and nSMase2 was detected with either indirect immunofluorescence 
(A-H) or by GFP fluorescence (I-L).   
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mouse lung tissue. RSV replication was reduced in Rab25 KO mice by approximately 0.5 
log10 pfu/mL. However, the differences were not significant. Although Rab25 and the 
ARE clearly affect viral replication, apparently Rab25 function could be compensated in 
vivo by other ARE proteins. Furthermore, RSV produces titers in mice of only 4x104 
pfu/mL, which is much lower than those obtained from human cell lines. Therefore, the 
limitations of the mouse model for RSV experiments may make it difficult to interpret the 
role of Rab25 in RSV replication. 
 
Discussion 
Mechanisms of RSV assembly and budding are of interest since it appears to use 
an unconventional pathway that is independent of host proteins of the multi-vesicular 
body apparatus (97). A number of viruses coopt the host cytoskeleton and related proteins 
to accomplish assembly and budding (88). I had determined previously that the RSV F 
CT coordinates filament formation, and here we show data suggesting that the F CT 
interacts with the host protein filamin A. We found this interaction interesting because it 
may function in anchoring emerging viral filaments to the cytoskeleton and therefore 
might allow some mechanical advantage needed to deform host cell membrane and 
elongate the viral filaments. Indeed, some of the images in chapter II in the setting of 
depolymerized actin suggested that the base of filaments might be transiently associated 
with actin. Comprehensive Y2H and proteomic studies done previously in the Crowe 
laboratory by Thomas Utley revealed that cytoskeletal elements are abundant in the 
apical region of polarized cells, but we found that the dominant apical cytoskeleton-
associated proteins did not localize to filaments (see Chapter II for details). Even filamin  
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Figure 4-9. RSV replication in Rab25 knockout mice. Rab25 knockout mice and age-
matched controls on a C57/BL6 background were inoculated with 106 pfu RSV 
intranasally. At six days post infection, mouse lungs were collected and homogenized. 
Viral titers were determined by plaque assay.   
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A, the sole host protein that we confirmed to be located reliably in filaments, was not 
required for viral replication, suggesting that an F CT-filamin A interaction is not 
necessary for viral assembly into filaments. 
While inhibition of filamin A expression did not affect viral replication, these data 
do not necessarily exclude a role for filamin A in viral replication. Filamin A is part of a 
larger family of filaments that connect the cortical actin network to the plasma 
membrane. Given the interaction of F CT and filamin A, the protein may still function in 
anchoring the F protein to the cortical actin network or to certain lipid microdomains, 
thereby localizing F to the appropriate location in the plasma membrane for assembly. It 
is possible that in the absence of filamin A, other members of the filamin family are able 
to substitute for filamin A.  
 Secondly, I performed a series of studies of the M protein. Viral M proteins are 
thought to provide a major component of the structure for viral particles. A recent study 
examining viral filaments by scanning electron microscopy showed that in the absence of 
the M protein, short filament-like structures with F and G were observed on the cell 
surface (64). These data suggest that while the viral glycoproteins are sufficient for the 
initial outward bud formation, elongation of filaments is driven by the M protein. The M 
proteins of other viruses oligomerize into higher order structures (32), and it is possible 
that oligomerization of the RSV M protein is responsible for elongation of the structure 
of viral filaments. To determine if host proteins are involved in this process, I screened a 
number of candidate proteins that were found to interact with the M protein by a Y2H 
screen. Although the function and localization of some of these candidates appeared 
promising, such as association of PICALM with viral inclusion bodies, none were found 
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to be required for viral replication. Furthermore, I also examined the mechanism by 
which the M protein associates with membranes. The data in this chapter suggest that this 
process is not dependent on myristoylation, and after these studies were performed, the 
crystal structure of the M protein was solved. The membrane-association properties of the 
M protein are likely attributed to large patches of basic residues on the surface of the M 
protein that span across both the N- and C-terminal domains that interact with 
phospholipids (66).  
 Finally, although many studies were performed to elucidate interactions of host 
proteins with F and M, the mechanism by which RSV performs the final scission event is 
still unknown. RSV budding appears to be independent of ESCRT and nSMase, 
suggesting that host proteins may not function in viral budding. The influenza M2 protein 
localizes to the neck of viral filaments and may mediate membrane scission through an 
amphipathic helix in the cytoplasmic tail (78). It is therefore possible for viruses to 
accomplish membrane scission with assistance from the host, and further study of viral 
proteins may elucidate the requirements for RSV budding.  
 
 
Chapter summary 
 In chapters II and III, I showed that viral proteins, and specifically a Phe residue 
in the F CT, may be the driving factors for viral assembly into filaments. However, many 
viruses interact with the host cell. In this chapter, I used the results of two Y2H screens to 
show that RSV assembly and budding is independent of many host proteins. These data 
are summarized in Table 4-4. These data show that although host proteins may be 
involved in viral processes, these proteins are not critical to viral replication. However,  
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Candidates  Colocalization Results Protein Knockdown Results 
   
Approach: F CT Y2H Screen 
GLUL VF - no colocalization No effect on viral replication 
shRNA expression confirmed by GFP 
FHL VF - no colocalization No effect on viral replication 
shRNA expression confirmed by GFP  
FLNA Colocalization with VF No effect on viral replication 
Knockdown confirmed by IB 
SRP9 Antibody did not work  No effect on viral replication 
shRNA expression confirmed by GFP 
TBC1D15 Antibody did not work  No effect on viral replication 
shRNA expression confirmed by GFP 
   
Approach: M Y2H screen  
AP3µ1 VF - no colocalization N/A 
OPTN Colocalization with M 
in cytoplasm 
shRNA expressing cell line – no effect 
on RSV titers 
PICALM Colocalization with IBs siRNA does not affect viral RNA levels 
Knockdown confirmed by IB  
STX18 Antibody did not work N/A 
GNAL Antibody did not work N/A 
   
Approach: exosome data validation 
nSMase2 Endogenous protein 
colocalization with VF 
GFP-nSMase2 does not 
colocalize with VF 
Inhibition by GW4869 and 
spiroexpoxide has minor affect on 
supernatant virus 
   
Approach: ARE protein validation 
Rab25 N/A Knockout in mice has no effect on viral 
replication in lungs 
 
Table 4-4: Summary of investigated RSV host interactions. Candidate genes and 
proteins were examined for localization with viral structures and proteins by indirect 
immunofluorescence, shRNA/siRNA protein knockdown approaches, knockdown cell 
lines, and knockout mouse models.  VF = viral filaments, IB = inclusion bodies.  
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there are many caveats to these experiments, including the fact that the function of these 
host proteins may be compensated by other cellular proteins. Certainly, RSV relies on 
host proteins for replication (15, 57, 58), and many more proteins have been shown to 
associate with viral structures (75). Therefore, further studies of RSV interactions with 
the host cell are required to define critical factors for viral replication. Collectively, these 
data indicate that RSV proteins interact with many host factors but may have evolved to 
accomplish efficient replication independent of these interactions. Alternatively, the data 
might indicate that these interactions are artificial results of the screening method. 
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Chapter V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Thesis summary 
 As described in chapter I, the viral and host determinants of RSV assembly and 
budding have not been well characterized. In this thesis, I demonstrate that assembly of 
viral filaments at the cell surface is driven by viral proteins and specifically depends on 
the F CT to incorporate internal virion proteins into filaments. I also show data about a 
number of host factors that participate in RSV assembly and budding.  
 I first attempted to characterize viral filamentous assembly at the cell surface. 
RSV filaments were shown to contain viral structural proteins and genomic RNA and 
were therefore considered to be sites of viral assembly prior to budding. The minimum 
viral protein requirements for filaments were determined to be F, M, N, and P, which 
resulted in formation of virus-like filaments at the cell surface and budded VLPs that 
could be detected in the cell supernatant. Formation of these filaments did not depend on 
host cell cytoskeletal rearrangements. In fact, both F-actin and tubulin were absent from 
viral filaments. However, disruption of the cytoskeleton did affect the efficiency of 
filament formation. Actin or actin-associated proteins may be involved in anchoring 
filaments below the plasma membrane. Overall, however, these data indicate that viral 
filaments are distinct from host cytoskeleton-based protrusions at the cell surface.  
In addition to the composition of viral filaments, my data show that the 
components of viral filaments suggest there is a mechanism for specific sorting of 
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cytosolic and membrane proteins into these viral assembly structures. A number of actin-
associated cytosolic proteins were excluded from viral filaments, as was cytosolic GFP 
expressed after transfection. RSV assembly is thought to occur at lipid rafts, but both raft 
and non-raft membrane proteins were excluded from viral filaments. These data suggest 
that viral filaments are the result of specific protein sorting at both the plasma membrane 
and the cell interior. Therefore, viral assembly into filaments may depend on direct 
interactions between viral proteins. 
Since viral proteins appeared to be the driving factors of filamentous assembly, I 
next sought to determine the viral determinants of the assembly process by focusing on 
the capacity of the F CT to coordinate internal virion protein assembly into viral 
filaments. A critical residue near the C terminus of the F CT was found to be required for 
the formation of virus-like filaments independent of infection. The terminal three 
residues, Phe-Ser-Asn, were both necessary and sufficient for filament formation. 
Furthermore, mutation of the Phe residue or deletion of the terminal three residues 
resulted in a reduced number of VLPs, and the VLPs that formed did not incorporate 
internal virion proteins into budded particles. These data provide a link between viral 
requirements of assembly into filaments and the generation of budded cell-free particles. 
Finally, M protein incorporation into VLPs most strongly correlated with filamentous 
assembly, suggesting that the F CT may interact with the M protein to facilitate RSV 
assembly and budding.  
 Finally, I examined host factors that may participate in RSV assembly and budding 
using a Y2H screen with the F CT and the M protein as bait for interaction with proteins 
expressed from a custom human lung cDNA library. The Y2H screen identified filamin 
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A, PICALM, and OPTN, as proteins that potentially interacted with RSV proteins. 
Filamin colocalized with F in viral filaments. Knockdown of filamin A indicated that it is 
dispensable for viral replication. Secondly, I found that PICALM localized to viral 
inclusion bodies, which are thought to be sites of viral transcription and replication. 
However, knockdown of PICALM did not disrupt RSV transcription. Third, OPTN 
colocalized with the M protein. However, knockdown of OPTN did not affect viral 
replication. In addition to Y2H screens, I also studied the role of the ARE in RSV 
replication using a mouse model. Knockout of Rab25 in mice resulted in a modest 
reduction of viral replication. The data from Y2H screens and other proteomics-based 
approaches indicate that a number of host proteins are associated with viral structures but 
not critical for viral replication. Collectively, these data indicate that RSV proteins 
interact with many host factors but may have evolved to accomplish efficient replication 
independent of these interactions.  
Finally, I examined viral budding. RSV budding is known to be ESCRT-
independent, but the mechanism by which the final membrane scission event occurs is 
unknown. Previous data in the Crowe laboratory had suggested that RSV may use an 
exosome pathway to exit the cell. In trying to validate those preliminary data, I found that 
although endogenous nSMase2 colocalized with F in viral filaments, chemical inhibition 
of the exosome pathway only modestly effected budding. These data suggest that RSV 
does not utilize this exosome pathway to exit from the cell and may depend on unknown 
host exocytic pathways. Additionally, it may be that viral proteins themselves are able to 
perform the final scission step, as has been shown for influenza virus (79). RSV budding 
is thought to depend on both glycoprotein pulling and internal protein pushing forces 
	   114 
acting in concert, perhaps driven by viral glycoprotein interactions with internal virion 
proteins. 
 The data presented in this thesis allow us to propose a model for RSV filament 
assembly and budding (Fig. 5-1). First, although viral proteins are able to coat host 
structures at the cell surface, filamentous assembly is distinct from actin-based cellular 
protrusions and incorporates viral proteins at specific lipid microdomains. However, actin 
or actin-associated proteins may play a role in anchoring filaments below the plasma 
membrane. Viral glycoproteins appear to be sufficient for the initial outward bud 
formation (64). The F CT, and specifically the Phe residue at the C terminus, may then be 
necessary for elongation of this bud by mediating the incorporation of internal virion 
proteins. This task may be accomplished by F CT interactions with the M protein. RSV 
M is then able to recruit the RNP complex, possibly through direct interactions with other 
viral or host proteins. As the filament elongates, viral proteins and RNA continue to be 
incorporated. Eventually, the viral filament undergoes a membrane scission event, which 
allows it to separate from the host cell and become a free virion. This scission event is 
independent of ESCRT and exosome budding, but further studies are needed to determine 
the specific mechanism.  
 
Future directions 
 Although this thesis presents data that help define both the viral and host 
determinants of RSV assembly and budding, there are many questions that remain 
unanswered. The F CT is critical for viral assembly into filaments, but the exact 
mechanism is unknown. Although the M protein is implicated as a potential interacting  
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Figure 5-1. Model of RSV assembly and budding. Viral and host structures are 
indicated below the plasma membrane. RSV F (blue), G (red), SH (green) are depicted on 
the surface of filaments as transmembrane proteins, while M (yellow) and the viral RNP 
complex (black) are shown on the interior of viral filaments. Viral assembly steps: (1) 
initial bud formation, (2) viral filament elongation, (3) viral filament pinches off from 
cell membrane in an ESCRT independent manner, and (4) the budded virion is free to 
infect another cell.  
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partner, a direct interaction has not been shown. In fact, it has been difficult to show 
direct protein interactions of viral glycoproteins with internal virion proteins. Previous 
work in the literature has been limited to VLP assays, colocalization studies by indirect 
immunofluorescence, and association with lipid microdomains. Likely, the limitation of 
showing a direct interaction by immunoprecipitation is due to a weak or transient 
interactions. The host membrane, a complex of viral proteins, or viral protein oligomers 
may also be required. F does not immunoprecipitate with M, N, or P, though the use of 
chemical crosslinkers could allow the stabilization of a transient interaction. Y2H screens 
also have not been successful at detecting viral protein-protein interactions.  
 Several approaches could be used to determine direct viral protein interactions, 
such as ELISAs or fluorescence resonance energy transfer (FRET) using F CT mutants 
that are both capable and incapable of mediating filamentous assembly. FRET, however, 
is limited by the fact that the fluorescent tags required for the assay would have to be 
placed at the C terminus of the F CT and therefore may disrupt the function of the protein 
in viral assembly. A second approach to determining direct viral protein interactions 
might include the use of peptides to mimic the F CT. These peptides could be used in 
direct immunoprecipitation studies, ELISAs, and potentially used in structure studies 
with the M or N proteins, for which the structures have already been solved. These 
studies could potentially indicate critical residues in the M or N protein that might 
interact with the F CT. A critical limiting factor in demonstrating direct protein 
interactions, however, is the potential weak or transient nature of these interactions. The 
nature of these interactions may require nuclear magnetic resonance (NMR)-based 
assays, which is more amenable to determining weak protein interactions by looking for 
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chemical shift perturbations to protein-protein interfaces. NMR may be able to detect 
small changes in protein conformation and could be combined with studies of F CT 
mutants that are functional or non-functional in viral assembly. Third, classic 
immunoprecipitation studies coupled with mass spectrometry could be used to determine 
weak interactions, due to the sensitivity of mass spectrometry. Fourth, additionally Y2H 
screens could be performed using both wt and mutant F CT constructs against an M or N 
library to determine if the Phe residue is critical for interactions with other viral proteins. 
These studies would elucidate the mechanism by which the F CT is able to mediate 
incorporation of internal virion proteins into filaments and VLPs.  
 Although viral assembly into filaments may be driven largely by direct viral 
protein-protein interactions, it is not possible to exclude host factors. Viral assembly and 
budding occurs at specific lipid microdomains, but most viral lipid studies have centered 
on detergent insolubility. To determine if lipids play a role in RSV assembly, it may be 
necessary to determine what types of lipids are incorporated into virions. Due to its 
pleomorphic nature, however, RSV is difficult to purify from cell-derived vesicles of 
similar size using centrifugation gradients. However, it may be possible to 
immunoprecipitate virions using antibodies to viral glycoproteins and then perform mass 
spectrometry to define the lipid species in the resulting purer virion population. Insight 
into the lipids that RSV selectively incorporates into virions may help determine the 
specific microdomains at which viral assembly occurs. Furthermore, as lipid 
microdomains continue to become better defined, the localization of viral proteins and 
viral assembly at specific locations in the plasma membrane may become better 
determined.   
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 Finally, the question of whether viral filaments become free virus has not been 
answered. Although I attempted some live imaging experiments of viral filaments with 
limited success, further studies are needed to determine definitively whether viral 
filaments become free virions. Live-cell imaging is often limited by photobleaching, but 
recent advances have produced fluorescent proteins can be imaged for longer periods of 
time. These photo-stable probes could be used to label vRNA or viral proteins to allow 
visualization of viral filaments for extended periods of time, thereby also allowing 
determination of budding kinetics. Live-cell imaging may also lead to information 
regarding the mechanism by which RSV performs the final membrane scission step.  
Currently, RSV is thought to be independent of host cell exocytic mechanisms. It 
is plausible that viral proteins are capable of mediating membrane scission by using 
amphipathic helices to perform membrane, though these helices have not been identified 
in RSV proteins. Studies involving giant unilaminar vesicles may be able to decipher 
whether viral proteins are sufficient for budding and further study of host cell exocytosis 
mechanisms may help determine if RSV relies on host machinery to bud from infected 
cells. Moreover, these studies may be able to answer how the F or M biophysically drives 
filament formation. Membrane curvature could be initiated by the presence of the F 
protein, in which a large ectodomain drives membrane curvature outward to create the 
larger leaflet while the smaller cytoplasmic domain can accommodate the smaller, inner 
leaflet. Elongation may be driven by oligomerization of the M protein with itself or as it 
interactions with the RNP complex. Furthermore, the effect of various lipid compositions 
could be tested in such a system. These studies may elucidate the biophysical mechanism 
by which F and other viral proteins drive bud initiation, elongation, and scission.   
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Appendix A 
 
A STABALIZED RESPIRATORY SYNCYTIAL VIRUS REVERSE GENETICS 
SYSTEM AMENABLE TO RECOMBINATION MEDIATED MUTAGENESIS 
 
Anne L. Hotard, Fyza Y. Shaikh, Sujin Lee, Michael N. Teng, James E. Crowe Jr., and 
Martin L. Moore 
 
The following work is presented as part the manuscript indicated above that is in 
preparation by Hotard et al. and is intended for submission to Cell Reports. Figures A1 
and A2 represent the data I contributed to this manuscript. 
 
ABSTRACT 
We describe the first example of combining bacterial artificial chromosome 
(BAC) mutagenesis via recombineering for reverse genetics for an RNA virus. A BAC-
based respiratory syncytial virus (RSV) rescue system was established in which RSV 
antigenomic cDNA was stabilized in a BAC vector. We efficiently generated RSV 
mutants by recombination-mediated BAC mutagenesis. Together with codon-optimized 
helper expression plasmids, BAC-RSV is a stable, versatile reverse genetics platform of a 
Pneumovirus. 
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RESULTS 
In order to determine if katushka can be used at a marker for infected cells 
expressing RSV F, we inoculated HEp-2 cells with rA2-line19F and rA2-kline19F at an 
MOI=3.0. At 24 h.p.i. cells were immunostained for cell surface RSV F and analyzed 
using flow cytometry (Fig. A1 A-C). For both rA2-line19F and rA2-kline19F infected 
cells, 97-98% of the cells were positive for RSV F surface expression (Fig A1 D). In rA2-
kline19F infected cells, 92% of the cells were positive for kaushka, with a more varied 
levels of expression than RSV F staining (Fig. A1 C). The expression of katushka did not 
affect the level of RSV F expressed on the cell surface.   
In order to test the whether expression of katushka affected the formation of viral 
filaments and cellular syncytia, we inoculated HEp-2 cells with rA2-line19F and rA2-
kline19F and immunostained cells using an anti-RSV F antibody and TO-PRO-3. At 24 
h.p.i., cells infected with both recombinant viruses show viral filaments at the cell surface 
as well as a pattern of peri-nuclear staining consistent with F expression in the secretory 
pathway (Fig. A2 A-C and D-F). Katushka is expressed diffusely throughout the cell as 
well as near the plasma membrane. At 48 h.p.i, cellular syncytia containing multiple 
nuclei are present (Fig. A2 G-H). These syncytia also express katushka and viral 
filaments marked with RSV F. 
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Figure A1. Cell surface expression of RSV F protein in cells inoculated with 
recombinant virus expressing Katushka is similar to that caused by recombinant 
virus lacking the marker. HEp-2 cell culture monolayers were inoculated with indicated 
virus at MOI=3 and incubated for 24 hours. RSV F protein was detected using indirect 
immunostaining. Panels A to C show scatter plots from representative samples with a 
percentage of total cells detected as indicated for each quadrant. Panel D shows the mean 
percentage of cells expressing the indicated markers +/- standard deviation, from 
triplicate samples in a representative experiment. 
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Figure A2. RSV filament formation induced by recombinant virus expressing 
Katushka protein is similar to that caused by recombinant virus lacking the marker. 
HEp-2 cell monolayer cultures were inoculated with indicated virus at MOI=1.0 and 
incubated for 24 hours. RSV F protein was detected using indirect immunostaining and 
cell nuclei were detected using TO-PRO-3 iodide stain. Panels A to C and D to F show 
infected cells 24 hours after inoculation. Panels A and D show RSV F only; panels B and 
E show Katushka only; panels C and F show an overlay with RSV F in green, Katushka 
in red, and nuclei in blue. Panels G to H show cells inoculated with the indicated virus 
after 48 hours. 	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Appendix B 
 
INTRACELLULAR NEUTRALIZATION OF A VIRUS USING A CELL-
PENETRATING MOLECULAR TRANSPORTER 
 
Gopal Sapparapu, Artez L. Sims, Fyza Y. Shaikh, Eva M. Harth, James E. Crowe, Jr. 
 
The following work is presented as part the manuscript indicated above that is in 
preparation by Sapparapu et al. and is intended for submission to Nature Biotechnology. 
Figures B1 represent the data I contributed to this manuscript. 
 
ABSTRACT 
We report here a new method for delivery of small recombinant antibody 
fragments into virus-infected cells using a dendrimer-based molecular transporter (MT). 
The construct penetrated virus-infected cells efficiently and inhibited virus replication. 
This approach provides a novel approach for the immediate delivery of inhibitory 
antibodies directed to virus proteins that are exposed only in the intracellular 
environment. This approach circumvents the need for the current and rather complicated 
expression of inhibitory antibodies in cells following gene transfer. 
 
RESULTS 
 We tested whether the MT-conjugated scFv was able to penetrate cells (Fig. B1). 
The unconjugated scFv, unconjugated MT, or MT-conjugated scFv was applied to 
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MA104 intestinal cell culture monolayers, then the location of the scFv molecules was 
investigated by laser scanning confocal microscopy using both conventional x-y images 
and reconstructions of stacks of x-y plane images to analyze distribution in the x-z and y-
z planes. The cytoplasm of cells was marked with a CellTracker dye, the plasma 
membranes were marked with a fluorescent wheat germ agglutinin (WGA), and the His10 
labeled scFv was detected using nickel conjugated to a fluorescent dye optimized for 647 
nm detection (Ni-NTA-647). Only the MT-conjugated scFv was detected inside cells; 
neither the dye alone nor unconjugated scFv were detected in cells. The fluorescence 
assay detection showed the antibody fragment to be within the confines of the treated 
cells in both x-y, x-z, and y-z planes. The antibody distributed throughout the cell to 
some degree, but was concentrated in discrete foci at the time points tested. 
 
	   127 
 
 
Figure B1. Intracellular localization of molecular transporter-conjugated rotavirus-
specific single chain variable fragment (ScFv). MA104 rhesus monkey kidney cells 
were loaded with CellTracker Green CMFDA, then treated with Ni+-647 dye alone, ScFv 
complexed with Ni+-647 dye, or MT-ScFv complexed with Ni+-647 dye. Cells were fixed 
and treated with wheat germ agglutinin (WGA) conjugated to Alexa Fluor 555 and 
imaged using laser scanning confocal microscopy. Column 1 (panels A, E, and I) shows 
the CellTracker; column 2 (panels B, F, and J) shows WGA; column 3 (panels C, G, and 
K) shows the Ni+-647 dye; and column 4 (panels D, H, and L) shows the overlay with the 
CellTracker in green, WGA in red, and the Ni+-647 in white. Panels M-O: Cells were 
treated as described for panels A-L with MT-ScFV complexed with Ni+-647 dye. YZ (M) 
and XZ (O) planes were reconstructed form the XY (N). White arrows indicate the 
location of a same Ni+-647 dye.  
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A Critical Phenylalanine Residue in the Respiratory Syncytial Virus
Fusion Protein Cytoplasmic Tail Mediates Assembly of Internal Viral
Proteins into Viral Filaments and Particles
Fyza Y. Shaikh,a Reagan G. Cox,a Aaron W. Liﬂand,b Anne L. Hotard,c John V. Williams,a,d Martin L. Moore,c Philip J. Santangelo,b and
James E. Crowe, Jr.a,d,e
Departments of Pathology, Microbiology and Immunologya and Pediatricsd and The Vanderbilt Vaccine Center,e Vanderbilt University Medical Center, Nashville,
Tennessee, USA; Department of Pediatrics, Emory University and Children’s Healthcare of Atlanta, Atlanta, Georgia, USAc; and Department of Biomedical Engineering,
Georgia Institute of Technology and Emory University, Atlanta, Georgia, USAb
ABSTRACT Respiratory syncytial virus (RSV) is a single-stranded RNA virus in the Paramyxoviridae family that assembles into
filamentous structures at the apical surface of polarized epithelial cells. These filaments contain viral genomic RNA and struc-
tural proteins, including the fusion (F) protein, matrix (M) protein, nucleoprotein (N), and phosphoprotein (P), while excluding
F-actin. It is known that the F protein cytoplasmic tail (FCT) is necessary for filament formation, but the mechanism by which
the FCTmediates assembly into filaments is not clear. We hypothesized that the FCT is necessary for interactions with other vi-
ral proteins in order to form filaments. In order to test this idea, we expressed the F protein with cytoplasmic tail (CT) trunca-
tions or specific point mutations and determined the abilities of these variant F proteins to form filaments independent of viral
infection when coexpressed withM, N, and P. Deletion of the terminal three FCT residues (amino acids Phe-Ser-Asn) or muta-
tion of the Phe residue resulted in a loss of filament formation but did not affect F-protein expression or trafficking to the cell
surface. Filament formation could be restored by addition of residues Phe-Ser-Asn to an FCT deletion mutant and was unaf-
fected by mutations to Ser or Asn residues. Second, deletion of residues Phe-Ser-Asn or mutation of the Phe residue resulted in a
loss of M, N, and P incorporation into virus-like particles. These data suggest that a C-terminal Phe residue in the FCTmediates
assembly through incorporation of internal virion proteins into virus filaments at the cell surface.
IMPORTANCE Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in infants and the elderly
worldwide. There is no licensed RSV vaccine and only limited therapeutics for use in infected patients. Many aspects of the RSV
life cycle have been studied, but the mechanisms that drive RSV assembly at the cell surface are not well understood. This study
provides evidence that a specific residue in the RSV fusion protein cytoplasmic tail coordinates assembly into viral filaments by
mediating the incorporation of internal virion proteins. Understanding the mechanisms that drive RSV assembly could lead to
targeted development of novel antiviral drugs. Moreover, since RSV exits infected cells in an ESCRT (endosomal sorting com-
plexes required for transport)-independent manner, these studies may contribute new knowledge about a general strategy by
which ESCRT-independent viruses mediate outward bud formation using viral protein-mediated mechanisms during assembly
and budding.
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Respiratory syncytial virus (RSV) is a leading cause of seriousviral lower respiratory tract illness in infants and the elderly
worldwide. The virus is a member of the Paramyxoviridae family,
and the genome consists of a single-stranded, negative-sense RNA
molecule that encodes 11 proteins. The virion contains three gly-
coproteins: the fusion (F) protein, attachment glycoprotein (G),
and small hydrophobic (SH) protein. The F protein is sufficient
for mediating viral entry into cells in vitro. The G protein plays a
role in viral attachment, and the SH protein is thought to inhibit
apoptosis (1). RSV also contains six internal structural proteins:
the matrix (M) protein, nucleoprotein (N), phosphoprotein (P),
large (L) polymerase protein, and two isoforms of matrix protein
2 (M2-1 and M2-1). The M protein provides structure for the
virus particle. RSVN, P, and L form the ribonucleoprotein (RNP)
complex, which encapsidates the RSV genome and functions as
the RNA-dependent RNA polymerase. M2-1 andM2-2 are acces-
sory proteins that control transcription and replication (2).
Viral proteins traffic to the apical surface of polarized epithelial
cells, where they assemble into virus filaments at the plasmamem-
brane (3). However, the mechanisms that drive assembly into fil-
aments and budding are not well understood. Generation of nas-
cent RSV genomic RNA appears to occur in discrete cytoplasmic
inclusion bodies that contain the RSV N, P, L, and M2-1 and -2
proteins but not the F, G, or SHprotein (4). It is suspected that the
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RNP complexes form in the inclusions and then traffic to the
apical membrane, where they meet with the surface glycoproteins
F, G, and SH arriving from the Golgi apparatus through the secre-
tory pathway (5). RSV proteins and viral RNA assemble into virus
filaments at the cell surface. These filaments are thought to con-
tribute to cell-cell spread of the virus andmorphologically resem-
ble the filamentous form of virions seen in electron microscopy
(EM) studies of virus produced in polarized cells (6). Live imaging
has shown these structures to be dynamic, with rotation and di-
rectional movement (7, 8). Filament formation can also be mod-
ulated by alterations in the function of host proteins, including
myosin Vb and Rab11a family interacting proteins 1 and 2. Bud-
ding occurs in a Vps-4-independent manner (6, 9), resulting in
pleomorphic particles ranging from150 to 250 nm in diameter for
spherical forms and up to 10 m long in filamentous forms (10).
Previously, we showed that the F protein traffics to the apical
surface in the absence of any other viral protein or viral RNA and
that the F-protein cytoplasmic tail (FCT) was completely dispens-
able for apical trafficking (5). It is unlikely, however, that a
paramyxovirus would retain such a domain if it did not play some
role in replication or pathogenesis, and indeed other investigators
showed that a virus lacking the FCT had a 100- to 1,000-fold
decrease in viral titers in a multicycle growth curve. This mutant
virus was unable to form filaments at the cell surface but was
capable of accomplishing cell-cell fusion (11, 12). Furthermore,
the cytoplasmic tail (CT) of many paramyxovirus glycoproteins
has been shown to be important for assembly and budding (11,
13).
Since the FCT is required for efficient replication but is not
required for fusion or trafficking, we hypothesized that the FCT
coordinates the assembly of viral proteins into filaments at the cell
surface. In this study, we demonstrate that a key phenylalanine
(Phe) residue in the FCT is critical for RSVassembly into filaments
at the cell surface. Moreover, when Phe was mutated, RSV F was
unable to recruit RSV M, N, and P efficiently into virus-like par-
ticles (VLPs). These studies indicate that the FCT, and specifically
a Phe residue at amino position 22 of the FCT, is responsible for
recruitment of internal viral proteins into filamentous structures
at the cell surface for efficient assembly and subsequent budding.
RESULTS
RSV infection induced virus filaments that containRSVF,M,N,
and P. We first tested whether the cell surface filaments induced
by RSV infection of epithelial cells contained all of the expected
RSV structural proteins. HEp-2 cell monolayer cultures were in-
oculatedwithRSVwild-type (wt) strainA2 and incubated in com-
plete growth medium for 24 h. The cell monolayers were then
fixed and immunostained for theRSVF,M,N, or Pprotein or host
cell filamentous actin (F-actin). In addition, we also stained cells
for the presence of RSV genomic RNA using a fluorescently con-
jugated probe designed to hybridize to RSV gene start sequences
(14). Figure 1 showsRSVfilaments protruding from the cellmem-
brane (A to P). Morphologically, these filaments often were clus-
tered and kinked, and they stained brightly with antibodies to the
RSVFprotein. The filamentous structures containedRSVF,M,N,
P, and viral RNA, indicating that both structural and genomic
components are present. Thus, these filaments likely are virions
assembling at the plasma membrane prior to budding.
Since RSV filaments might resemble host cell protrusions that
contain cytoskeletal proteins, we next sought to distinguish viral
filaments from cell projections simply decorated with the RSV F
protein. Previous work in the field has shown that F-actin is not
found in viral filaments (15). Therefore, we visualized F-actin us-
ing phalloidin to distinguish viral filaments from host structures
containing F-actin (e.g., microvilli, filapodia, lamellipodia, and
membrane ruffles). Figure 1Q to T show that viral filaments,
marked by the presence of the RSV F protein, did not contain
F-actin. Viral filaments also did not contain either tubulin or ezrin
(data not shown). Although the viral and host filamentous struc-
tures often occurred in the same regions of the plasmamembrane,
viral filaments were distinct from the cell projections that con-
tained cytoskeletal proteins. These data are consistent with previ-
ously published data that provide evidence for specific RSV pro-
tein sorting into viral filaments (6).
RSVvirus-like filaments can be generated independent of vi-
ral infection. We next sought to determine the minimal require-
ments for RSV filament formation by transfecting combinations
of plasmids encoding RSV proteins. Transfection of cDNAs en-
coding the RSV F, M, N, and P genes into HEp-2 cells induced
formation of virus-like filaments that resembled viral filamentous
structures formed during infection. Figure S1 in the supplemental
material shows a representative image of filaments formed when
these four RSV structural proteins were expressed in HEp-2 cells.
Consistent with RSVfilaments formed during infection, virus-like
filaments contained RSV proteins and were often kinked, clus-
tered, and stained brightly for the F protein (see Fig. S1A to D).
RSV Fwas found to be necessary for virus-like filament formation
(see Fig. S1E to H), and in fact, exclusion of any single gene of the
four during transfection eliminated filament formation (data not
shown). Thus, the filaments formed using the transfection-based
assay were similar to filaments formed during viral infection in
both morphology and composition. We used the transfection-
based filament formation assay as a tractable systemwith which to
study the role of the F protein CT domain in viral assembly at the
plasma membrane.
RSV FCT terminal residues Phe-Ser-Asn are required for fil-
ament formation. We and others have shown that the FCT do-
main is not required for F-protein trafficking to the cell surface (5,
12). We asked here whether the CT domain was dispensable for
viral assembly into filaments at the cell surface. We designed a
panel of altered cDNAs of the F protein gene in which the CT
domain was truncated or otherwise mutated (Fig. 2). We tested
the effect of the tail mutations on virus-like filament formation at
the cell surface using the transfection-based assay characterized in
Fig. S1 in the supplemental material. When expressed alone, the F
protein with wild-type cytoplasmic tail (FCT wt) did not form
virus-like filaments and localized to cellular projections that con-
tained F-actin (Fig. 3A toD).However, when coexpressedwithM,
N, and P, FCT wt was able to form virus-like filaments that were
distinct from cellular projections containing F-actin (Fig. 3E to
H). Therefore, we used the presence of F-actin as a marker to
distinguish virus-like filaments from cellular projections, since
only the latter contained F-actin. In contrast to FCT wt, deletion
of the terminal 3 amino acids from the FCT (residues Phe-Ser-
Asn, or FSN) resulted in a loss of virus-like filament formation and
altered localization of the F protein only to F-actin-containing
cellular protrusions (Fig. 3I to L). This pattern of altered F staining
at the cell surface was similar to the pattern of FCT wt when it was
expressed alone inHEp-2 cells (i.e., in the absence of the RSVN, P,
andMproteins). Deletion of the three terminal amino acids of the
Shaikh et al.
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CT domain resulted in the same phenotype of F distribution as
deletion of the entire tail domain (Fig. 3M toP). This FCTdeletion
construct was similar to the transmembrane-domain-plus-one-
anchor-residue (“TM1”) construct that we previously described
(5) and is designated FCT23. For each truncation construct, to-
tal cellular expression and total surface expression of the F protein
were measured at levels equivalent to those of FCT wt (Fig. 3M
and N, respectively). Therefore, reduced expression or trafficking
of the mutant protein to the cell surface did not play a role in the
failure of these CT truncation constructs to form virus-like fila-
ments. These data indicate that the terminal CT residues Phe-Ser-
Asn are necessary for assembly of RSV
proteins into virus-like filaments.
Phe-Ser-Asn residues are sufficient
for viral protein assembly intofilaments
at the cell surface. Based on the data pre-
sented in Fig. 3, we next sought to deter-
mine if the specific residues Phe-Ser-Asn
on the C terminus of FCT were necessary
for filament formation when coexpressed
with M, N, and P or alternatively if only
the 24-amino-acid length of the CT do-
main determined filament formation.
Wemutated all three terminal residues to
alanines (FCT3 AAA) in order to test
the hypothesis that a CT of a certain
length was necessary for viral assembly.
FCT3 AAA was impaired for virus-like
filament formation when coexpressed
with RSVM,N, and P (Fig. 4E toH) com-
pared to results for FCTwt (Fig. 4A toD).
In order to determine if residues Phe-Ser-
Asn were sufficient for virus-like filament
formation, we deleted the entire FCT ex-
cept for the terminal residues Phe-Ser-
Asn (designated FCT FSN). FCT FSN
formed virus-like filaments at the cell sur-
face (Fig. 4I to L) that were similar in
length to FCTwt filaments (Fig. 4M), but
the percentage of transfected cells with
filaments was reduced 10-fold (Fig. 4N).
These data suggest that other residues in
the CT or a minimum length of the CT
may be important for initiation of fila-
ment formation. The total cellular ex-
pression and total surface expression of
FCT3 AAA or FCT FSN were similar
to those of FCT wt, again indicating that
neither expression nor trafficking to the
cell surface was impaired (Fig. 4O and P,
respectively). These data suggest that res-
idues Phe-Ser-Asn are necessary and suf-
ficient for assembly of viral structural
proteins into virus-like filaments at the
cell surface.
The Phe residue in the RSV FCT is
necessary for filament formation. In or-
der to determine if a particular residue of
the FCT Phe-Ser-Asn motif was the de-
termining factor for viral assembly into
filaments, we designed FCT constructs that contained mutations
of each of the three terminal residues individually. We compared
the abilities of the mutant FCT constructs to form virus-like fila-
ments when coexpressed with M, N, and P to that of FCT wt
(Fig. 5A to D). When the Phe residue was mutated to an alanine
(F22A), virus-like filaments failed to form, and the F construct
colocalized with cellular structures containing F-actin (Fig. 5E to
H). However, if either the Ser or Asn residue was mutated to an
alanine, the mutant FCT constructs were able to assemble into
virus-like filaments, distinct from cellular structures containing
F-actin (Fig. 5I to L and 5M to P, respectively). Total cellular
FIG 1 RSV F, M, N, P, and viral RNA localize to viral filaments during infection. HEp-2 cells were
inoculated with RSV strain A2 at aMOI of 1.0 and incubated for 24 h. RSV F,M, N, and Pwere detected
by indirect immunofluorescence; viral RNA (vRNA) was detected using an RNA probe specific to the
RSV genomic gene start sequences; actin was detected using phalloidin. Column 1 (A, E, I, M, and Q)
shows the entire cell. Panels B to D, F to H, J to L, N to P, and R to T show an enlargement of the inset
shown in column 1. Column 2 (B, F, J, N, and R) shows RSVM,N, P, vRNA, or phalloidin staining only;
column3 (C,G,K,O, and S) showsRSVFonly; and column4 (D,H, L, P, andT) shows the overlay, with
RSV F in red and RSV M, N, P, vRNA, or actin in green.
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expression and total surface expression of each of the FCT con-
structs with single amino acid mutations were equivalent to FCT
wt levels, indicating that neither expression nor trafficking was
impaired (Fig. 5Q and R, respectively). We also designed and
tested FCT constructs with conservative mutations (F22Y, S23T,
and N24Q). The results were similar to the data described for the
alanine point mutations in Fig. 5 (data not shown). Collectively,
these data show that the Phe residue near the C-terminal end of
FCT plays a key role in filamentous viral assembly at the plasma
membrane.
The Phe residue is required for incorporation of RSV M, N,
and P into RSVVLPs.Next, we sought to determine why the FCT
Phe residue was necessary for virus assembly into filaments. We
first introduced the FCT3 mutation into a recombinant virus
using a plasmid-based virus rescue system, but this mutant virus
could not be rescued, likely due to the drastic effect on assembly.
We then developed aVLP assay to determinewhether the FCTPhe
FIG 2 Schematic of FCT constructs. (A) FCT mutant constructs were gen-
erated using site-directed mutagenesis from FCT wt in the pcDNA3.1 vector.
Functional regions are indicated by color: SS, signal sequence (orange); ect-
odomain (blue); TM, transmembrane domain (green); CT, cytoplasmic do-
main (purple). (B) Sequences of the TM andCT domain are indicated for each
construct. Point mutations are indicated in red. We designated residue K as
FCT residue 1. The schematic is not to scale.
FIG 3 FCT terminal residues Phe-Ser-Asn are required for filamentous assembly at the cell surface. HEp-2 cells were transfected with FCT wt only (A to D) or
with the indicated FCT construct and plasmids encoding RSVM, N, and P (E-P). Column 1 shows images of the whole cell (A, E, I, and M). Columns 2 to 4 (B
toD, F toH, J to L, andN to P) show an enlargement of the corresponding inset in column 1. Column 2 shows actin staining only (B, F, J, andN); column 3 shows
RSV F staining only (C, G, K, and O); and column 4 shows the overlay, with actin in red and RSV F in green (D, H, L, and P). (Q) Total cell lysate was collected
from HEp-2 cells transfected with the indicated FCT construct, and RSV F or actin was detected by immunoblotting. The RSV F band was normalized against
actin, and the expression (exp) ratio represents a normalization to results for FCT wt. (R) Total surface expression of RSV F was determined by flow cytometry
using HEp-2 cells transfected with the indicated FCT construct and RSV M, N, and P. Data are plotted as means, and error bars represent standard deviations.
Weighted MFI is mean fluorescence intensity (MFI) the frequency of positive cells. MPV F wt is used as a specificity control.
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residue determined the ability of the F protein to assemble internal
virion proteins into VLPs. 293-F cells were used for their high
growth rate, dense cell growth, and transfection efficiency, all of
which have been limiting factors in previous efforts to develop
VLP assays with conventional transformed epithelial cells lines,
such asHEp-2 cells (data not shown). Using this system, sufficient
VLPs were produced for relative protein quantification by immu-
noblotting using the Lycor Odyssey infrared imaging system. Sec-
ond, previous work in the field has shown that F, M, N, and P are
the minimal requirements for passage of a minigenome construct
FIG 4 FCT residues Phe-Ser-Asn are sufficient for filamentous assembly at the cell surface. HEp-2 cells were transfected with the indicated FCT construct and
RSV M, N, and P (A to L). Column 1 shows images of the whole cell (A, E, and I). Columns 2 to 4 (B to D, F to H, and J to L) show an enlargement of the
corresponding inset in column 1. Column 2 shows actin staining only (B, F, and J); column 3 shows RSV F staining only (C, G, and K); and column 4 shows the
overlay, withRSVF in green and actin in red (D,H, and L). (MandN)HEp-2 cells were transfected as described for panels A to L. Filament lengthwas determined
by measuring the lengths of individual filaments using Zeiss LSM software as described inMaterials andMethods (M). Percent transfected cells was determined
by counting RSV F-transfected cells with filaments and then dividing that number by the total number of RSV F-transfected cells (N). (O) Total cell lysate was
collected fromHEp-2 cells transfectedwith the indicated FCT construct, andRSVF and actinwere detected by immunoblotting. TheRSVFbandwas normalized
against actin, and the expression (exp) ratio represents a normalization to FCTwt. (P) Total surface expression of RSV Fwas determined by flow cytometry using
HEp-2 cells transfectedwith the indicated FCT construct andRSVM,N, andP.Data are plotted asmeans, and error bars represent standard deviations.Weighted
MFI is mean fluorescence intensity (MFI) the frequency of positive cells. MPV F wt is used as a specificity control.
RSV FCT and Virus Assembly into Filaments and Particles
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consisting of the RSV leader and trailer sequences flanking a re-
porter gene (16). Since we found that these proteins are also the
minimum requirements for filament formation independent of
viral infection, we choose to express VLPs using all four proteins
to recapitulate theminimum requirements for assembly and bud-
ding.
RSV VLPs were produced by transfecting cells with plasmids
encoding the indicated F construct and wt M, N, and P. TEM
analysis of VLPs showed characteristic F-protein spikes (black
arrows) on the surface of particles similar to those seen on RSV
virion particles produced and imaged in the same manner
(Fig. 6A and B). Second, the diameter of the VLPs was similar to
that of RSV and within the usual range of diameter of virions
grown in other cell types (10). In addition to structure, we also
compared the protein composition of VLPs with that of virus.
Figure 6C shows a representative immunoblot comparing the
level of each viral protein in the VLPs to that in virions. These
data were quantified from three independent experiments and
are presented as percentages of RSV virion protein levels
(Fig. 6D). Compared to virus, the VLPs contained equivalent
amounts of the F protein but less M, N, and P. Although the
ratios of the F protein to internal proteins differed between
VLPs and RSV, VLPs did still incorporate RSV internal pro-
teins, thus allowing us to study the relative abilities of various
FCT constructs to incorporate internal virion proteins into
budded vesicles. Several possibilities could explain the discrep-
ancy of ratios. The VLPs may incorporate a higher proportion
of F into each particle than M, N, and P, compared to those for
virions, or there may be vesicles containing the F protein alone
escaping into the supernatant. We favor the latter, since trans-
fection of cDNA encoding the F protein alone led to a baseline
transport of F into the supernatant (data not shown).
After initial validation of the VLP system, we sought to de-
termine how the FCT Phe residue affected VLP budding and
the incorporation of internal virion proteins. We performed
the VLP assay as described above and collected the cell pellets
for total protein expression. Figure 6E shows immunoblots
from a representative experiment. Data were normalized to the
FIG 5 The Phe residue at position 22 in the RSV FCT is necessary for filamentous assembly at the cell surface. HEp-2 cells were transfected with the indicated
FCT construct and RSVM, N, and P (A to P). Column 1 shows images of the whole cell (A, E, I, andM). Columns 2 to 4 (B to D, F to H, J to L, and N to P) show
an enlargement of the corresponding inset in column 1. Column 2 shows actin staining only (B, F, J, and N); column 3 shows RSV F staining only (C, G, K, and
O); and column 4 shows the overlay, with RSV F in green and actin in red (D, H, L, and P). (Q) Total cell lysate was collected fromHEp-2 cells transfected with
the indicated FCT construct, and RSV F or actin were detected by immunoblotting. The RSV F bandwas normalized against actin, and the expression (exp) ratio
represents a normalization to FCT wt. (R) Total surface expression of RSV F was determined by flow cytometry using HEp-2 cells transfected with the indicated
FCT construct andRSVM,N, andP.Data are plotted asmeans, and error bars represent standard deviations.WeightedMFI ismean fluorescence intensity (MFI)
 the frequency of positive cells. MPV F wt is used as a specificity control.
Shaikh et al.
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levels in the FCT wt sample, and the means and standard devi-
ations from three independent experiments are shown in
Fig. 6F. Compared to FCT wt, when residues Phe-Ser-Asn were
deleted (FCT3) or Phe was mutated to an alanine (F22A),
there was a significant loss of RSV M, N, and P protein incor-
poration into VLPs. In contrast, point mutations of residue Ser
or Asn (S23A or N24A, respectively) did not affect incorpora-
tion of RSV M, N, or P into VLPs. The FCT3 and F22A con-
structs also induced less transfer of the F protein into the su-
pernatant than the FCT wt, S23A, or N24A constructs,
consistent with less budding of VLPs. These data show that the
Phe residue in the FCT is necessary for RSV M, N, and P incor-
poration into VLPs. Collectively, the data in this report show
that the FCTmediates viral assembly through a C-terminal Phe
residue in order to incorporate RSV M, N, and P into virus
filaments at the cell surface prior to budding.
DISCUSSION
The RSV FCT domain is known to play a
critical role in viral replication, but the
mechanism by which the FCT functions
in assembly and budding has not been
well characterized. In this study, we de-
termined that a single critical Phe residue
in the FCT at amino acid position 22 me-
diates assembly of virus-like filaments,
incorporation of RSV internal proteins
into VLPs, and subsequent budding of
VLPs from cells. The finding that a single
amino acid residue in the FCT can con-
trol both assembly and budding is re-
markable. We studied the role of RSV
proteins in assembly of filaments inde-
pendent of viral infection by expressing
proteins from plasmids, and we found
that filament formation requires the F,M,
N, and P proteins. This assembly process
likely is driven by interactions of these vi-
ral proteins with each other or collec-
tively with host proteins. Using cDNA-
based expression of F proteins with
alterations in the FCT, we determined the
key residue in the FCT that is required for
assembly of virus-like filaments contain-
ing the four minimally required struc-
tural proteins, F, M, N, and P. Further-
more, we used a VLP budding assay
under the same protein expression condi-
tions to reveal that the FCT coordinates
assembly through its ability to incorpo-
rateM,N, and P into particles. These data
provide a direct link between FCT coor-
dination of viral assembly into filaments
and budding of viral particles. Alterna-
tively, the formation of filaments and vi-
rus particles may be two different out-
comes of essentially the same assembly
process, with the Phe residue serving in a
critical role for both processes.
The specific mechanisms that govern
FCT-mediated assembly, however, are
still not well defined. Our data show that expression, trafficking,
and surface expression of F are not affected by mutations in the
FCT. This finding is consistent with findings of previous studies
that indicated the TM domain of F is responsible for targeting the
protein to the apical surface (5), and localization to specific lipid
microdomains in the plasma membrane appears to depend on an
unidentified domain in the ectodomain (17). Therefore, it is likely
that the FCT Phe residue we identified is critical for a protein-
protein interaction. A simple explanationmay be that this residue
directly interacts with one of the internal virion proteins, such as
M, N, or P, or a complex of these proteins. On the other hand, the
F protein is a trimer, and the FCT is located in close proximity to
the plasma membrane. It may be that the hydrophobic Phe resi-
due confers a specific conformation to the cytoplasmic portion of
the trimer. Finally, the possibility of an interaction with a host
FIG 6 The Phe residue at position 22 in the RSV FCT is necessary for incorporation of internal virion
proteins into VLPs. 293-F cells were transfected with plasmids encoding RSV FCT wt, M, N, and P or
infected with RSV at an MOI of 0.05. Panels A and B show transmission electron micrographs of a
representative VLP and virion, respectively. Scale bars represent 100 nm. (C to D) Supernatants from
RSV-infected or FCT wt-transfected cells were clarified and pelleted through a 20% sucrose cushion.
Panel C shows a representative blot comparing protein levels in VLPs to RSV. Panel D shows a quanti-
fication of three independent experiments as shown in panel C. The indicated protein levels in VLPs
were normalized to that of the corresponding protein in RSV. For panels E and F, 293-F cells were
transfected with plasmids encoding the indicated FCT construct and RSVM, N, and P. Panel E shows a
representative experiment with indicated protein levels in cell lysates (left) or VLPs (right). Panel F
shows a quantification of data from three independent experiments as shown in panel E (cell lysates in
grey; VLPs in black). Data are plotted as means, and error bars represent standard deviations.
RSV FCT and Virus Assembly into Filaments and Particles
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protein or complex of proteins cannot be excluded. Future studies
will focus on elucidating the specific protein-protein interactions
mediated by the FCT and how these interactions lead to the incor-
poration of other viral proteins into filaments.
Coordination of RSV assembly by the FCTwould be consistent
with findings of many other studies citing paramyxovirus glyco-
protein cytoplasmic tails as crucial to both assembly and budding
(13). For RSV and human metapneumovirus (HMPV), members
of the Pneumovirus subfamily, the G protein is dispensable for
viral replication in vitro (18, 19). Although the FCT may be suffi-
cient, optimal incorporation of viral proteins and RNA might re-
quire both F and G since residues in the RSV G protein CT are
thought to be important for interactions with M (20). However,
for the Paramyxoviridae subfamily, the requirement of glycopro-
tein CTs varies with each virus. Formeasles virus and Sendai virus
assembly, the F protein CT is required. Newcastle disease virus F
and HN glycoproteins interact with different internal viral pro-
teins, M and N, respectively. In contrast, the F and HN CTs of
parainfluenza virus 5 serve somewhat redundant functions (13).
The lack of a common theme for the role of CT domains in
paramyxoviruses may simply indicate that many questions about
the specific mechanisms of viral assembly remain unanswered,
and further investigation into the RSV FCT may contribute to
general knowledge regarding glycoprotein CT-mediated assembly
for other paramyxoviruses.
In addition to viral protein incorporation, the structural for-
mation of RSV particles at the cell surface also requires viral inter-
actions with the host cell lipidmembrane. The viral particlemem-
brane first must be deformed outward as an extension of the cell
membrane. Then, the particlemust be elongated by incorporation
of additional membrane to create long filaments. Finally, a scis-
sion event must occur to release the viral particle from the cell
membrane. All of these processes are energy intensive and require
complex coordination of surface proteins and nucleocapsids con-
taining RNA and viral proteins (21). Many viruses usurp endo-
somal sorting complexes required for transport (ESCRT)machin-
ery to accomplish the task of outward bud formation and
membrane scission using late domains found in viral proteins
(13). Viral budding using late domains requires the AAA ATPase
Vps4. However, inhibition of Vps4 does not affect RSV budding
(6), and like other ESCRT-independent viruses, RSVmay use viral
protein-mediated pushing and pulling forces to initiate mem-
brane bending at lipidmicrodomains in order to exit the cell (21).
RSV has been shown to assemble into filaments at lipid microdo-
mains (22, 23). The RSV F protein has been shown to associate
with detergent-resistant membranes (DRMs), as have the RSVM,
N, P, M2-1, and L proteins during viral infection (17, 23–25).
Furthermore, the M protein associates with lipid microdomains
in the presence of the F protein (26). Our data suggest that the Phe
residue in the FCT is critical for F-protein interactions with inter-
nal virion proteins in order to provide both the pulling and push-
ing forces needed to bend the membrane in order to form fila-
ments, presumably at lipid microdomains. Our data also provide
some insight about how the FCT mediates initial membrane
bending and filament elongation. The ability of a shortened CT
with only residues Phe-Ser-Asn to form virus-like filaments was
reduced by 10-fold. However, once this was initiated, the short-
ened CT was able to induce filaments that elongated to lengths
comparable to those generated by FCTwt. These data suggest that
other residues or a minimum length of the CT may be important
for initiation of outward bud formation.
Manipulation of the plasma membrane also likely involves a
variety of host proteins that function at the cell surface. Many
cellular structures extending outward from the cell surface depend
on actin polymerization (e.g., microvilli, filapodia, lamellipodia,
andmembrane ruffles), and lipidmicrodomains have been linked
to the cortical actin network (27). In fact, disruption of actin-
associated signaling pathways has been shown to affect filament
formation, and -actin and actin-related proteins have been
found in the same sucrose gradient-purified fractions as RSV (15,
28–32). However, actin polymerization has been shown to be dis-
pensable for filament formation, and F-actin is excluded from
viral filaments (15). While actin and actin-related proteins likely
are involved in aspects of RSV assembly, our data support the
hypothesis that the process by which viral proteins extend the cell
membrane outward to form filaments is distinct from the process
used by actin-based cellular structures. Exclusion of cellular pro-
teins from viral filaments also argues for specific sorting of viral
and host proteins into filaments, a process that likely is highly
regulated and involves interactions among viral proteins, host
proteins, and lipid microdomains.
Despite these studies, the mechanism by which RSV assembles
and buds is still incompletely defined. Viral protein-protein and
protein-lipid interactions likely play a significant role, and further
investigation will yield insight into what motifs mediate these in-
teractions for both viral and cellular glycoproteins. Further study
of RSV assembly and budding will contribute to general under-
standing of howESCRTpathway-independent viruses can exit the
cell and how viral surface and internal proteins contribute to
egress. Finally, understanding the mechanisms that drive RSV as-
sembly and budding could lead to targeted development of novel
antiviral drugs for prophylactic or therapeutic use against RSV
infection.
MATERIALS AND METHODS
Cell culture and wt RSV virus preparations. HEp-2 cells (ATCC CCL-
23)weremaintained inOpti-MEM Imedium (Invitrogen) containing 2%
(vol/vol) fetal bovine serum (FBS), 1% (vol/vol) l-glutamine, 2.5 g/ml
amphotericin B, and 1% (vol/vol) penicillin-streptomycin. Suspension
293-F cells were maintained as recommended by themanufacturer (Free-
style 293 expression system; Invitrogen). Transfections were performed
using the Effectene transfection reagent (Qiagen) for HEp-2 cells and the
Polyfect transfection reagent (Qiagen) for 293-F cells. The RSV wt strain
A2 was expanded in HEp-2 cells.
RSV infections. For filament visualization, HEp-2 cell monolayers on
12-mmmicro-cover glasses (no. 2; VWR) were inoculated at a multiplic-
ity of infection (MOI) of 1.0 and incubated for 24 h. For flow cytometric
analysis, HEp-2 cells in tissue culture flasks were inoculated at an MOI of
3.0 and incubated for 24 h. For the virus-like particle (VLP) assay, 293-F
cells were infected at an MOI of 0.05 for 72 h.
Generation of RSV F proteinmutant constructs.All DNAs encoding
the RSV fusion (F) protein constructs in this study were made from a
sequence-optimized cDNAencoding theRSVwt strainA2 Fprotein in the
pcDNA3.1 plasmid vector (Invitrogen) (5). DNAs encoding RSV F pro-
teins with truncations or other alterations of the cytoplasmic tail at the C
terminus of the protein were cloned using PCR primers to amplify the
desired length of the tail and subcloned into pcDNA3.1. Targeted muta-
tions, insertions, or deletions were introduced using the Lightning site-
directed mutagenesis kit (Stratagene) and confirmed by sequencing.
Filament formation. Plasmids encoding the wt or a mutant RSV F
protein along with pcDNA3.1 plasmids containing inserts encoding the
Shaikh et al.
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RSV A2 strain matrix (M), nucleoprotein (N), and phosphoprotein (P)
gene (synthesized by GeneArt, Regensburg, Germany) were transfected
into HEp-2 cell culture monolayers using 0.2 g of each plasmid DNA,
and cells were incubated for 72 h. Cells were fixed, immunostained, and
imaged as described below. All images for virus-like filament formation
were collected in a single experiment using identical microscopy param-
eters.
Fixation and immunostaining. Cells were fixed with 3.7% (wt/vol)
paraformaldehyde in phosphate-buffered saline (PBS) for 10 min. Cells
were permeabilized with 0.3% (wt/vol) Triton X-100 and 3.7% parafor-
maldehyde in PBS for 10 min at room temperature (RT). After fixation,
cells were blocked in 3% (wt/vol) bovine serum albumin (BSA) in PBS for
60 min, followed by addition of primary antibody (Ab) in the blocking
solution for 60 min. Cells were then washed three times in PBS, and
species-specific IgG Alexa Fluor (Invitrogen) was added at a dilution of
1:1,000 in block solution for 60 min to detect primary Abs. Cells were
washed three times in PBS and fixed on glass slides using the Prolong
Antifade kit (Invitrogen). All steps were performed at RT. Images were
obtained on a Zeiss inverted LSM510 confocal microscope using a 63/
1.40 Plan-Apochromat oil lens. Anti-RSV M (clone B135), anti-RSV P
protein (clone 3_5), and anti-RSV N protein (clone B130) monoclonal
Abs were a kind gift of Earling Norrby and Ewa Bjorling. An anti-RSV F
protein humanized mouse monoclonal Ab (palivizumab; MedImmune)
was obtained from the Vanderbilt Pharmacy. F-actin was visualized using
rhodamine phalloidin, and To-Pro-3 iodide was used to visualize the nu-
cleus (Invitrogen).
Imaging with RSV-specific RNA probe and live cell delivery. Single-
copy sensitive RNA probes designed to target the RSV genomic gene start
regions were delivered into RSV wt- or mock-infected HEp-2 cells using
streptolysin O reversible permeabilization 24 h after inoculation, as pre-
viously described (14). After probe delivery, cells were immunostained for
RSV proteins as described above. Images were processed in Volocity im-
aging software (version 5.1; Improvision). Shadow and highlight input
sliders were adjusted to the beginning and end of the histogram curve to
optimize tonal levels for the entire image; middle tones were not adjusted.
Quantitative analysis of images. To determine filament length, im-
ages from 12 high-powered fields were obtained on a Zeiss inverted
LSM510 confocal microscope using a 40/1.30 Plan-Neofluar oil lens.
Images were analyzed using laser scanning microscopy (LSM) image ac-
quisition software (Rel 4.2; Zeiss). The length of virus-like filaments was
determined using the ruler tool in the LSM software to trace individual
filaments in the images. The four longest filamentsmeasured per cell were
used in calculation of overall filament length for each construct. For quan-
titation of the percentage of RSV F-transfected cells showing filaments,
images from 20 high-powered fields were collected on a Zeiss inverted
LSM510 confocal microscope using a 20/0.75 Plan-Apochromat lens.
The percentage of RSVF-transfected cells with filaments was calculated by
counting the total number of RSV F-transfected cells with filaments and
dividing that number by the total number of RSV F-transfected cells.
Quantitative analysis of total cell lysate.HEp-2 cells in 6-well plates
were transfected with 0.4 g of plasmid DNA encoding the indicated
F-protein cytoplasmic tail (CT) construct using the Qiagen Effectene
transfection reagent. Cells were harvested at 48 h after transfection using a
single detergent lysis buffer (50 mM Tris-HCl, 150 mMNaCl, 1% Triton
X-100, pH 8.0) containing a 1:200 dilution ofmammalian protease inhib-
itor cocktail (Sigma). Lysates were separated on 4 to 12% NuPAGE bis-
Tris gels and transferred to polyvinylidene difluoride (PVDF)membranes
using an iBlot dry blotting system (Invitrogen).Membranes were blocked
for 1 h usingOdyssey blocking buffer (Li-Cor) diluted 1:1 in PBS. Primary
Abs for -actin (1:5,000; Abcam) or the RSV F protein (motavizumab
expressed from recombinant cDNA; 0.85g/ml) were diluted in blocking
buffer diluted 1:1 with PBS 0.1% Tween 20 (PBS-T), applied to mem-
branes, and incubated overnight at 4°C. Membranes then were washed
four times in PBS  0.1% Tween for 5 min each. Secondary Abs were
diluted 1:2,500 (goat anti-human IRDye 680CW;Kirkegaard&Perry Labs
Inc.) or 1:5,000 (goat anti-mouse IRDye 800CW; Li-Cor) in blocking
buffer and added to eachmembrane for 60min.Membranes were washed
four times in PBS-T. Bands were imaged and quantitated using the Odys-
sey infrared imaging system. The quantitative signals from RSV F protein
bands were normalized against those of -actin in the same lane and used
to generate an expression (exp) ratio that represented a comparison of
expression of the mutant F protein to that of the wt F protein.
Flow cytometric assay for quantitative surface expression of RSV F.
HEp-2 cells on 6-well plates were transfected with 0.4 g of each plasmid
encoding the wt RSV M, N, and P proteins and either RSV F wt or a
mutant F construct using the Effectene transfection reagent (Qiagen).
After 48 h, cells were treated with 20 mM EDTA in PBS to form a single-
cell suspension. Cells were washed two times in wash buffer (2% FBS in
PBS) and then incubated with palivizumab at 1 g/ml for 30 min at RT.
Cell were again washed two times with wash buffer and immunostained
with an Alexa Fluor goat anti-mouse 488 secondary Ab at a final concen-
tration of 2 g/ml. Cells were washed two times in wash buffer and ana-
lyzed on a 5-laser customLSR II flow cytometer (BectonDickinson) in the
Vanderbilt Medical Center Flow Cytometry Shared Resource. Data anal-
ysis was performed using the FlowJo software program (version 7.6.1).
Weightedmean fluorescent intensity (MFI) was calculated bymultiplying
the raw mean fluorescent intensity by the frequency of positive cells. All
flow cytometry data from Fig. 3, 4, and 5 were collected using the same
negative and positive control samples in three independent experiments.
Statistical analysis was performed using a Student’s t test. P values less
than 0.05 were considered significant.
VLP assay. A recent protocol developed for the generation of human
metapneumovirus VLPs (R. G. Cox and J. V. Williams, unpublished re-
sults) was modified for the preparation of RSV VLPs. 293-F cells were
transfected with plasmids encoding either vector alone or RSV M, N, P,
and the indicated RSV F construct in equal amounts. Seventy-two hours
after transfection, cell supernatants and pellets were separated and col-
lected by using low-speed centrifugation. Cell pellets were resuspended in
cell lysis buffer as described above. Cell supernatant was pelleted through
a 20% sucrose cushion using a Sorvall Surespin 630 rotor at 26,000 rpm
for 90 min. The resulting pellet was resuspended in equal volumes of cell
lysis buffer with protease inhibitors (Sigma). Western blotting was per-
formed as described above. The quantitative signals from RSV F,M, N, or
P protein bands were corrected for background using vector alone and
then normalized to the signal fromwt FCT. Bars represent the means and
standard deviations for three independent experiments. Statistical analy-
sis was performed using Student’s t test. All values less than 0.05 were
considered significant.
Transmission electronmicroscopy.VLP transfections were prepared
as described for the VLP assay with FCT wt. For RSV-infected samples,
293-F cells were inoculated at an MOI of 0.05 for 72 h. Cell supernatants
were clarified and pelleted though 20% sucrose in sterile MHN buffer
(0.1 MMgSO4, 50 mMHEPES, 150 mMNaCl). Pellets were resuspended
in 20% sucrose in MHN, applied to formvar-carbon grids with 300 mesh
Cu (Ted Pella Inc.), and stained with 1% aqueous sodium phosphotung-
state acid (Electron Microscopy Sciences). Grids were imaged on a FEI
Morgagni electron microscope operated at an acceleration voltage of
100 kV. Images were collected using a 1,000 1,000 active pixel charge-
coupled-device (CCD) camera (AMT) at a magnification of 44,000.
Image contrast was enhanced in the Adobe Photoshop (CS5) software
program using the levels adjustment. Shadow and highlight input sliders
were adjusted to the beginning and end of the histogram curve to optimize
tonal levels for the entire image; middle tones were not adjusted.
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